
<html lang="en"     class="pb-page"  data-request-id="1b73c585-7f8f-4e16-911f-d2defe724967"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2016.59.issue-13;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.6b00297;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="New 6-Aminoquinoxaline Derivatives with Neuroprotective Effect on Dopaminergic Neurons in Cellular and Animal Parkinson Disease Models" /></meta><meta name="dc.Creator" content="Gael  Le Douaron" /></meta><meta name="dc.Creator" content="Laurent  Ferrié" /></meta><meta name="dc.Creator" content="Julia E.  Sepulveda-Diaz" /></meta><meta name="dc.Creator" content="Majid  Amar" /></meta><meta name="dc.Creator" content="Abha  Harfouche" /></meta><meta name="dc.Creator" content="Blandine  Séon-Méniel" /></meta><meta name="dc.Creator" content="Rita  Raisman-Vozari" /></meta><meta name="dc.Creator" content="Patrick P.  Michel" /></meta><meta name="dc.Creator" content="Bruno  Figadère" /></meta><meta name="dc.Description" content="Parkinson’s disease (PD) is a neurodegenerative disorder of aging characterized by motor symptoms that result from the loss of midbrain dopamine neurons and the disruption of dopamine-mediated neur..." /></meta><meta name="Description" content="Parkinson’s disease (PD) is a neurodegenerative disorder of aging characterized by motor symptoms that result from the loss of midbrain dopamine neurons and the disruption of dopamine-mediated neur..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 5, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b00297" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00297" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b00297" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00297" /></link>
        
    
    

<title>New 6-Aminoquinoxaline Derivatives with Neuroprotective Effect on Dopaminergic Neurons in Cellular and Animal Parkinson Disease Models | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b00297" /></meta><meta property="og:title" content="New 6-Aminoquinoxaline Derivatives with Neuroprotective Effect on Dopaminergic Neurons in Cellular and Animal Parkinson Disease Models" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0021.jpeg" /></meta><meta property="og:description" content="Parkinson’s disease (PD) is a neurodegenerative disorder of aging characterized by motor symptoms that result from the loss of midbrain dopamine neurons and the disruption of dopamine-mediated neurotransmission. There is currently no curative treatment for this disorder. To discover druggable neuroprotective compounds for dopamine neurons, we have designed and synthesized a second-generation of quinoxaline-derived molecules based on structure–activity relationship studies, which led previously to the discovery of our first neuroprotective brain penetrant hit compound MPAQ (5c). Neuroprotection assessment in PD cellular models of our newly synthesized quinoxaline-derived compounds has led to the selection of a better hit compound, PAQ (4c). Extensive in vitro characterization of 4c showed that its neuroprotective action is partially attributable to the activation of reticulum endoplasmic ryanodine receptor channels. Most interestingly, 4c was able to attenuate neurodegeneration in a mouse model of PD, making this compound an interesting drug candidate for the treatment of this disorder." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b00297"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b00297">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b00297&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b00297&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b00297&amp;href=/doi/10.1021/acs.jmedchem.6b00297" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 13</span><span class="cit-fg-pageRange">, 6169-6186</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/13" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b00044" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b00374" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">New 6-Aminoquinoxaline Derivatives with Neuroprotective Effect on Dopaminergic Neurons in Cellular and Animal Parkinson Disease Models</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gael++Le+Douaron">Gael Le Douaron</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Laurent++Ferri%C3%A9">Laurent Ferrié</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Julia+E.++Sepulveda-Diaz">Julia E. Sepulveda-Diaz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Majid++Amar">Majid Amar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Abha++Harfouche">Abha Harfouche</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Blandine++S%C3%A9on-M%C3%A9niel">Blandine Séon-Méniel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rita++Raisman-Vozari">Rita Raisman-Vozari</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Patrick+P.++Michel">Patrick P. Michel</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bruno++Figad%C3%A8re">Bruno Figadère</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">BioCIS, Université Paris-Sud, CNRS, Université Paris-Saclay, 92290 Châtenay-Malabry, France</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Institut du Cerveau et de la Moelle Epinière, Sorbonne Universités, Université Pierre et Marie Curie Paris 06, INSERM U1127, CNRS UMR7225, 75013 Paris, France</span></div><div class="corresp-info"><strong>*</strong>For P.P.M.: phone, (+33) 1 57 27 45 34; E-mail, <a href="/cdn-cgi/l/email-protection#5b2b3a2f29323830762b323e29293e75363238333e371b2e2b3638753d29"><span class="__cf_email__" data-cfemail="4939283d3b202a226439202c3b3b2c6724202a212c25093c39242a672f3b">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>For B.F.: phone, (+33) 1 46 83 55 92; fax, (+33) 01 46 83 53 99; E-mail, <a href="/cdn-cgi/l/email-protection#b3d1c1c6dddc9dd5dad4d2d7d6c1d6f3c69ec3c0c6d79dd5c1"><span class="__cf_email__" data-cfemail="c2a0b0b7acadeca4aba5a3a6a7b0a782b7efb2b1b7a6eca4b0">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00297&amp;href=/doi/10.1021%2Facs.jmedchem.6b00297" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 13</span><span class="cit-pageRange">, 6169–6186</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 24, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>25 February 2016</li><li><span class="item_label"><b>Published</b> online</span>5 July 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 July 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b00297" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00297</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6169%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DGael%2BLe%2BDouaron%252C%2BLaurent%2BFerri%25C3%25A9%252C%2BJulia%2BE.%2BSepulveda-Diaz%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D13%26contentID%3Dacs.jmedchem.6b00297%26title%3DNew%2B6-Aminoquinoxaline%2BDerivatives%2Bwith%2BNeuroprotective%2BEffect%2Bon%2BDopaminergic%2BNeurons%2Bin%2BCellular%2Band%2BAnimal%2BParkinson%2BDisease%2BModels%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6186%26publicationDate%3DJuly%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b00297"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1595</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">15</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b00297" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;New 6-Aminoquinoxaline Derivatives with Neuroprotective Effect on Dopaminergic Neurons in Cellular and Animal Parkinson Disease Models&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Gael&quot;,&quot;last_name&quot;:&quot;Le Douaron&quot;},{&quot;first_name&quot;:&quot;Laurent&quot;,&quot;last_name&quot;:&quot;Ferrié&quot;},{&quot;first_name&quot;:&quot;Julia&quot;,&quot;last_name&quot;:&quot;E. Sepulveda-Diaz&quot;},{&quot;first_name&quot;:&quot;Majid&quot;,&quot;last_name&quot;:&quot;Amar&quot;},{&quot;first_name&quot;:&quot;Abha&quot;,&quot;last_name&quot;:&quot;Harfouche&quot;},{&quot;first_name&quot;:&quot;Blandine&quot;,&quot;last_name&quot;:&quot;Séon-Méniel&quot;},{&quot;first_name&quot;:&quot;Rita&quot;,&quot;last_name&quot;:&quot;Raisman-Vozari&quot;},{&quot;first_name&quot;:&quot;Patrick&quot;,&quot;last_name&quot;:&quot;P. Michel&quot;},{&quot;first_name&quot;:&quot;Bruno&quot;,&quot;last_name&quot;:&quot;Figadère&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;05&quot;,&quot;issue&quot;:&quot;13&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;6169-6186&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b00297&quot;},&quot;abstract&quot;:&quot;Parkinson’s disease (PD) is a neurodegenerative disorder of aging characterized by motor symptoms that result from the loss of midbrain dopamine neurons and the disruption of dopamine-mediated neurotransmission. There is currently no curative treatment for this disorder. To discover druggable neuroprotective compounds for dopamine neurons, we have designed and synthesized a second-generation of quinoxaline-derived molecules based on structure–activity relationship studies, which led previously to the discovery of our first neuroprotective brain penetrant hit compound MPAQ (5c). Neuroprotection assessment in PD cellular models of our newly synthesized quinoxaline-derived compounds has led to the selection of a better hit compound, PAQ (4c). Extensive in vitro characterization of 4c showed that its neuroprotective action is partially attributable to the activation of reticulum endoplasmic ryanodine receptor channels. Most interestingly, 4c was able to attenuate neurodegeneration in a mouse model of PD, making t&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00297&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00297" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00297&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00297" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00297&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00297" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00297&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00297&amp;href=/doi/10.1021/acs.jmedchem.6b00297" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b00297" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b00297" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b00297%26sid%3Dliteratum%253Aachs%26pmid%3D27341519%26genre%3Darticle%26aulast%3DLe%2BDouaron%26date%3D2016%26atitle%3DNew%2B6-Aminoquinoxaline%2BDerivatives%2Bwith%2BNeuroprotective%2BEffect%2Bon%2BDopaminergic%2BNeurons%2Bin%2BCellular%2Band%2BAnimal%2BParkinson%2BDisease%2BModels%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D13%26spage%3D6169%26epage%3D6186%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292070" title="Neuroprotection">Neuroprotection</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=291594" title="Silica">Silica</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/13" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/jmcmar.2016.59.issue-13/20160714/jmcmar.2016.59.issue-13.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/medium/jm-2016-00297a_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00297&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Parkinson’s disease (PD) is a neurodegenerative disorder of aging characterized by motor symptoms that result from the loss of midbrain dopamine neurons and the disruption of dopamine-mediated neurotransmission. There is currently no curative treatment for this disorder. To discover druggable neuroprotective compounds for dopamine neurons, we have designed and synthesized a second-generation of quinoxaline-derived molecules based on structure–activity relationship studies, which led previously to the discovery of our first neuroprotective brain penetrant hit compound MPAQ (<b>5c</b>). Neuroprotection assessment in PD cellular models of our newly synthesized quinoxaline-derived compounds has led to the selection of a better hit compound, PAQ (<b>4c</b>). Extensive in vitro characterization of <b>4c</b> showed that its neuroprotective action is partially attributable to the activation of reticulum endoplasmic ryanodine receptor channels. Most interestingly, <b>4c</b> was able to attenuate neurodegeneration in a mouse model of PD, making this compound an interesting drug candidate for the treatment of this disorder.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20663" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20663" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Parkinson’s disease (PD) is a neurodegenerative disorder of aging, characterized by motor symptoms resulting from the loss of dopamine (DA) neurons in the substantia nigra (SN) and the depletion of the neurotransmitter DA in the striatum.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The molecular mechanisms at the origin of the disease are not yet completely understood, but several hypotheses are currently considered. In particular, mitochondrial dysfunction, oxidative and excitotoxic stresses, protein misfolding, calcium dyshomeostasis, and neuroinflammation processes have been reported to be involved in disease progression.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4">(1-4)</a> Most likely, these pathological processes interact with one another to lead to DA cell demise.</div><div class="NLM_p">The pharmacological treatment of PD can be divided into neuroprotective and symptomatic therapies. In practice, nearly all of the available treatments are symptomatic ones, as they act principally, if not uniquely, on the motor symptoms of the disease.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Neuroprotective agents, having the potential to slow down or reverse the natural course of the disease, are therefore greatly needed. Many agents developed for neuroprotection in PD have shown great promise in preclinical assays, but none of them resulted in a treatment for patients until now.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> This is probably partly due to the fact that a large number of these compounds have poor brain bioavailability. Another reason is our limited understanding of PD pathomechanisms.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Although the number of mechanisms targeted by PD drug candidates is steadily increasing, the search for an effective neuroprotective agent is continuing.</div><div class="NLM_p">In the search for neuroprotective molecules for PD treatment, our laboratory has synthesized small nonpeptide chemicals, based on structure–activity relationship (SAR) studies of molecules with neuroprotective/neuritogenic effects.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> We initially synthesized hydrids of melatonin and fatty acids, i.e., natural products previously described for their antioxidative, neuroprotective, or neurotrophic effects.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a> As a result, we obtained an in-house collection of <i>N</i>-acylated tryptamine derivatives that was screened in a PD cellular model of DA cell death. This work led to the identification of good antioxidative and neuroprotective/neuritogenic compounds, but, unfortunately, these products did not possess all the physicochemical properties expected for a good blood–brain barrier (BBB) permeation.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Therefore, <i>N</i>-alkyl-6-aminoquinoxaline derivatives were synthesized in order to obtain better BBB permeability. Interestingly, a compound with no aliphatic side chain exerted both neuroprotective and neuritogenic activities on DA neurons in midbrain cultures, through a mechanism of action, that was apparently indirect, as it involved astroglial cells.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> This product, <b>5c</b>, had almost all the physicochemical prerequisites for good BBB permeation.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> The ability of this product to cross the BBB was confirmed by two complementary analytical methods: matrix-assisted laser desorption/ionization/time-of-flight (MALDI-TOF) mass spectrometry imaging of brain tissue sections and high-performance liquid chromatography–tandem mass spectrometry (HPLC-MS/MS) quantification of brain tissue homogenates. Interestingly, this compound also exerted antioxidant effects.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><div class="NLM_p">To improve the neuroprotective activity of compound <b>5c</b>, we designed and synthesized derivatives and carried out their screening using the same PD cellular model as before.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> For that, several structural modifications were designed based on our previous studies, which reported that the phenyl ring in position 3 of the quinoxaline core structure is important for neuroprotection.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> In addition, the presence of a C16 aliphatic chain on an <i>N</i>-alkyl-6-aminoquinoxaline derivative was correlated with a neuritogenic activity.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> On this basis, we prepared several <b>5c</b> derivatives with either an aryl or a heteroaryl ring in position 3 of the quinoxaline. The role of the methyl substituent in position 2 was also studied. We also synthesized 6-amino-quinoxaline derivatives functionalized by a chlorine and/or bromine atom in position 5 and 7, as halogenation of quinolines can be associated with neuroprotection, as previously reported in the case of clioquinol.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a><i>N</i>-Alkyl derivatives of <b>5c</b> were also synthesized because a number of <i>N</i>-alkyl-6-aminoquinoxaline derivatives and propargylamine-derived compounds, such as rasagiline exhibit interesting pharmacological features; rasagiline is a monoamine oxidase inhibitor used as symptomatic treatment for PD and this compound is also believed to delay disease progression.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a></div><div class="NLM_p last">After characterization of the neuroprotective activity of our derivatives on DA cells, we also studied the activity of our new hit compounds on glial cells because neuroprotection can be indirect in this model system as in the case of <b>5c</b>.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> The protective effect of compound <b>4c</b>, one of our hit compounds that was closely related structurally to <b>5c</b>, had no effect on glial cells but seemed to operate directly on DA neurons. Its effect was due in part to the activation of ryanodine receptor (RyR) calcium release channels. Such a mechanism of action has been previously described for paraxanthine, the main neuroprotective metabolite of caffeine, which demonstrated in vivo neuroprotection.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> Interestingly, <b>4c</b> also exerted substantial neuroprotection against DA cell death triggered by trophic support withdrawal or by induction of low-level oxidative stress, suggesting that this compound may be effective against different PD-related mechanisms. Most interestingly, these neuroprotective properties were still observed in vivo as <b>4c</b> exerted a robust neuroprotective action toward nigrostriatal DA neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of PD.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14083" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14083" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemistry</h3><div class="NLM_p">Disubstituted 6-aminoquinoxalines were obtained by various methods. Hinsberg condensation between a dianiline (e.g., 4-nitrophenylene-1,2-diamine) and a 1,2-dicarbonyl compound in refluxing water gave the corresponding quinoxaline in good yield. Ketoaldehyde (e.g., pyruvaldehyde, phenylglyoxal) gave preferentially the 2-substituted-6-aminoquinoxaline (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> After reduction of the nitro group to the corresponding aniline (H<sub>2</sub>, Pd/C in EtOH), the major regioisomer was obtained as a pure product after column chromatography.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/medium/jm-2016-00297a_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0016.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 6-Aminoquinoxaline and 2-Substituted-6-aminoquinoxalines by Hinsberg Condensation<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00297&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) H<sub>2</sub>O, reflux; (b) H<sub>2</sub>, Pd/C in EtOH, 60 °C, then purification by flash chromatography.</p></p></figure><div class="NLM_p">Starting from 2-substituted-6-aminoquinoxalines, which are prepared by Hinsberg condensation, various 2,3-disubstituted quinoxalines were obtained by addition of an organolithium reagent at −78 °C and subsequent oxidation by manganese dioxide<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Yields are low to moderate, depending on the nature of the organolithium reagent; aryllithium gave the expected compounds in low yields. Indeed, the reactivity of the organolithium reagent in this reaction is correlated with its basicity, which explains these contrasting results.</div><figure id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/medium/jm-2016-00297a_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0017.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 2,3-Disubstituted Quinoxalines<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00297&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) R<sub>1</sub>Li (2.5 equiv), THF, −78 °C or <i>t</i>BuLi (8 equiv), R<sub>1</sub>Br (4 equiv), −78 °C, Et<sub>2</sub>O/THF if R<sub>1</sub> is aryl; (b) MnO<sub>2</sub> (5 equiv), CHCl<sub>3</sub>, reflux.</p></p></figure><div class="NLM_p">Because of the weak reactivity of aryl lithium reagents, 3-aryl-6-aminoquinoxalines were produced by an alternative approach. Regioselective nitration at position 7 of quinoxalin-2-ol was performed by treatment with nitric acid in acetic acid. Then 7-nitroquinoxalinol <b>1l</b> was treated with POCl<sub>3</sub> to yield 2-chloro-7-nitroquinoxaline <b>1m</b>.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> SnCl<sub>2</sub> mediated reduction of nitro function gave 2-chloro-7-aminoquinoxaline <b>4m</b>. Finally, palladium-catalyzed cross-coupling reaction of the latter with diverse arylboronic acids led to the expected 3-aryl-6-aminoquinoxalines in excellent yields. Alternatively, an acetylene function was introduced in position 3 through a Sonogashira cross coupling reaction, albeit in a low yield. These steps are presented in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>.</div><figure id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/medium/jm-2016-00297a_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0018.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of 3-Aryl-6-aminoquinoxalines from Quinoxalin-2-ol<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00297&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HNO<sub>3</sub> (2 equiv), acetic acid, rt; (b) POCl<sub>3</sub>, reflux; (c) SnCl<sub>2</sub>, EtOAc, reflux; (d) ArB(OH)<sub>2</sub> or ArB(MIDA) (1.3 equiv), (PPh<sub>3</sub>)<sub>2</sub>PdCl<sub>2</sub> (0.03 equiv), K<sub>2</sub>CO<sub>3</sub> (2.6 equiv), dioxane/water, reflux; (e) TMS–acetylene or 4-methoxy-phenylacetylene, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, CuI, Et<sub>3</sub>N, THF, reflux. When R = TMS subsequent basic treatment (K<sub>2</sub>CO<sub>3</sub>, MeOH, reflux 10 min) furnishes compound <b>4s</b>. MIDA = <i>N</i>-methyliminodiacetic acid.</p></p></figure><div class="NLM_p">Starting from the above synthesized 6-aminoquinoxalines, several other derivatives were obtained. For instance, regioselective bromination in position 5 of compound <b>5c</b> was prepared in almost quantitative yield by reaction of <b>5c</b> with one equivalent of bromine in AcOH or with a slight excess of NBS in CH<sub>2</sub>Cl<sub>2</sub> at room temperature (rt) to give <b>7c</b>. Chlorination of <b>5c</b> was very effective as well by using NCS in CH<sub>2</sub>Cl<sub>2</sub>, at rt, to give regioselectively, compound <b>8c</b>. Position 7 of <b>8c</b> could be halogenated (e.g., bromine in excess) with more difficulties to give for instance compound <b>9c</b> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>).</div><figure id="sch4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/medium/jm-2016-00297a_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0019.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Regioselective Halogenation of 6-Aminoquinoxaline <b>5c</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00297&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Br<sub>2</sub> (1 equiv), AcOH, rt, 1 h or NCS/NBS (1.2 equiv), DCM, rt., 2 h; (b) excess Br<sub>2</sub>, AcOH, rt, 2 h.</p></p></figure><div class="NLM_p"><i>N</i>-Propargyl-6-aminoquinoxaline derivatives have been also prepared. Thus, <i>N</i>-propargyl-6-aminoquinoxaline derivatives <b>10c</b>, <b>10e</b>, <b>11c</b>, <b>11d</b>, <b>11e</b>, <b>11f</b>, <b>11g</b>, <b>11h</b>, <b>11n</b>, and <b>11r</b>, were respectively obtained by reaction of compounds <b>4c</b>, <b>4e</b>, <b>5c</b>, <b>5d</b>, <b>5e</b>, <b>5f</b>, <b>5g</b>, <b>5h</b>, <b>5j</b>, and <b>5r</b>, with propargyl-bromide and K<sub>2</sub>CO<sub>3</sub> in hot DMF. In a similar manner, propargyl derivative <b>12c</b> was prepared from <b>5c</b> and 3-chloro-3-methyl-1-butyne in the presence of a catalytic amount of CuCl and trimethylamine.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a><i>N</i>-Propargylation of 5-bromo-2-methyl-3-phenyl-6-aminoquinoxaline derivative <b>7c</b> was also performed, affording compound <b>13c</b>. These steps are presented in <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>.</div><figure id="sch5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/medium/jm-2016-00297a_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0020.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of <i>N</i>-Propargyl-6-aminoquinoxaline Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00297&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) propargyl bromide (1.5 equiv), KI (1 equiv), K<sub>2</sub>CO<sub>3</sub> (1 equiv), DMF, 70 °C; (b) 1,1-dimethyl-propargyl chloride (1.4 equiv), CuCl (cat.), Et<sub>3</sub>N (1,4 equiv), THF/water, rt.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Neuroprotective Potential of Newly Synthesized Compounds Using a Culture System That Models DA Cell Loss in PD</h3><div class="NLM_p">All synthesized compounds (<b>4c</b>, <b>4e</b>, <b>4h</b>, <b>4m</b>, <b>4n</b>, <b>4o</b>, <b>4p</b>, <b>4q</b>, <b>4r</b>, <b>4s</b>, <b>4t</b>, <b>5a</b>–<b>k</b>, <b>6a</b>, <b>6d</b>, <b>7c</b>, <b>8c</b>, <b>9c</b>, <b>10c</b>, <b>10e</b>, <b>11c</b>–<b>h</b>, <b>11n</b>, <b>11r</b>, <b>13c</b>, <b>12c</b>) were evaluated for their neuroprotective potential using a PD culture model in which DA neurons die spontaneously and selectively as a consequence of a mechanism involving immature astrocytes and calcium dyshomeostasis.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22, 23)</a> Cultures were maintained for 10 days in the presence or absence of the different test compounds, and neuroprotection was then evaluated by counting surviving TH immunopositive (TH<sup>+</sup>) neurons.</div><div class="NLM_p">Consistent with previous results, we observed that more than 60% of TH<sup>+</sup> neurons were generally lost after 10 days of culture in the absence of any treatment.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22, 23)</a><i>N</i>-(6),2′-<i>O</i>-dibutyryladenosine 3′:5′ cyclic monophosphate (DbcAMP), a lipophilic analogue of cAMP that is commonly used as a reference molecule in this model system<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> exhibited robust protective effects for DA neurons in the present study (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). Among a series of 25 6-aminoquinoxaline derivatives (<b>4c</b>, <b>4e</b>, <b>4h</b>, <b>4m</b>, <b>4n</b>, <b>4o</b>, <b>4p</b>, <b>4q</b>, <b>4r</b>, <b>4s</b>, <b>4t</b>, <b>5b</b>–<b>k</b>, <b>6a</b>, <b>6d</b>, <b>7c</b>, <b>8c</b>, <b>9c</b>), 14 of them showed a significant neuroprotective effect at 50 μM (<b>4m</b>, <b>4c</b>, <b>4p</b>, <b>4r</b>, <b>4e</b>, <b>4h</b>, <b>4n</b>, <b>4o</b>, <b>4q</b>, <b>5e</b>, <b>5j</b>, <b>6a</b>, <b>7c</b>, <b>8c</b>). This effect was either lower or higher than that provided by <b>5c</b>, used at 100 μM. On the basis of these results, we noticed that all synthesized compounds with a 2-hydrogen-3-aryl-6-aminoquinoxaline core structure (<b>4c</b>, <b>4e</b>, <b>4h</b>, <b>4n</b>,<b>4o</b>, <b>4p</b>, <b>4q</b>, <b>4r</b>) were significantly neuroprotective, thus suggesting that the lack of a substituent at position 2 of the quinoxaline ring was always associated with neuroprotection. When comparing <b>6a</b> to its regioisomer <b>4c</b>, we found that these two compounds had strong and similar neuroprotective activities (compound <b>4c</b> at 50 μM, 226.0 ± 9.4%, vs compound <b>6a</b> at 50 μM, 187.3 ± 6.1%). This suggests that a lack of substitution in position 2 is not a necessary requirement for neuroprotection. Instead, to be optimally effective, 6-aminoquinoxalines need to be monosubstituted in position 2 or 3 by an aryl group.</div><figure id="fig1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/medium/jm-2016-00297a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0004.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Screening of 6-aminoquinoxaline derivatives in a cellular system that models selective DA cell death in midbrain cultures. Number of TH<sup>+</sup> neurons surviving after 10 days in vitro (DIV) in midbrain cultures treated or not with 6-aminoquinoxalines (50 μM, except <b>5c</b> 100 μM). Note that <b>5c</b> is inactive at 50 μM.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> DbcAMP (1 mM) is used as reference protective molecule for DA neurons. Inactive 6-aminoquinoxaline derivatives (<b>4s</b>, <b>4t</b>, <b>5b</b>, <b>5d</b>, <b>5f</b>, <b>5g</b>, <b>5h</b>, <b>5i</b>, <b>5k</b>, <b>6d</b>, <b>9c</b>) are not included in the figure. A 185% increase in survival at 50 μM is our cutoff for the selection of the most active compounds (above red line). *, <i>p</i> < 0.05 vs controls.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00297&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Halogenation of the quinoxaline ring (<b>7c</b>, <b>8c</b>) or substitution of the phenyl ring in position 3 (<b>4e</b>, <b>5e</b>, <b>5j</b>) with a halogen group (chlorine or bromine) led generally to active compounds. Replacement of the phenyl ring by a chlorine atom led also to an active compound (<b>4m</b>), while replacement of the phenyl ring by an alkyl or alkyne group led to inactive (<b>5b</b>) or even toxic compounds (<b>4s</b>, <b>4t</b>, data not shown). The effects of 6-aminoquinoxaline derivatives, which are protective for DA neurons at 50 μM, are described in <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>. The effects of the other test compounds (<b>4s</b>, <b>4t</b>, <b>5b</b>, <b>5d</b>, <b>5f</b>, <b>5g</b>, <b>5h</b>, <b>5i</b>, <b>5k</b>, <b>6d</b>, <b>9c</b>) with no protective activity are not shown. Chemical structures of all test compounds (active and inactive) are depicted in <a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>.</div><figure id="cht1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/medium/jm-2016-00297a_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Chemical Structures of All 6-Aminoquinoxaline Derivatives Tested in the Cellular PD Model of Spontaneous DA Cell Death<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00297&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Chart a</span>Compounds having significant protective effects towards DA neurons at 50 μM are colored in purple. Protective compounds selected for further investigations (see <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a> for selection criteria) are colored in green.</p></p></figure><div class="NLM_p">To find 6-aminoquinoxaline derivatives more potent and efficient than <b>5c</b>, we selected six compounds of the present series (<b>4c</b>, <b>4p</b>, <b>4r</b>, <b>4e</b>, <b>6a</b>, <b>7c</b>) on the basis of their efficacy to protect DA neurons at 50 μM. More specifically, we selected compounds improving the survival rate of DA neurons at 10 DIV by more than 185% in comparison to corresponding control cultures, a protection similar or superior to that provided by <b>5c</b>, at 100 μM. The selected compounds were then tested at 10 μM using the same cellular assay (see <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>).</div><figure id="fig2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/medium/jm-2016-00297a_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0005.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Evaluation of previously selected 6-aminoquinoxaline derivatives for their efficacy at a concentration of 10 μM. Selected 6-aminoquinoxaline derivatives were applied to midbrain cultures at 10 μM, and the survival rate of DA neurons was assessed at 10 DIV. Derivatives not providing protection at 10 μM (<b>4p</b>, <b>4r</b>, <b>7c</b>) are not shown in this figure. DbcAMP (1 mM) was used as reference protective molecule for DA neurons. * <i>p</i> < 0.05 vs controls.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00297&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Only compounds <b>4c</b>, <b>4e</b>, and <b>6a</b> remained neuroprotective at 10 μM. These compounds possessed similar efficacy at 10 μM (compound <b>4c</b> vs <b>4e</b> vs <b>6a</b>: 151.5 ± 6.2% vs 144.2 ± 7.0% vs 134.4 ± 4.9%), with, however, a slightly better protective effect for <b>4c</b>. Interestingly, compound <b>4c</b>, which has a core structure very close to that of <b>5c</b> (<b>4c</b>, 3-phenyl-6-aminoquinoxaline, vs <b>5c</b>, 2-methyl-3-phenyl-6-aminoquinoxaline), was significantly more effective than <b>5c</b> at 100 μM (<b>5c</b> 100 μM, 199.2 ± 11.8%, vs <b>4c</b> 50 μM, 226.0 ± 9.4%). This confirms the idea that a lack of substituent in position 2 of the quinoxaline ring is beneficial for neuroprotection.</div><div class="NLM_p">Among another series of 12 <i>N</i>-propargyl-6-aminoquinoxaline derivatives (<b>10c</b>, <b>10e</b>, <b>11c</b>, <b>11d</b>, <b>11e</b>, <b>11f</b>, <b>11g</b>, <b>11h</b>, <b>11n</b>, <b>11r</b>, <b>13c</b>, <b>12c</b>), five compounds showed a significant neuroprotective effect at 50 μM (<b>10c</b>, <b>10e</b>, <b>11c</b>, <b>11e</b>, <b>13c</b>). The protective effect was either lower or higher than that provided by <b>5c</b>, at 100 μM. The activity of <i>N</i>-propargyl-6-aminoquinoxaline derivatives at 50 μM, and their chemical structures are described in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>. The effects of the other test compounds (<b>11f</b>, <b>11g</b>, <b>11h</b>, <b>11n</b>, <b>12c</b>) with no protective activity are not shown. Chemical structures of all test compounds (active and inactive) are presented in <a class="ref internalNav" href="#cht2" aria-label="Chart 2">Chart 2</a>.</div><figure id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/medium/jm-2016-00297a_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0006.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Screening of <i>N</i>-propargyl-6-aminoquinoxaline derivatives in a cellular system that models selective DA cell death in midbrain cultures. Number of TH<sup>+</sup> neurons surviving after 10 DIV in cultures treated or not with <i>N</i>-propargyl-6-aminoquinoxaline derivatives (50 μM). DbcAMP (1 mM) is used as reference protective molecule for DA neurons. Inactive <i>N</i>-propargyl-6-aminoquinoxaline derivatives (<b>11d</b>, <b>11f</b>, <b>11g</b>, <b>11h</b>, <b>11n</b>, <b>11r</b>, <b>12c</b>) are not included in this figure. A 185% increase in survival at 50 μM is our cutoff for active compounds (above red line). *, <i>p</i> < 0.05 vs controls.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00297&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="cht2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/medium/jm-2016-00297a_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. Chemical Structures of All <i>N</i>-Propargyl-6-aminoquinoxaline Derivatives Synthesized and Tested in the Cellular PD Model of Spontaneous DA Cell Death<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00297&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Chart a</span>Compounds having significant protective effects towards DA neurons at 50 μM are colored in purple. Protective compounds selected for further investigations (see <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a> for selection criteria) are colored in green.</p></p></figure><div class="NLM_p">Consistent with previous results obtained with 2,3-disubstituted-6-aminoquinoxalines, we noticed that, among five <i>N</i>-propargyl-6-aminoquinoxaline derivatives (<b>10c</b>, <b>10e</b>, <b>11c</b>, <b>11e</b>, <b>13c</b>) that are neuroprotective for DA neurons, two are not substituted in position 2 (<b>10c</b>, <b>10e</b>), which confirms our hypothesis that lack of substitution at position 2 of the quinoxaline ring is beneficial for neuroprotection.</div><div class="NLM_p">To find <i>N</i>-propargyl-6-aminoquinoxaline derivatives more potent and efficient than <b>5c</b>, we selected two compounds of this series (<b>10c</b>, <b>10e</b>) on the basis of their efficacy to protect DA neurons at 50 μM. More specifically, we selected compounds improving the survival rate of DA neurons at 10 DIV by more than 185% in comparison to corresponding control cultures, a protection similar or superior to that provided by <b>5c</b>, at 100 μM. The selected compounds were then tested at 10 μM using the same cellular assay (see <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>).</div><figure id="fig4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/medium/jm-2016-00297a_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0007.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Evaluation of previously selected <i>N</i>-propargyl-6-aminoquinoxaline derivatives for their efficacy at 10 μM. Selected <i>N</i>-propargyl-6-aminoquinoxaline derivatives were applied to midbrain cultures at 10 μM and the survival rate of DA neurons was assessed at 10 DIV. DbcAMP (1 mM) is used as reference protective molecule for DA neurons. *, <i>p</i> < 0.05 vs controls.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00297&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Compounds <b>10c</b> and <b>10e</b> conserved a significant neuroprotective activity at 10 μM. Compound <b>10c</b> had a better efficacy than <b>10e</b> and a similar efficacy to dbcAMP, at 1 mM (dbcAMP 1 mM, 225.3 ± 13.1%, vs <b>10c</b> 10 μM, 211.6 ± 7.6%). Interestingly, compound <b>10c</b>, which has a core structure very close to <b>5c</b>, like <b>4c</b>, was significantly more potent and efficient than <b>5c</b> (<b>5c</b> 100 μM, 199.2 ± 11.8%, vs <b>10c</b> 10 μM, 211.6 ± 7.6%).</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Effect of Quinoxaline Derivatives on Glial Cell Proliferation</h3><div class="NLM_p">In the cellular model used herein, we reported previously that neuroprotection could result from a repressive effect on dividing glial cells, in particular, on astrocytes and their precursor cells, which represent the bulk of proliferating cells.<a onclick="showRef(event, 'ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref27">(25-27)</a> In particular, we have shown that the reference compound dbcAMP and <b>5c</b> were protective by decreasing glial cell proliferation.<a onclick="showRef(event, 'ref12 ref28'); return false;" href="javascript:void(0);" class="ref ref12 ref28">(12, 28)</a> Therefore, we wished to have first a rough estimate of the impact that 6-aminoquinoxaline derivatives may have on glial cells. For that, we determined semiquantitatively whether test compounds had an effect on the density and morphology of glial cells that were labeled with the glial marker protein, vimentin, using fluorescence microscopic examination of the cultures. We tested at two concentrations (10 and 50 μM) the three 6-aminoquinoxaline and the two <i>N</i>-propargyl-6-aminoquinoxaline derivatives that were selected on the basis of their neuroprotective effect for DA neurons at 10 μM. Data are presented in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Impact of 6-Aminoquinoxaline and <i>N</i>-Propargyl-6-aminoquinoxaline Derivatives on the Density and the Morphology of Labeled Glial Cells with Glial Cell Marker Vimentin<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">semiquantitative effect of test treatments on the density and morphology of vimentin<sup>+</sup> glial cells</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">10 μM</th><th class="colsep0 rowsep0" align="center">50 μM</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dbcAMP<a class="ref internalNav" href="#t1fn1" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">+++</td><td class="colsep0 rowsep0" align="center">+++</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5c</b></td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center">++<a class="ref internalNav" href="#t1fn2" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4c</b></td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center">±</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4e</b></td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center">+</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6a</b></td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center">±</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10c</b></td><td class="colsep0 rowsep0" align="center">+</td><td class="colsep0 rowsep0" align="center">++</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10e</b></td><td class="colsep0 rowsep0" align="center">±</td><td class="colsep0 rowsep0" align="center">++</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">(±) no effect or only weak effects, (+) weak effects, and (++) marked effects on vimentin<sup>+</sup> cells.</p></div><div class="footnote" id="t1fn1"><sup>b</sup><p class="last">DbcAMP (1 mM) is used as reference molecule.</p></div><div class="footnote" id="t1fn2"><sup>c</sup><p class="last">Tested at 100 μM.</p></div></div></div><div class="NLM_p">Almost all the neuroprotective compounds had at least a weak effect on glial cells. Similar to <b>5c</b> at 100 μM, <i>N</i>-propargyl derivatives exerted the strongest effects on the astrocytic glial cell population. Thus, we may assume that neuroprotective effects of compounds <b>10c</b> and <b>10e</b> resulted from a glial-dependent mechanism, as observed with the first generation compound, <b>5c</b>. By contrast, compounds <b>6a</b> and <b>4c</b>, which possess a strong neuroprotective effect at 50 and 10 μM, did not seem to exert an effect on glial cells. This result is surprising for compound <b>4c</b> because this product is structurally very close to the previous hit compound <b>5c</b>.</div><div class="NLM_p">Overall, <b>4c</b> presents a number of interesting features: (i) it is very effective for neuroprotection, (ii) it is apparently inactive toward glial cells, which suggests that it may operate via a direct effect on DA neurons, and (iii) it is the closest structural homologue of <b>5c</b>, which is a druggable candidate in particular due to its capability to penetrate the brain parenchyma.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> To further demonstrate that <b>4c</b> had no significant effects on glial cells, we used [methyl-<sup>3</sup>H]-thymidine as a marker of proliferation of glial cells. The amount of incorporated [methyl-<sup>3</sup>H]-thymidine was measured as previously described.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> As shown in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>, <b>4c</b> did not significantly affect the incorporation of tritium-labeled thymidine in midbrain cultures (93.8 ± 1.7% vs control 100.0 ± 1.5%), which is consistent with our previous semiquantitative analysis. This result suggests that compound <b>4c</b> may be protective through a direct effect on DA neurons. This is a key advantage, as it may reduce the risk of side effects possibly associated with systemic drug administration in an animal model of PD and ultimately in PD patients.</div><figure id="fig5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/medium/jm-2016-00297a_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0008.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. <b>4c</b> does not reduce glial cell proliferation in midbrain cultures. Quantification of [<sup>3</sup>H]-thymidine incorporation in 8 DIV cultures treated or not with <b>4c</b> (10–50 μM). DbcAMP at 1 mM was used as a positive control. NS: no significant effect.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00297&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Characterization of the Effects of <b>4c</b> toward DA Neurons: Morphological and Functional Effects</h3><div class="NLM_p">We wished to further characterize the effect of <b>4c</b> toward DA neurons. In particular, we were interested to determine (i) whether rescued DA neurons remained functional and (ii) whether <b>4c</b> exerted neuritogenic effects on these neurons. To characterize these effects, we performed experiments in which midbrain cultures treated with different concentrations of <b>4c</b> (10, 25, 50 μM) were processed either for TH immunodetection or for tritium-labeled DA uptake, a marker of both DA cell function and differentiation.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></div><div class="NLM_p">The protective effects of <b>4c</b> observed between 10 and 50 μM were associated with an increase of DA uptake in the same range of concentrations (see <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>A–C), suggesting that <b>4c</b>-treated DA neurons were fully functional. Also, the rate of DA uptake per TH<sup>+</sup> neuron was significantly increased in <b>4c</b>-treated cultures (see <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>D). This latter observation suggested that DA neurons rescued by <b>4c</b> were not only functional but that they were also more differentiated, as DA uptake sites are preferentially localized on neuritic extensions.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Consistent with this observation, microscopic examination of the cultures revealed that TH<sup>+</sup> neurons treated with <b>4c</b> had generally a more developed neuritic network in comparison to control neurons (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>B). Note that TH<sup>+</sup> cell survival and DA uptake were increased in similar proportions in cultures treated with dbcAMP. This is in agreement with the absence of neuritogenic effects of this compound on TH<sup>+</sup> neurons (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>B).</div><figure id="fig6" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/medium/jm-2016-00297a_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0009.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Neuroprotective and neuritogenic effects of <b>4c</b> onto DA neurons in midbrain cultures. (A) Number of TH<sup>+</sup> neurons, in 10 DIV cultures treated or not with <b>4c</b> (1–50 μM). (B) Illustration showing TH<sup>+</sup> neurons, in 10 DIV cultures treated or not with <b>4c</b> (10–50 μM). Illustrations of the effects of <b>4c</b> on TH<sup>+</sup> cells are presented under an inverted format. Scale bars = 60 μm. In A–D, DbcAMP (1 mM) was used as reference protective molecule. (C) Quantification of [<sup>3</sup>H]-DA uptake in 10 DIV cultures treated or not with <b>4c</b> (10–50 μM). (D) Rate of DA uptake per TH<sup>+</sup> neuron in 10 DIV cultures treated or not with <b>4c</b> (10–50 μM). *<i>P</i> < 0.05 vs control cultures.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00297&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Mechanism of Action of <b>4c</b>: Role of Intracellular Calcium Stores</h3><div class="NLM_p">Previous studies have shown that DA neurons can be rescued in this culture system by compounds that have a repressive effect on glial cells, i.e., immature astrocytes.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Such a mechanism is unlikely for <b>4c</b>, as this compound does not prevent glial cell proliferation, as shown in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>. Another set of neuroprotective molecules is represented by depolarizing compounds that have the ability of maintaining cytosolic calcium levels within a neuroprotective range of concentrations.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> To explore the possible impact of <b>4c</b> on intracellular calcium levels, we exposed <b>4c</b>-treated cultures to molecules having the capacity to prevent Ca<sup>2+</sup> influx at the plasma membrane. We used blockers of L-type (nifedipine) and N-type (ω-conotoxin MVIIA) voltage gated calcium channels. None of these compounds caused a decrease of <b>4c</b> neuroprotective effects. However, the blockade of endoplasmic reticulum calcium release channels, namely ryanodine receptor channels (RyRs), by dantrolene led to a substantial reduction of the effects of <b>4c</b>. This indicates that RyRs may represent a potential target for neuroprotection by <b>4c</b> (see <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>). This is reminiscent of previous observations showing that activation of this receptor by paraxanthine, the primary metabolite of caffeine, is protective for DA neurons in experimental PD models.<a onclick="showRef(event, 'ref16 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref16 ref31 ref32">(16, 31, 32)</a></div><figure id="fig7" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/medium/jm-2016-00297a_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0010.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Neuroprotection by <b>4c</b> requires calcium mobilization through RyRs. Number of TH<sup>+</sup> neurons in 10 DIV cultures chronically exposed or not to <b>4c</b> (50 μM) in the presence or not of nifedipine (NIF, 20 μM), ω-conotoxin MVIIA (ω-CON, 0.5 μM), or dantrolene (DAN, 30 μM). *<i>P</i> < 0.05 vs no treated cultures. #<i>P</i> < 0.05 vs <b>4c</b> treated cultures.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00297&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> The Neuroprotective Effect of <b>4c</b> on DA Neurons Is Independent of Glial Cell-Derived Neurotrophic Factor (GDNF)</h3><div class="NLM_p">GDNF is a trophic peptide that exerts potent neuroprotective and neuritogenic effects on DA neurons.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Interestingly, we observed that <b>4c</b> had about the same efficacy as GDNF in rescuing DA neurons in midbrain cultures. Furthermore, like GDNF, <b>4c</b> promoted neuritogenesis. This led us to postulate that <b>4c</b> could operate by stimulating the endogenous production of GDNF. To test this possibility, we assessed the activity of <b>4c</b> in the presence of an anti-GDNF antibody (AB-212-NA; 10 μg/mL) that neutralizes the biological activity of the neurotrophic peptide, as previously described.<a onclick="showRef(event, 'ref12 ref22'); return false;" href="javascript:void(0);" class="ref ref12 ref22">(12, 22)</a> Whereas the antibody was sufficient to prevent the increase in DA cell survival resulting from a treatment with GDNF, it failed to reduce neuronal survival in the presence of 50 μM of <b>4c</b> (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>). This indicates that the effects of <b>4c</b> are unrelated to that of GDNF.</div><figure id="fig8" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/medium/jm-2016-00297a_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0011.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Protective effect of <b>4c</b> is unrelated to that of GDNF. Number of TH<sup>+</sup> neurons in 10 DIV cultures treated or not with <b>4c</b> (50 μM), in the presence or not of an anti-GDNF antibody (AB-212-NA, 10 μg/mL). GDNF at 20 ng/mL was used as a positive control. *<i>P</i> < 0.05 vs control cultures. <sup>#</sup><i>P</i> < 0.05 vs GDNF-treated cultures.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00297&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Mature DA Neurons Deprived of GDNF Can Be Efficiently Rescued by <b>4c</b></h3><div class="NLM_p">To verify that the effect of <b>4c</b> was not restricted to a short developmental period after plating, we used midbrain cultures in which the spontaneous death of DA neurons was prevented by chronic application of 20 ng/mL trophic peptide GDNF.<a onclick="showRef(event, 'ref12 ref22'); return false;" href="javascript:void(0);" class="ref ref12 ref22">(12, 22)</a> Removal of GDNF from these cultures at 10 DIV leads to a massive loss of TH<sup>+</sup> neurons within the next 5 days.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> We confirmed this finding and established that <b>4c</b> was potently protective for DA neurons in this particular setting. DA cell rescue was already highly significant at 10 μM and reached an optimum between 25 and 50 μM. The neuroprotective effect of <b>4c</b> following GDNF withdrawal is depicted in <a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>.</div><figure id="fig9" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/medium/jm-2016-00297a_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0012.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Mature DA neurons dependent on GDNF for their survival can be rescued by <b>4c</b>. Rescuing effect of <b>4c</b> (10–50 μM) in midbrain cultures exposed to 20 ng/mL GDNF for 10 days and then deprived of the trophic peptide between 11 DIV and 15 DIV. Comparison to cultures maintained continuously with GDNF up to 15 DIV. *<i>P</i> < 0.05 vs GDNF-treated cultures. #<i>P</i> < 0.05 vs GDNF-deprived cultures.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00297&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Antioxidant Potential of <b>4c</b> for DA Neurons</h3><div class="NLM_p"><b>5c</b>, a close structural analogue of <b>4c</b>, is a potent antioxidant molecule.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Thus, we tested whether <b>4c</b> could also operate via an antioxidant effect.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> For this purpose, we used a culture setting where the death of DA neurons is caused by a Fenton-type reaction that is generated by the presence in the culture medium of catalytically active iron (i.e., ferrous iron) reacting with molecular oxygen.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Like <b>5c</b>, we found that <b>4c</b> was strongly protective for DA neurons. Optimal effects were obtained at 5 μM (see <a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>); <b>4c</b> at 5 μM was as effective as desferrioxamine (10 μM), a molecule with iron chelating properties that has a clinical use.<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36, 37)</a></div><figure id="fig10" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/medium/jm-2016-00297a_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0013.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Antioxidant effect of <b>4c</b>. Neuroprotective effect of <b>4c</b> (1–10 μM) for DA neurons in a model system of chronic oxidative stress. Desferrioxamine (Desf 10 μM) is used as a positive control. *<i>P</i> < 0.05 vs control cultures.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00297&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Neuroprotective Effects of <b>4c</b> on SN DA Neurons in the MPTP Mouse Model of PD</h3><div class="NLM_p">One of the most commonly used animal models for DA depletion in PD is achieved through systemic administration of the neurotoxin MPTP in mice. This PD model reproduces a number of pathological processes, such as oxidative stress, mitochondrial dysfunction, and inflammation, that are thought to participate in disease progression.<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38, 39)</a> Herein, C57BL/6 mice received a subchronic MPTP treatment in order to induce the degeneration of nigrostriatal DA neurons and a depletion in striatal DA and related metabolites.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></div><div class="NLM_p">SN DA neurons were detected by immunostaining the TH enzyme using an anti-TH antibody, following a revelation step with the chromogenic substrate 3,3-diaminobenzidine (DAB). In line with previous studies,<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40, 41)</a> a subchronic MPTP treatment in C57BL/6 mice led to a massive degeneration of nigrostriatal DA neurons (MPTP/vehicle, 61 ± 5%, vs vehicle, 100 ± 2% TH<sup>+</sup> neurons). Following 11 days of <b>4c</b> treatment at the dose of 2 × 25 mg/kg/day (per os), there was a partial but substantial rescue of TH<sup>+</sup> neurons in comparison to MPTP/vehicle-treated mice (MPTP/<b>4c</b> (2 × 25 mg/kg/day), 78 ± 7%, vs MPTP/vehicle, 61 ± 5% TH<sup>+</sup> neurons). At the highest dosage (2 × 50 mg/kg/day), <b>4c</b> prevented almost entirely the toxic effect of MPTP on DA neurons (MPTP/<b>4c</b> (2 × 50 mg/kg/day), 91 ± 5%, vs vehicle, 100 ± 2% TH<sup>+</sup> neurons, no significant difference; <i>P</i> > 0.05). The neuroprotective effect of <b>4c</b> onto DA neurons in the SN of MPTP-treated mice is depicted in <a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>. Importantly, we found that <b>4c</b> was only a poor inhibitor of MAO-B, the enzyme that converts MPTP into its active metabolite MPP<sup>+</sup> within the brain.<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38, 39)</a> More specifically, IC<sub>50</sub> values for the reference MAO-B inhibitor selegiline and <b>4c</b> were estimated to be 1.86 and 513 μM, respectively. This signifies that the neuroprotective effect of <b>4c</b> against MPTP is unlikely to result from a reduced bioavailability of MPP<sup>+</sup> for target DA neurons.</div><figure id="fig11" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/medium/jm-2016-00297a_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0014.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Neuroprotective effects of <b>4c</b> onto DA neurons in the SN of MPTP-treated mice. (A) Neuroprotective effect of 11 days of treatment with <b>4c</b> (2 × 25, 2 × 50 mg/kg/day; po) on the number of TH<sup>+</sup> neurons in the SN of MPTP-treated mice (one hemisphere analyzed by mouse). Data expressed as mean ± SEM (<i>n</i> = 9–12). *<i>P</i> < 0.05 vs vehicle + MPTP (20 mg/kg/day) (one-way ANOVA with Dunnett’s multiple comparisons). #<i>P</i> < 0.05 vs vehicle (one-way ANOVA with Dunnett’s multiple comparisons). (B) Illustration showing the impact of <b>4c</b> (2 × 25, 2 × 50 mg/kg/day; po) on the number of DA neurons in the SN of MPTP or vehicle-treated mice. High-resolution bright-field digital images of the labeled sections were acquired using a NanoZoomer digital scanner (Hamamatsu Photonics France, Massy, France. objective ×40) equipped with the NDP software (Hamamatsu Photonics France, Massy, France, magnification ×4.5). Scale bar = 1 mm. Veh: vehicle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00297&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Partial Restoration of Striatal DA in the MPTP Mouse Model of PD</h3><div class="NLM_p">Following 11 days of treatment, <b>4c</b> (2 × 25 mg/kg/day, per os), partially restored striatal DA (MPTP/<b>4c</b> (2 × 25 mg/kg/day), 39 ± 2%, vs MPTP/vehicle, 28 ± 2%), and homovanillic acid (HVA) (MPTP/<b>4c</b> (2 × 25 mg/kg/day), 64 ± 2%, vs MPTP/vehicle, 53 ± 3%) levels and reduced the elevation of the 3,4-dihydroxyphenylacetic acid (DOPAC) + HVA)/DA ratio (an index of DA turnover) by 36% in MPTP-treated mice (see <a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>). At the highest dosage (2 × 50 mg/kg/day), <b>4c</b> produced quite similar effects. There was no significant effect of <b>4c</b> treatment on DOPAC levels. These data show that <b>4c</b> treatment not only robustly counteracted nigral DA cell loss and attenuated striatal DA depletion but also limited the rise in DA turnover caused by MPTP exposure.</div><figure id="fig12" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/medium/jm-2016-00297a_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0015.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. (A–C) Effect of 11 days of treatment with <b>4c</b> (2 × 25, 2 × 50 mg/kg/day; po) on the level of DA (A) and its metabolites (DOPAC, (B); HVA, (C)) in the striatum of MPTP-treated mice. (D) Effect of 11 days of treatment with <b>4c</b> (2 × 25, 2 × 50 mg/kg/day; po) on the ratio of (DOPAC + HVA)/DA in the striatum of MPTP-treated mice. Data expressed as mean ± SEM (<i>n</i> = 9–12). *<i>P</i> < 0.05 vs vehicle + MPTP (20 mg/kg) (one-way ANOVA with Dunnett’s multiple comparisons). Veh: vehicle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00297&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24448" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24448" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The present study reports on the synthesis of 6-aminoquinoxalines and their <i>N</i>-propargyl derivatives through an efficient, high-yielding strategy that relies on palladium-catalyzed Suzuki cross-coupling of arylboronic acids with 2-chloro-6-aminoquinoxaline and aryllithium addition to 2-methyl-6-aminoquinoxaline. The desired compounds were obtained in moderate to good yields. Propargylation of the 6-aminoquinoxalines gave the expected monoalkylated products in moderate yields. Some halogenated derivatives were also prepared in reasonable yields using NCS or NBS or alternatively bromine.</div><div class="NLM_p">The synthesized compounds were tested in a PD cellular model of selective and spontaneous DA cell death.<a onclick="showRef(event, 'ref22 ref30'); return false;" href="javascript:void(0);" class="ref ref22 ref30">(22, 30)</a> Several test compounds were more effective in rescuing DA neurons than our first-generation hit compound <b>5c</b>. Most importantly, these compounds were also active at a lower concentration than <b>5c</b>. Note, however, that among 3-aryl-6-aminoquinoxalines, the presence of a methyl at position 2 of the quinaxoline ring resulted in less active compounds compared to nonsubstituted products. Overall, three products provided neuroprotection at 10 μM, with 3-phenyl-6-aminoquinoxaline, <b>4c</b>, being the most active one. Among the <i>N</i>-propargyl-3-aryl-6-aminoquinoxalines, the 2-nonmethylated substituted products seemed also to be slightly more active than the <i>N</i>-propargyl-2-methyl-3-aryl-6-aminoquinoxalines. At 10 μM, <i>N</i>-propargyl-3-phenyl-6-aminoquinoxaline <b>10c</b> was as effective as the reference neuroprotectant dbcAMP at 1 mM. Thus, propargylation of compound <b>4c</b>, leading to <b>10c</b>, significantly improved neuroprotection for DA neurons.</div><div class="NLM_p">In this cellular model, neuroprotection can possibly result from a direct effect on target DA neurons or from an indirect effect on dividing glial cells.<a onclick="showRef(event, 'ref22 ref30'); return false;" href="javascript:void(0);" class="ref ref22 ref30">(22, 30)</a> Indeed, we have shown before that the first-generation hit compound <b>5c</b> was protective by decreasing glial cell proliferation.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Therefore, we evaluated the potential of second-generation hit compounds (i.e., <b>4c</b>, <b>4e</b>, <b>6a</b>, <b>10c</b>, <b>10e</b>) to operate via a glial-dependent mechanism at two concentrations that were found neuroprotective. These compounds had generally a weak to strong effect on glial cells based on fluorescent microscopic examination. In particular, <i>N</i>-propargyl-6-aminoquinoxalines had a strong effect on astrocytic cells comparable to that of the reference compound dbcAMP. 6-Aminoquinoxaline <b>4c</b>, which was the only compound with no obvious effect on glial cells based on microscopic criteria, had also no impact on the incorporation of [methyl-<sup>3</sup>H]-thymidine used as a marker of glial cell proliferation. This means that <b>4c</b> was neuroprotective, presumably via a direct effect on DA neurons. Taking this into account, <b>4c</b> was selected for further investigations.</div><div class="NLM_p">First, we established that <b>4c</b>-treated DA neurons were functional by showing that they efficiently accumulated tritiated DA via the active transport system for the neurotransmitter.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Noticeably, the ratio DA uptake/DA neurons was also substantially increased, suggesting that the rescued neurons had a more developed neuritic network as DA uptake sites are preferentially localized on neuritic extensions of DA neurons.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> In accordance with this hypothesis, microscopic examination of <b>4c</b>-treated cultures revealed that TH<sup>+</sup> neurons were more differentiated. This means <b>4c</b> did not only afford protection to DA neurons but also provided neurotrophic support to them.</div><div class="NLM_p">A number of neuroprotective compounds, characterized in this model system, were reported to exert their rescuing effect by promoting slight elevations of cytosolic calcium levels through the modulation of ion channels or receptor/channels.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> This is in particular the case for the alkaloid nicotine and the caffeine metabolite paraxanthine.<a onclick="showRef(event, 'ref16 ref23'); return false;" href="javascript:void(0);" class="ref ref16 ref23">(16, 23)</a> To address the possibility that <b>4c</b> could operate also through a calcium-dependent mechanism, we coincubated <b>4c</b>-treated cultures with molecules having the capacity to block calcium influx through voltage-gated calcium channels. We found that neither nifedipine, a L-type Ca<sup>2+</sup> channel blocker, nor ω-conotoxin MVIIA, a N-type Ca<sup>2+</sup> channel blocker, were able to reduce the neuroprotective effect of <b>4c</b> for DA neurons. However, dantrolene, a blocker of RyRs (an endoplasmic reticulum calcium release channel), significantly reduced the protective effect of <b>4c</b>. This suggests that <b>4c</b> may operate by activation of this receptor/channel. This is coherent with previous observations showing that RyRs may represent a potential target for neuroprotection in PD.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> Note, however, that part of the survival promoting effect of <b>4c</b> was resistant to dantrolene treatment, which suggests that a mechanism unrelated to RyR activation was also involved in neuronal rescued mediated by <b>4c</b>. The nature of this mechanism remains to be clarified.</div><div class="NLM_p">Besides exerting pure protective effects for DA neurons, <b>4c</b> also provided trophic support for these neurons. This led us to hypothesize that <b>4c</b> could provide protection and neurotrophic effects by stimulating the endogenous production of GDNF, a neurotrophic factor for DA neurons. In contradiction with this possibility, we found that a GDNF antibody failed to reduce neuronal rescue by <b>4c</b>, whereas it neutralized efficiently the biological activity of GDNF as previously reported.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Indirectly, this suggests that the protective component of <b>4c</b> that is unrelated to RyR stimulation cannot be explained by stimulation of endogenous GDNF synthesis and release.</div><div class="NLM_p">To further explore the neuroprotective potential of <b>4c</b>, we used two other experimental settings that model DA cell death. First, we found that <b>4c</b> was strongly protective in a situation where DA neurons had acquired dependency on GDNF for their survival. Noticeably, <b>4c</b> (25–50 μM) was almost as protective as GDNF (20 ng/mL) in this experimental context, suggesting that the effect of <b>4c</b> was well preserved in more mature cultured DA neurons. Second, in another culture setting where DA neurons die as a result of low-level oxidative stress generated by Fenton-type reaction catalyzed by trace amounts of ferrous iron in the culture medium,<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a><b>4c</b> (5 μM) afforded the same level of protection for DA neurons than the iron chelator desferrioxamine (10 μM).<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Overall, this signifies that <b>4c</b> has the potential to counteract different mechanisms possibly contributive to DA cell death in PD.</div><div class="NLM_p">Because <b>4c</b> is structurally closely related to <b>5c</b>, which readily diffuses through the BBB,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> we wished to study the in vivo activity of <b>4c</b> in the most commonly used animal model for DA depletion in PD, the MPTP-lesioned mouse model.<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39, 40)</a> When C57BL/6 mice received a MPTP subchronic treatment, we observed a substantial loss of nigrostriatal DA neurons. This led to reduced levels of DA and its metabolites DOPAC and HVA in the striatum and to an increased DA turnover reflected by a rise in the DOPAC + HVA/DA ratio. After 11 days of <b>4c</b> treatment in MPTP-treated mice, we observed a robust neuroprotective effect at the level of DA cell bodies in the SN. This was correlated to a partial restoration of striatal DA levels and to a reduction of DOPAC + HVA/DA ratios at both doses of <b>4c</b> (2 × 25 and 2 × 50 mg/kg/day). Noticeably, TH<sup>+</sup> neurons had also a well-preserved dendritic network in midbrain tissue sections from MPTP-treated mice receiving <b>4c</b>. The conversion of MPTP into its active metabolite MPP<sup>+</sup> within the brain requires the MAO-B.<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38, 39)</a> Thus, we tested whether MAO-B inhibition could explain the neuroprotection provided by <b>4c</b> against MPTP. Excluding this possibility, we found that <b>4c</b> was only a very weak MAO-B inhibitor in comparison to the reference compound selegiline. This means that <b>4c</b> did not afford protection by reducing MPP<sup>+</sup> bioavailability in MPTP-intoxicated mice.</div><div class="NLM_p last">Overall, present results suggest that <b>4c</b> has a very interesting neuroprotective potential and presumably good central nervous system bioavailability after oral treatment. Further experiments will be required, however, for the evaluation of pharmacokinetic parameters. Protective effects of <b>4c</b> in MPTP-intoxicated mice is also an indication that the PD cellular models used in this study are relevant for the screening of neuroprotective drugs for Parkinson’s disease. Concentrations reported to be protective in vitro were, however, relatively high and therefore not necessarily predictive of active-site concentrations in the brain.</div></div><div id="sec99" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78481" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78481" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In conclusion, we have designed and synthesized new 6-aminoquinoxalines and their <i>N</i>-propargyl derivatives. After testing them in a cellular PD model system of selective and spontaneous DA cell death, we selected one of the most active one, <b>4c</b>. This compound seemed to operate through a direct effect on DA neurons via a mechanism that is partially dependent on RyRs. Finally, we demonstrated that orally administered <b>4c</b> had the potential to reduce substantially DA loss and striatal DA depletion in the MPTP mouse model of PD. These results are of great interest, as they offer a new strategy for PD treatment. However, additional studies are warranted to further establish the neuroprotective potential of <b>4c</b> for PD-vulnerable DA neurons.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75213" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75213" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Chemistry: General</h3><div class="NLM_p">Tetrahydrofuran was distilled over sodium/benzophenone under nitrogen atmosphere prior to use. All reactions involving moisture-sensitive reactants were performed under nitrogen atmosphere using oven-dried glassware. Routine monitoring of reactions was performed using Riedel-deHaën, S, 0.063 mm, 0.032 silica gel plates, which were dipped in a sulfomolybdic acid solution or <i>o</i>-vanillin in EtOH/H<sub>2</sub>SO<sub>4</sub> (95:5) and then heated to stain or dipped few min in a mixture of silica and iodide. Flash chromatography was performed using Riedel-deHaën, S, 0.063 mm, 0.032 silica under moderate pressure with the appropriate solvent, giving us a migrating front (Rf) in the range of 0.2–0.3. <sup>1</sup>H NMR spectra were recorded on Bruker AR 200 P (200 MHz), Bruker Avance 300 (300 MHz), and AM-400 (400 MHz) spectrometers as solutions in CDCl<sub>3</sub>. Chemical shifts are expressed in parts per million (ppm, δ) downfield from tetramethylsilane (TMS) and are referenced to CHCl<sub>3</sub> (7.26 ppm) as internal standard. <sup>13</sup>C NMR spectra were recorded on Bruker AR 200 P (50 MHz) and AM-400 (100 MHz) spectrometers as solutions in CDCl<sub>3</sub>. Chemical shifts are expressed in parts per million (ppm, δ) downfield from tetramethylsilane (TMS) and are referenced to CDCl<sub>3</sub> (77.0 ppm) as internal standard. The attribution of the different carbons (C, CH, CH<sub>2</sub>, CH<sub>3</sub>) was determined by <sup>13</sup>C to <sup>1</sup>H polarization transfer (J modulation). Mass spectra (MS) were measured on a Nermag- Sidar R10-10C spectrometer with a quadrupole filter. High resolution mass spectra (HRMS) were measured on a Xevo Q-Tof Waters spectrometer. Analytical HPLC was performed for compound purity determination using Xbridge C18 3.5 μm 2.1 mm × 150 mm columns and UV detection. The solvent system used for HPLC analyses was water + 0.1% formic acid:acetonitrile with a gradient from 99:1 to 100:0 over 20 min at 1.0 mL/min. The purity of all the tested compounds is higher than 95% unless noted.</div><div id="sec4_1_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 6-Nitroquinoxaline (<b>1a</b>)</h4><div class="NLM_p last">An aqueous solution (30 mL) of 4-nitro-phenylene-1,2-diamine (1.53 g, 10 mmol, 1 equiv) and glyoxal (1.2 mL, 10 mmol, 1 equiv, 40% in water) was heated at reflux during 4 h. After cooling, the precipitate was filtered, washed with water, and dried at 100 °C overnight to give a yellow/brown powder (1.58 g, 90% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.01 (s, 3H), 8.52 (dd, <i>J</i> = 9.2, 2.4 Hz, 1H), 8.26 (d, <i>J</i> = 9.2 Hz, 1H). <sup>13</sup>C NMR (50 MHz, CDCl<sub>3</sub>): δ 147.9. 147.6, 147.0, 145.3, 141.9, 131.3, 125.9, 123.4. MS (ESI) <i>m</i>/<i>z</i>: 176 ([M + H]<sup>+</sup>, 23). HRMS (ESI) calcd <i>m</i>/<i>z</i> for [M + H]<sup>+</sup> C<sub>8</sub>H<sub>8</sub>N<sub>3</sub> 146.0718, found 146.0712.</div></div><div id="sec4_1_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 7-Nitroquinoxalin-2-ol (<b>1l</b>)</h4><div class="NLM_p last">To a suspension of 2-quinoxalinol (20.0 g, 0.137 mol, 1 equiv) in acetic acid (200 mL) was added dropwise a solution of nitric acid at 70% (17.4 mL, 0.274 mol, 2 equiv) in acetic acid (20 mL). The reaction mixture was stirred at room temperature for 18 h and the bright-yellow precipitate filtered and washed with water. The solid obtained was dried in vacuo over P<sub>2</sub>O<sub>5</sub> during 48 h (17.6 g, 67% yield). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.79 (brs, 1H, OH), 8.33 (s, 1H), 8.05 (d, <i>J</i> = 2.4 Hz, 1H), 8.03 (dd, <i>J</i> = 8.6, 2.4 Hz, 1H), 7.96 (d, <i>J</i> = 8.6 Hz, 1H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 155.2, 154.2, 147.2, 132.0, 129.9, 117.1, 110.9. HRMS (ESI) calcd <i>m</i>/<i>z</i> for [M – H]<sup>−</sup> C<sub>8</sub>H<sub>4</sub>N<sub>3</sub>O<sub>3</sub> 190.0253, found 190.0259.</div></div><div id="sec4_1_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 2-Chloro-7-nitroquinoxaline (<b>1m</b>)</h4><div class="NLM_p last">To a solution of compound <b>1l</b> (17.568 g, 91.50 mmol, 1 equiv) in POCl<sub>3</sub> (80 mL) was added DMF (100 μL). The reaction mixture was heated at reflux for 3 h. After cooling, the dark reaction mixture was poured carefully into a 500 mL beaker full of crushed ice. The gray precipitate was filtered, washed with water, and dried in vacuo over P<sub>2</sub>O<sub>5</sub> for 48 h (17.02 g, 88% yield). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.93 (s, 1H), 8.91 (d, <i>J</i> = 2.4 Hz, 1H), 8.55 (dd, <i>J</i> = 9.2, 2.4 Hz, 1H), 8.29 (d, <i>J</i> = 9.2 Hz, 1H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 149.8, 148.0, 143.2 (2C), 141.1, 131.1, 124.8, 123.7. MS (EI) <i>m</i>/<i>z</i>: 211 (Cl<sup>37</sup> M<sup>•+</sup>, 31), 209 (Cl<sup>35</sup> M<sup>•+</sup>, 97), 181 (33), 179 (100), 165 (Cl<sup>37</sup> M<sup>•+</sup> – NO<sub>2</sub>, 29), 163 (Cl<sup>35</sup> M<sup>•+</sup> – NO<sub>2</sub>, 89), 163 (Cl<sup>35</sup> M<sup>•+</sup> – NO<sub>2</sub>, 89).</div></div><div id="sec4_1_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 2-Methyl-6-nitroquinoxaline (<b>2a</b>)</h4><div class="NLM_p last">An aqueous suspension (50 mL) of 4-nitro-phenylene-1,2-diamine (3.06 g, 20 mmol, 1 equiv) and pyruvic aldehyde (3.65g, 30 mmol, 1.5 equiv, 40% in water) was heated at reflux for 1.5 h. After cooling, the beige precipitate was filtered, washed with water, and dried at 100 °C overnight to give a purple/brown powder (3.40 g, 90% yield) as a 90:10 mixture of regioisomers. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, <i>major regioisomer</i>): δ 8.92 (s, 1H), 8.87 (s, 1H), 8.45 (d, <i>J</i> = 8.0 Hz, 1H), 8.10 (d, <i>J</i> = 8.4 Hz, 1H), 2.82 (s, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>, <i>major regioisomer</i>): δ 157.3, 148.1, 147.0, 144.5, 139.7, 130.2, 125.5, 123.3, 22.8. MS (ESI) <i>m</i>/<i>z</i>: 190 ([M + H]<sup>+</sup>, 100). HRMS (ESI) calcd <i>m</i>/<i>z</i> for [M + H]<sup>+</sup> C<sub>9</sub>H<sub>8</sub>N<sub>3</sub>O<sub>2</sub> 190.0619, found 190.0617.</div></div><div id="sec4_1_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 2,3-Dimethyl-6-nitroquinoxaline (<b>2b</b>)</h4><div class="NLM_p last">An aqueous suspension (50 mL) of 4-nitro-phenylene-1,2-diamine (1.530 g, 10 mmol, 1 equiv) and butanedione (1.0 mL, 11.8 mmol, 1.2 equiv) was heated at reflux during 30 min. The formation of an orange precipitate was immediately observed. After cooling and water addition, the precipitate was filtered, washed with water, and dried at 100 °C overnight to give compound <b>2b</b> (1.50 g, 74% yield). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.85 (d, <i>J</i> = 2.5 Hz, 1H), 8.41 (dd, <i>J</i> = 9.2, 2.5 Hz, 1H), 8.07 (d, <i>J</i> = 9.2 Hz, 1H), 2.78 (s, 6H). <sup>13</sup>C NMR (50 MHz, CDCl<sub>3</sub>): δ 157.2, 156.3, 147.2, 143.7, 139.9, 129.9, 124.9, 122.4, 23.5, 23.3. HRMS (ESI) calcd <i>m</i>/<i>z</i> for [M + H]<sup>+</sup> C<sub>10</sub>H<sub>10</sub>N<sub>3</sub>O<sub>2</sub> 204.0773, found 204.0765.</div></div><div id="sec4_1_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 2-Phenyl-6-nitroquinoxaline (<b>3a</b>)</h4><div class="NLM_p last">A suspension of 4-nitro phenylene-1,2-diamine (1.52 g, 10.0 mmol, 1equiv) and phenylglyoxal monohydrate (1.52 g, 10.0 mmol, 1 equiv) in water (40 mL) was heated at reflux for 1 h. After cooling, the precipitate was filtered and washed with water. The orange solid was dried in an oven for 24 h to give a mixture of compound <b>3a</b> and <b>1c</b> in a 3:1 mixture of regioisomers. (2.46 g, 98% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, <i>major regioisomer</i>): δ 9.49 (s, 1H), 9.02 (d, <i>J</i> = 2.4 Hz, 1H), 8.55 (dd, <i>J</i> = 9.3, 2.3 Hz, 1H), 8.24–8.29 (m, 3H), 7.61 (m, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>, <i>major regioisomer</i>): δ 154.3, 147.4, 145.5, 144.9, 140.3, 135.6, 131.6, 131.4, 131.4, 131.2, 129.4, (2C), 127.9 (2C), 125.6, 123.8. HRMS (ESI) calcd <i>m</i>/<i>z</i> for [M + H]<sup>+</sup> C<sub>14</sub>H<sub>10</sub>N<sub>3</sub>O<sub>2</sub>, 252.0773, found 252.0771.</div></div><div id="sec4_1_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 6-Aminoquinoxaline (<b>4a</b>)</h4><div class="NLM_p last">To a solution of 6-nitroquinoxaline (<b>1a</b>) (6.48 g, 42.6 mmol, 1 equiv) in ethanol (150 mL) and EtOAc (100 mL) was added Pd/C 10% (10% w/w, 650 mg). The mixture was stirred at 60 °C under hydrogen atmosphere for 8 h. After cooling, the reaction was filtered on Celite then washed with ethanol and concentrated in vacuo. Recrystallization (dioxane/H<sub>2</sub>O) afforded a yellow solid (4.16 g, 80% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.62 (s, 1H), 8.52 (s, 1H), 7.84 (d, <i>J</i> = 8.8 Hz, 1H), 7.15 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H), 7.12 (d, <i>J</i> = 2.4 Hz, 1H), 4.10 (s, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 148.1, 144.9, 140.9, 137.9, 130.3, 122.0, 107.8. MS (ESI) <i>m</i>/<i>z</i>: 146 ([M + H]<sup>+</sup>, 100). HRMS (ESI) calcd <i>m</i>/<i>z</i> for [M + H]<sup>+</sup> C<sub>8</sub>H<sub>8</sub>N<sub>3</sub> 146.0718, found 146.0712.</div></div><div id="sec4_1_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 3-Phenyl-6-aminoquinoxaline (<b>4c</b>)</h4><div class="NLM_p last">A suspension of quinoxaline <b>4m</b> (1.7 g, 9.5 mmol, 1 equiv), K<sub>2</sub>CO<sub>3</sub> (3.41 g, 24.7 mmol, 2.6 equiv), phenylboronic acid (1.5 g, 12.35 mmol, 1.3 equiv), and PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (200 mg, 0.285 mmol, 0.03 equiv) in a dioxane:H<sub>2</sub>O (20 mL: 10 mL) mixture was heated at reflux for 3 h. Column chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>: EtOAc, 85:15) afforded compound <b>4c</b> as bright-yellow crystals (1.98 g, 95% yield). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 9.04 (s, 1H), 8.14 (dd, <i>J</i> = 7.2, 1.2 Hz, 2H), 7.89 (d, <i>J</i> = 8.9 Hz, 1H), 7.49–7.57 (m, 3H), 7.21 (d, <i>J</i> = 2.5 Hz, 1H), 7.16 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 4.21 (brs, 2H NH). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 151.1, 147.2, 143.2, 138.5, 136.3, 135.7, 129.1, 128.8, 128.0 (2C), 126.5 (2C), 120.5, 107.5. HRMS (ESI) calcd <i>m</i>/<i>z</i> for [M + H]<sup>+</sup> C<sub>14</sub>H<sub>12</sub>N<sub>3</sub> 222.1031, found 222.1030.</div></div><div id="sec4_1_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 3-(4-Fluorophenyl)-6-aminoquinoxaline (<b>4e</b>)</h4><div class="NLM_p last">To a solution of 1-bromo-4-fluorobenzene (1.3 mL, 12.2 mmol, 4 equiv) in anhydrous Et<sub>2</sub>O (6 mL) at −78 °C was added dropwise <i>t</i>-BuLi (13 mL, 24.4 mmol, 8 equiv, 1.9 M in hexane). After 1 h at −78 °C, a solution of quinoxaline (0.44 g, 3.05 mmol, 1 equiv) in THF (8 mL) was added dropwise to the reaction mixture and the reaction mixture was stirred at this temperature for 2 h and then allowed to warm to rt. The reaction mixture was quenched by the addition of a saturated aqueous solution of NaHCO<sub>3</sub>. The aqueous layout was extracted by ethyl acetate, and the combined organic layers were washed with a saturated aqueous solution of NaCl, dried over MgSO<sub>4</sub>, and concentrated in vacuo. The residue obtained was dissolved in CHCl<sub>3</sub> (10 mL), then MnO<sub>2</sub> (1.3 g, 15.3 mmol, 5 equiv) was added and the reaction mixture was heated at reflux during 2 h. The reaction mixture was filtered on Celite and concentrated in vacuo, and the residue was then purified by silica gel flash chromatography (EtOAc:petroleum ether (50:50) to give compound <b>4e</b> (48.0 mg, 7% yield). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.99 (s, 1H), 8.14 (m, 2H), 7.88 (d, <i>J</i> = 9.0 Hz, 1H), 7.13–7.27 (m, 4H), 4.2 (brs, 2H, NH). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 164.0, 152.7, 150.1, 148.3, 144.2, 139.0, 136.6 (d, <i>J</i> = 3.3 Hz), 130.1, 129.4 (d, <i>J</i> = 8.5 Hz, 2C), 116.0 (d, <i>J</i> = 22.8 Hz, 2C), 121.6, 108.3. HRMS (ESI) calcd <i>m</i>/<i>z</i> for [M + H]<sup>+</sup> C<sub>14</sub>H<sub>11</sub>FN<sub>3</sub> 240.0935, found 240.0937.</div></div><div id="sec4_1_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 3-(Naphthalen-2-yl)quinoxalin-6-amine (<b>4h</b>)</h4><div class="NLM_p last">For experimental protocol, see compound <b>4c</b>. Yield: 73% (110.0 mg). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 9.19 (s, 1H), 8.61 (s, 1H), 8.31 (dd, <i>J</i> = 8.6, 1.6 Hz, 1H), 8.01 (m, 2H), 7.91 (m, 2H), 7.57 (t, <i>J</i> = 3.5 Hz, 1H), 7.54 (t, <i>J</i> = 3.5 Hz, 1H), 7.18 (dd, <i>J</i> = 9.0, 2.6 Hz, 1H), 7.26 (d, <i>J</i> = 2.6 Hz, 1H), 4.2 (brs, 2H, NH<sub>2</sub>). <sup>13</sup>C NMR (75 MHz, acetone-<i>d</i><sub>6</sub>): δ 151.93, 151.59, 145.51, 139.31, 137.31, 135.89, 135.08, 134.58, 130.76, 129.80, 129.53, 128.69, 128.00, 127.86, 127.52, 125.53, 122.88, 107.51. HRMS (ESI) calcd <i>m</i>/<i>z</i> for [M + H]<sup>+</sup> C<sub>18</sub>H<sub>14</sub>N<sub>3</sub> 272.1188, found 272.1192.</div></div><div id="sec4_1_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 3-Chloroquinoxalin-6-amine (<b>4m</b>)</h4><div class="NLM_p last">To a suspension of 2-chloro-7-nitroquinoxaline (<b>1m)</b> (14.36 g, 68.5 mmol, 1 equiv) in EtOAc (300 mL) was added SnCl<sub>2</sub>.2H<sub>2</sub>O (45.5 g, 239.9 mmol, 3.5 equiv) and the reaction mixture refluxed for 2h. After cooling to rt, NaOH (480 mmol, 6 equiv, 50% in water) was added dropwise at 0 °C and the reaction mixture filtered on a pad of silica gel, then eluted with hot acetone. After concentration, the yellow residue was purified by recrystallization (dioxane/H<sub>2</sub>O) to afford 3-chloroquinoxalin-6-amine (<b>4m</b>) as a bright-yellow solid (9.65 g, 78% yield). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.47 (s, 1H), 7.85 (d, <i>J</i> = 8.8 Hz, 1H), 7.15 (dd, <i>J</i> = 8.8, 1.7 Hz, 1H), 7.03 (d, <i>J</i> = 1.7 Hz, 1H), 4.30 (brs, 2H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 149.1, 147.7, 144.2, 140.3, 135.98, 130.3, 121.7, 107.2. HRMS (ESI) calcd <i>m</i>/<i>z</i> for [M + H]<sup>+</sup> C<sub>8</sub>H<sub>7</sub>N<sub>3</sub>Cl 180.0329, found 180.0326.</div></div><div id="sec4_1_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 3-(Naphthalen-1-yl)quinoxalin-6-amine (<b>4n</b>)</h4><div class="NLM_p last">For experimental protocol, see compound <b>4c</b>. Yield: 73% (220.7 mg). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.86 (s, 1H), 8.16 (dd, <i>J</i> = 7.3, 1.8 Hz, 1H), 7.96 (dt, <i>J</i> = 9.9, 5.3 Hz, 2H), 7.95 (m 1H), 7.73 (dd, <i>J</i> = 7.1, 1.1 Hz, 1H), 7.61 (dd, <i>J</i> = 8.0, 7.1 Hz), 7.54 (td, <i>J</i> = 6.7, 1.5 Hz, 1H), 7.50 (td, <i>J</i> = 6.7, 1.5 Hz, 1H), 7.26 (d, <i>J</i> = 2.4 Hz, 1H), 7.26 (dd, <i>J</i> = 7.2, 2.4 Hz, 1H), 4.25 (brs, 2H, NH<sub>2</sub>). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 154.33, 148.32, 144.10, 142.61, 136.41, 135.65, 133.98, 131.24, 130.23, 129.73, 128.48, 128.15, 126.89, 126.16, 125.33, 125.29, 121.83, 108.38. HRMS (ESI) calcd <i>m</i>/<i>z</i> for [M + H]<sup>+</sup> C<sub>18</sub>H<sub>14</sub>N<sub>3</sub> 272.1188, found 272.1193.</div></div><div id="sec4_1_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 3-(Pyridin-3-yl)quinoxalin-6-amine (<b>4o</b>)</h4><div class="NLM_p last">For experimental protocol, see compound <b>4c</b>. Yield: 93% (115.0 mg). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 9.36 (dd, <i>J</i> = 2.3, 0.8 Hz, 1H), 9.03 (s, 1H), 8.73 (dd, <i>J</i> = 4.9, 1.6 Hz, 1H), 8.45 (ddd, <i>J</i> = 8.0, 2.3, 1.6 Hz, 1H), 7.90 (m, 1H), 7.46 (ddd, <i>J</i> = 8.0, 4.9, 0.8 Hz, 1H), 7.20 (d, <i>J</i> = 2.6 Hz, 1H), 7.18 (dd, <i>J</i> = 6.5, 2.4 Hz, 1H), 4.29 (brs, 1H, NH<sub>2</sub>). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 150.62, 149.50, 148.63, 148.53, 144.32, 138.67, 137.06, 134.75, 132.98, 130.24, 123.75, 122.18, 108.14. HRMS (ESI) calcd <i>m</i>/<i>z</i> for [M + H]<sup>+</sup> C<sub>13</sub>H<sub>11</sub>N<sub>4</sub> 223.0984, found 223.0978.</div></div><div id="sec4_1_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 3-(7-Aminoquinoxalin-2-yl)phenol (<b>4p</b>)</h4><div class="NLM_p last">For experimental protocol, see compound <b>4c</b>, Yield: 87% (115.0 mg). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.66 (s, 1H, OH), 8.98 (s, 1H), 7.74 (d, <i>J</i> = 9.0 Hz, 1H), 7.65 (d, <i>J</i> = 1.2 Hz, 1H), 7.64 (m, 1H), 7.35 (t, <i>J</i> = 8.0 Hz, 1H), 7.22 (dd, <i>J</i> = 7.0, 0.5 Hz, 1H), 6.95 (d, <i>J</i> = 2.2 Hz, 1H), 6.91 (dt, <i>J</i> = 9.0, 2.2 Hz, 1H), 6.07 (brs, 2H, NH<sub>2</sub>). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>): δ 157.9, 150.8, 150.4, 143.9, 138.1, 137.4, 135.4, 135.4, 130.0, 129.3, 122.0, 117.8, 116.9, 113.6, 105.11. HRMS (ESI) calcd <i>m</i>/<i>z</i> for [M + H]<sup>+</sup> C<sub>14</sub>H<sub>12</sub>N<sub>3</sub>O 238.0980, found 238.0983.</div></div><div id="sec4_1_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 3-(Quinolin-3-yl)quinoxalin-6-amine (<b>4q</b>)</h4><div class="NLM_p last">For experimental protocol, see compound <b>4c</b>, however, the reaction was conducted with <i>N</i>-methyliminodiacetic acid (MIDA) boronate in conjunction with sodium hydroxide rather than K<sub>2</sub>CO<sub>3</sub>. Yield: 86% (130.0 mg). <sup>1</sup>H NMR (300 MHz, DMSO): δ 9.73 (d, <i>J</i> = 2.1 Hz, 1H), 9.28 (s, 1H), 9.21 (d, <i>J</i> = 2.1 Hz, 1H), 8.16 (d, <i>J</i> = 8.3 Hz, 1H), 8.10 (d, <i>J</i> = 8.3 Hz, 1H), 7.84 (td, <i>J</i> = 6.9, 1.3 Hz, 1H), 7.79 (d, <i>J</i> = 8.9 Hz, 1H), 7.69 (ddd, <i>J</i> = 8.0,7.0, 1.0 Hz, 1H), 7.26 (dd, <i>J</i> = 8.9, 2.4 Hz, 1H), 7.02 (d, <i>J</i> = 2.4 Hz, 1H), 6.17 (brs, 2H, NH<sub>2</sub>). <sup>13</sup>C NMR (75 MHz, DMSO): δ 151.14, 149.13, 148.52, 147.82, 144.06, 137.61, 135.65, 134.25, 134.12, 130.55, 129.49, 128.95, 128.78, 127.32, 127.28, 122.62, 104.95. HRMS (ESI) calcd <i>m</i>/<i>z</i> for [M + H]<sup>+</sup> C<sub>18</sub>H<sub>13</sub>N<sub>4</sub> 273.1140, found 273.1148. Purity (HPLC/UV λ at 250 nm): 88%.</div></div><div id="sec4_1_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 3-(3,4,5-Trimethoxyphenyl)quinoxalin-6-amine (<b>4r</b>)</h4><div class="NLM_p last">For experimental protocol, see compound <b>4c</b>. Yield: 73% (127 mg). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.98 (s, 1H), 7.88 (d, <i>J</i> = 8.8 Hz, 1H), 7.36 (s, 2H), 7.20 (d, <i>J</i> = 2.4 Hz, 1H), 7.15 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 4.24 (s, 2H), 4.00 (s, 6H), 3.92 (s, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 153.8, 151.7, 148.3, 144.1, 139.9, 139.3, 136.6, 132.9, 130.1, 121.5, 108.3, 104.8, 61.0, 56.4. HRMS (ESI) calcd <i>m</i>/<i>z</i> for [M + H]<sup>+</sup> C<sub>17</sub>H<sub>18</sub>N<sub>3</sub>O<sub>3</sub> 312.1348, found 312.1350.</div></div><div id="sec4_1_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 3-Ethynylquinoxalin-6-amine (<b>4s</b>)</h4><div class="NLM_p last">To a solution of compound of compound <b>4m</b> (100 mg, 0.557 mmol, 1 equiv) in THF (5 mL), was added trimethylsilylacetylene (314 μL, 2.23 mmol, 4 equiv), CuI (10.0 mg, 0.056 mmol, 0.1 equiv), PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (13.0 mg, 0.022 mmol, 0.04 equiv), and then Et<sub>3</sub>N (3 mL). The reaction mixture was refluxed under argon atmosphere for 48 h then filtered on a pad of silica gel and washed with EtOAc. The filtrate was concentrated, then diluted in MeOH (10 mL), K<sub>2</sub>CO<sub>3</sub> was added (500 mg), and the reaction mixture refluxed for 10 min. The reaction mixture was then diluted with water, extracted with EtOAc, and washed with brine. The organic layer was dried over MgSO<sub>4</sub>, filtered, concentrated, and the residue then purified by silica gel column chromatography (EtOAc:CH<sub>2</sub>Cl<sub>2</sub>, 8:92 to 15:85) to give orange crystals (25.6 mg, 27% yield). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.63 (s, 1H), 7.86 (d, <i>J</i> = 8.9 Hz, 1H), 7.19 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 7.10 (d, <i>J</i> = 2.4 Hz, 1H), 4.27 (brs, 2H), 3.36 (s, 1H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 148.57, 144.03, 143.26, 138.40, 136.51, 130.24, 122.85, 107.60, 81.38, 80.45. HRMS (ESI) calcd <i>m</i>/<i>z</i> for [M + H]<sup>+</sup> C<sub>10</sub>H<sub>8</sub>N<sub>3</sub> 170.0718, found 170.0713.</div></div><div id="sec4_1_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 3-(2-(4-Methoxyphenyl)ethynyl)quinoxalin-6-amine (<b>4t</b>)</h4><div class="NLM_p last">To a solution of compound of compound <b>4m</b> (100 mg, 0.557 mmol, 1 equiv) in THF (5 mL) was added trimethylsilylacetylene (314 μL, 2.23 mmol, 4 equiv), CuI (10.0 mg, 0.056 mmol, 0.1 equiv), PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (13.0 mg, 0.022 mmol, 0.04 equiv), and then Et<sub>3</sub>N (3 mL).The reaction mixture was refluxed under argon atmosphere for 48 h then filtered on a pad of silica gel and washed with EtOAc. The filtrate was then concentrated and then purified by silica gel column chromatography (EtOAc:CH<sub>2</sub>Cl<sub>2</sub>, 10:92 to 15:85) to give orange crystals (36.0 mg, 23% yield). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.67 (s, 1H), 7.84 (d, <i>J</i> = 8.8 Hz, 1H), 7.60 (d, <i>J</i> = 8.9 Hz, 2H), 7.15 (dd, <i>J</i> = 8.8, 2.5 Hz, 1H), 7.11 (d, <i>J</i> = 2.3 Hz, 1H), 6.91 (d, <i>J</i> = 8.9 Hz, 2H), 4.25 (m, 2H), 3.84 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 160.60, 148.46, 144.11, 143.47, 139.89, 135.89, 133.94, 130.15, 122.10, 114.17, 113.66, 107.69, 93.38, 86.48, 55.34. HRMS (ESI) calcd <i>m</i>/<i>z</i> for [M + H]<sup>+</sup> C<sub>17</sub>H<sub>14</sub>N<sub>3</sub>O 276.1145, found 276.1137.</div></div><div id="sec4_1_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 2-Methyl-6-aminoquinoxaline (<b>5a</b>)</h4><div class="NLM_p last">To a solution of 2-methyl-6-nitroquinoxaline (<b>2a</b>) (3.18 g, 20 mmol, 1 equiv) in ethanol (100 mL) was added Pd/C 10% (10% w/w, 318 mg). The mixture was stirred at 60 °C under hydrogen atmosphere for 4 h. After cooling, the reaction was filtered on Celite then washed with ethanol and finally concentrated in vacuo to afford a yellow solid (2.54 g, 80% yield). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.52 (s, 1H), 7.73 (d, <i>J</i> = 4.2 Hz, 1H), 7.09–7.11 (m, 2H), 4.22 (s, 2H), 2.62 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 149.3, 147.1, 145.7, 142.5, 141.7, 136.8, 129.4, 121.7, 108.1, 121.8. MS (ESI) <i>m</i>/<i>z</i>: 160 ([M + H]<sup>+</sup>, 100). HRMS (ESI) calcd <i>m</i>/<i>z</i> for [M + H]<sup>+</sup> C<sub>9</sub>H<sub>10</sub>N<sub>3</sub> 160.0876, found 160.0876.</div></div><div id="sec4_1_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 2,3-Dimethyl-6-aminoquinoxaline (<b>5b</b>)</h4><div class="NLM_p last">For experimental protocol, see compound <b>5g</b>. Yield: 84% (1.08 g). <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>): δ 7.67 (d, <i>J</i> = 8.4 Hz, 1H), 6.98 (m, 2H), 4.11 (s, 2H), 2.59 (s, 3H), 2.58 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 153.2. 149.0, 147.0, 142.7, 135.8, 129.1, 120.5, 107.9, 23.0, 22.5. HRMS (ESI) calcd <i>m</i>/<i>z</i> for [M + H]<sup>+</sup> C<sub>10</sub>H<sub>12</sub>N<sub>3</sub> 174.1032, found 174.1031.</div></div><div id="sec4_1_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 2-Methyl-3-phenyl-6-aminoquinoxaline (<b>5c</b>)</h4><div class="NLM_p last">To a solution of 2-methyl-6-aminoquinoxaline (<b>5a</b>) (4.0 g, 25.15 mmol, 1 equiv) in THF (65 mL) under N<sub>2</sub> at −78 °C was slowly added 48.9 mL of PhLi (48.9 mL, 88.0 mmol, 1.8 M in dibutyl ether, 3.5 equiv). The reaction mixture turned to dark-red and was stirred at −78 °C during 3 h then hydrolyzed by a saturated aqueous solution of NH<sub>4</sub>Cl and extracted three times with ethyl acetate. The combined organic layers were washed with a saturated aqueous solution of NaCl, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was dissolved in CHCl<sub>3</sub> (600 mL) and then MnO<sub>2</sub> (10.940 g, 125.74 mmol, 5 equiv) was added and the mixture heated at reflux for 4 h, cooled down, filtered on Celite, and then concentrated in vacuo. The residue was then purified by flash chromatography on silica gel (cyclohexane:EtOAc, 90:10) to give a yellow powder (2.66 g, 45% yield). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.83 (d, <i>J</i> = 8.7 Hz, 1H), 7.61 (m, 2H), 7.48 (m, 3H), 7.16 (m, 2H), 3.88 (s, 2H), 2.68 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 154.8, 148.0, 147.3, 142.6, 139.4, 136.2, 129.2, 128.9, 128.7, 128.4, 121.7, 108.4, 23.8. HRMS (ESI) Calcd <i>m</i>/<i>z</i> for [M + H]<sup>+</sup> C<sub>15</sub>H<sub>14</sub>N<sub>3</sub> 236.1188, found 236.1187.</div></div><div id="sec4_1_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 2-Methyl-3-(4-methoxyphenyl)-6-aminoquinoxaline (<b>5d</b>)</h4><div class="NLM_p last">For experimental protocol, see compound <b>5g</b>. Yield: 34% (168.2 mg). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.79 (d, <i>J</i> = 9.1 Hz, 1H). 7.58 (d, <i>J</i> = 9.1 Hz, 2H), 7.14 (s, 1H), 7.09 (d, <i>J</i> = 9.1 Hz, 1H), 7.00 (d, <i>J</i> = 8.4 Hz, 2H), 4.16 (brs, 2H), 3.85 (s, 3H), 2.68 (s, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 160.0, 154.4, 148.1, 147.3, 142.7, 135.9, 131.8, 130.3 (2C), 129.1, 121.4, 113.8 (2C), 108.3, 55.3, 23.8. HRMS (ESI) calcd <i>m</i>/<i>z</i> for [M + H]<sup>+</sup> C<sub>16</sub>H<sub>16</sub>N<sub>3</sub>O 266.1293, found 266.1291.</div></div><div id="sec4_1_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 2-Methyl-3-(4-fluorophenyl)-6-aminoquinoxaline (<b>5e</b>)</h4><div class="NLM_p last">For experimental protocol, see compound <b>5g</b>. Yield: 35% (352.2 mg). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.85 (d, <i>J</i> = 9.2 Hz, 1H), 7.63 (d, <i>J</i> = 8.4 Hz, 1H), 7.61 (d, <i>J</i> = 8.4 Hz, 1H), 7.16–7.21 (m, 4H), 3.90 (brs, 2H, NH), 2.68 (s, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 163.1 (d, <i>J</i> = 250.4 Hz), 153.6, 147.8, 147.5, 142.6, 136.2, 135.3 (d, <i>J</i> = 2.5 Hz), 130.9 (d, <i>J</i> = 8.1 Hz), 129.2, 122.0, 115.5 (d, <i>J</i> = 21.5 Hz), 108.1, 23.7. HRMS (ESI) calcd <i>m</i>/<i>z</i> for [M + H]<sup>+</sup> C<sub>15</sub>H<sub>13</sub>FN<sub>3</sub> 254.1094, found 254.1088. Purity (HPLC/UV λ at 254 nm): 92%.</div></div><div id="sec4_1_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 2-Methyl-3-(4-chlorophenyl)-6-aminoquinoxaline (<b>5f</b>)</h4><div class="NLM_p last">For experimental protocol, see compound <b>5g</b>. Yield: 70% (1.128 g). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.83 (d, <i>J</i> = 9.1 Hz, 1H), 7.58 (d, <i>J</i> = 7.9 Hz, 2H), 7.47 (d, <i>J</i> = 7.9 Hz, 2H), 7.16 (d, <i>J</i> = 7.5 Hz, 1H), 7.15 (s, 1H), 4.15 (brs, 2H, NH), 2.67 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 153.5, 147.8, 147.4, 142.7, 137.9, 136.4, 134.9, 130.4 (2C), 129.3, 128.7 (2C), 122.0, 108.2, 23.7. HRMS (ESI) calcd <i>m</i>/<i>z</i> for [M + H]<sup>+</sup> C<sub>15</sub>H<sub>13</sub>ClN<sub>3</sub> 270.0798, found 270.0795.</div></div><div id="sec4_1_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 2-Methyl-3-<i>p</i>-tolyl-6-aminoquinoxaline (<b>5g</b>)</h4><div class="NLM_p last">To a solution of 4-bromotoluene (24.0 mmol, 4 equiv) in anhydrous ether (60 mL) under nitrogen at −78 °C was slowly added <i>tert</i>-BuLi (10 mL, 1.6 M in pentane, 8 equiv). After 1 h of stirring at −78 °C, compound <b>5a</b> (0.954 g, 6 mmol, 1 equiv) in anhydrous THF (15 mL) was added slowly. The mixture was stirred at −78 °C during 2 h and then warmed to room temperature. After 24 h, the mixture was hydrolyzed by an aqueous solution of NaHCO<sub>3</sub> then extracted with ethyl acetate. The combined organic layers were washed by a saturated aqueous solution of NaCl, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was dissolved in CHCl<sub>3</sub> (50 mL) and then MnO<sub>2</sub> (2.607 g, 30.0 mmol, 5 equiv) was added. The mixture was heated to reflux for 4 h, cooled down filtered over Celite, and then concentrated in vacuo. The residue was then purified by flash chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>:MeOH, 98:2) to give a yellow powder (851.7 mg, 56% yield). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.84 (d, <i>J</i> = 8.9 Hz, 1H), 7.56 (d, <i>J</i> = 7.6 Hz, 2H), 7.32 (d, <i>J</i> = 7.6 Hz, 2H), 7.20 (d, <i>J</i> = 2.1 Hz, 1H), 7.12 (dd, <i>J</i> = 8.9, 2.1 Hz, 1H), 4.28 (brs, 2H, NH), 2.72 (s, 3H), 2.45 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 154.6, 147.9, 147.3, 142.6, 138.5, 136.4, 135.9, 128.9 (3C), 128.7 (2C), 121.5, 108.0, 23.7, 21.2, HRMS (ESI) calcd <i>m</i>/<i>z</i> for [M + H]<sup>+</sup> C<sub>16</sub>H<sub>16</sub>N<sub>3</sub> 250.1344, found 250.1346.</div></div><div id="sec4_1_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 2-Methyl-3-(naphthalen-2-yl)-6-aminoquinoxaline (<b>5h</b>)</h4><div class="NLM_p last">For experimental protocol, see compound <b>5g</b>. Yield: 48% (531.8 mg). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.10 (s, 1H), 7.97 (d, <i>J</i> = 8.9 Hz, 1H), 7.92 (d, <i>J</i> = 9.5 Hz, 1H), 7.86 (d, <i>J</i> = 8.9 Hz, 1H), 7.74 (dd, <i>J</i> = 8.1, 1.8 Hz, 1H), 7.91 (d, <i>J</i> = 9.5 Hz, 1H), 7.52–7.57 (m, 2H), 7.21 (d, <i>J</i> = 2.5 Hz, 1H), 7.16 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 4.14 (brs, 2H, NH<sub>2</sub>), 2.74 (s, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 154.8, 148.3, 147.4, 142.8, 136.9, 136.3, 133.2, 133.1, 129.3, 128.5, 128.4, 128.1, 127.7, 126.7 (2C), 126.4, 121.7, 108.4, 23.9. HRMS (ESI) calcd <i>m</i>/<i>z</i> for [M + H]<sup>+</sup> C<sub>19</sub>H<sub>16</sub>N<sub>3</sub> 286.1344, found 286.1343. Purity (HPLC/UV λ at 254 nm): 88%.</div></div><div id="sec4_1_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 3-(3,4-Dimethoxyphenyl)-2-methyl-6-aminoquinoxaline (<b>5i</b>)</h4><div class="NLM_p last">For experimental protocol, see compound <b>5g</b>. Yield: 31% (310.0 mg). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.87 (d, <i>J</i> = 8.8 Hz, 1H), 7.27 (s, 1H), 7.22 (d, <i>J</i> = 6.0 Hz, 1H), 7.21 (s, 1H), 7.17 (d, <i>J</i> = 8.8 Hz, 1H), 6.99 (d, <i>J</i> = 8.8 Hz, 1H), 3.96 (s, 3H), 3.95 (s, 3H), 3.94 (brs, 2H, NH<sub>2</sub>), 2.74 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 154.5, 149.6, 148.9, 148.2, 147.3, 142.7, 136.1, 132.1, 129.2, 121.7, 121.5, 112.3, 110.9, 108.4, 56.0 (2C), 23.8. HRMS (ESI) calcd <i>m</i>/<i>z</i> for [M + H]<sup>+</sup> C<sub>17</sub>H<sub>18</sub>N<sub>3</sub>O<sub>2</sub> 296.1401, found 296.1399.</div></div><div id="sec4_1_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 2-Methyl-3-(3,4-dichlorophenyl)-6-aminoquinoxaline (<b>5j</b>)</h4><div class="NLM_p last">For experimental protocol, see compound <b>5g</b>. Yield: 45% (813.9 mg). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.83 (d, <i>J</i> = 8.9 Hz, 1H), 7.18 (dd, <i>J</i> = 9.1 and 2.3 Hz, 1H), 7.75 (d, <i>J</i> = 2.0 Hz, 1H), 7.58 (d, <i>J</i> = 8.4 Hz, 1H), 7.47 (dd, <i>J</i> = 8.4, 2.0 Hz, 1H), 7.14 (d, <i>J</i> = 2.0 Hz, 1H), 4.17 (brs, 2H, NH<sub>2</sub>), 2.68 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 152.2, 147.6, 147.4, 142.7, 139.4, 136.5, 133.1, 132.8, 131.1, 130.4, 129.3, 128.3, 122.3, 108.1, 23.7. HRMS (ESI) calcd <i>m</i>/<i>z</i> for [M + H]<sup>+</sup> C<sub>15</sub>H<sub>12</sub>Cl<sub>2</sub>N<sub>3</sub> 304.0408, found 304.0405.</div></div><div id="sec4_1_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 2-Methyl-3-biphenyl-6-aminoquinoxaline (<b>5k</b>)</h4><div class="NLM_p last">For experimental protocol, see compound <b>5g</b>. Yield: 30% (219.3 mg). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.84 (d, <i>J</i> = 8.7, 1H), 7.71 (m, 4H), 7.66 (d, <i>J</i> = 7.5 Hz, 2H), 7.47 (t, <i>J</i> = 7.5 Hz, 2H), 7.38 (t, <i>J</i> = 7.5 Hz, 1H), 7.18 (d, <i>J</i> = 1.8 Hz, 1H), 7.12 (dd, <i>J</i> = 8.7, 1.8 Hz, 1H), 4.23 (brs, 2H, NH<sub>2</sub>), 2.77 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 154.3, 127.5, 147.9, 147.4, 142.7, 141.4, 140.4, 138.2, 136.0, 129.3 (2C), 129.0, 128.8 (2C), 127.0 (4C), 121.7, 108.1, 23.7. HRMS (ESI) calcd <i>m</i>/<i>z</i> for [M + H]<sup>+</sup> C<sub>21</sub>H<sub>18</sub>N<sub>3</sub> 312.1501, found 312.1505. Purity (HPLC/UV λ at 254 nm): 92%.</div></div><div id="sec4_1_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 2-Methyl-3-(3,4,5-trimethoxyphenyl)-6-aminoquinoxaline (<b>5r</b>)</h4><div class="NLM_p last">For experimental protocol, see compound <b>5g</b>. Yield: 21% (317.4 mg). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.83 (d, <i>J</i> = 8.1 Hz, 1H), 7.18 (s, 1H), 7.17 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H), 6.84 (s, 2H), 4.28 (brs, 2H, NH), 3.92 (s, 9H), 2.72 (s, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 154.4, 153.1 (2C), 147.8, 147.5, 142.4, 138.5, 136.1, 134.9, 129.1, 121.7, 108.0, 106.2 (2C), 60.8, 56.1 (2C), 23.7. HRMS (ESI) calcd <i>m</i>/<i>z</i> for [M + H]<sup>+</sup> C<sub>18</sub>H<sub>20</sub>N<sub>3</sub>O<sub>3</sub> 326.1505, found 326.1498.</div></div><div id="sec4_1_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 2-Phenyl-6-aminoquinoxaline (<b>6a</b>)</h4><div class="NLM_p last">To a solution of compound <b>3a</b> (9.8 mmol) in EtOH (150 mL) was added Pd/C (245 mg, 10% w/w) under nitrogen and the reaction mixture stirred at 60 °C under hydrogen atmosphere for 24 h. After cooling, the reaction was filtered over Celite then rinsed with EtOAc, and the filtrate was then concentrated in vacuo. The residue was then purified on a silica gel flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>:MeOH, 98:2) to give compound <b>6a</b> (453.3 mg, 21% yield) and its isomer <b>4c</b> (79.5 mg, 4% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.15 (s, 1H), 8.11 (dd, <i>J</i> = 7.3, 1.6 Hz, 2H), 7.9 (d, <i>J</i> = 8.9 Hz, 1H), 7.52 (td, <i>J</i> = 7.4, 1.6 Hz, 2H), 7.45 (tt, <i>J</i> = 7.4, 1.6 Hz, 1H), 7.18 (dd, <i>J</i> = 8.9, 2.6 Hz, 1H), 7.17 (brs, 1H), 3.99 (brs, 2H NH<sub>2</sub>). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 148.1, 147.7, 143.2 (2C), 137.1 (2C), 130.5, 129.2, 128.9 (2C), 126.8 (2C), 122.2, 107.8. MS (ESI) <i>m</i>/<i>z</i>: 222.2 ([M + H]<sup>+</sup>, 100). HRMS (ESI) calcd <i>m</i>/<i>z</i> for [M + H]<sup>+</sup> C<sub>14</sub>H<sub>12</sub>N<sub>3</sub> 222.1026, found 222.1026.</div></div><div id="sec4_1_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 3-(4-Methoxyphenyl)-2-phenyl-6-aminoquinoxaline (<b>6d</b>)</h4><div class="NLM_p last">For experimental protocol, see compound <b>5g</b> from compound <b>6a</b>. The crude material was then purified by semipreparative HPLC chromatography (SunFire (Waters C18, 150 mm × 19 mm; H<sub>2</sub>O:MeOH, 30:70) to give the compound <b>6d</b>. Yield: 2% (8.3 mg). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.94 (d, <i>J</i> = 8.9 Hz, 1H), 7.46–7.49 (m, 2H), 7.44 (d, <i>J</i> = 8.8 Hz, 2H), 7.32 (m, 3H), 7.22 (d, <i>J</i> = 2.2 Hz, 1H), 7.16 (dd, <i>J</i> = 8.8, 2.1 Hz, 1H), 6.83 (d, <i>J</i> = 8.8 Hz, 2H), 3.81 (s, 3H), 3.63 (brs, 2H, NH<sub>2</sub>). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 160.0, 152.9, 149.6, 148.0, 143.0, 139.7, 136.1, 131.7, 131.3 (2C), 130.2, 129.7 (2C), 128.2 (2C), 128.1, 121.7, 113.6 (2C), 107.9, 55.3. HRMS (ESI) calcd <i>m</i>/<i>z</i> for [M + H]<sup>+</sup> C<sub>21</sub>H<sub>18</sub>N<sub>3</sub>O 328.1447, found 328.1450.</div></div><div id="sec4_1_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 5-Bromo-2-methyl-3-phenyl-6-aminoquinoxaline (<b>7c</b>)</h4><div class="NLM_p last">To a solution of compound <b>5c</b> (401.0 mg, 1.7 mmol, 1 equiv) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) was added <i>N</i>-bromosuccinimide (303.7 mg, 1.7 mmol, 1 equiv). After 2 h, the reaction mixture was quenched by the addition of 20 mL of a solution of NaOH 5%. The reaction mixture was then extracted with ethyl acetate, dried over Na<sub>2</sub>SO<sub>4</sub>, and then concentrated in vacuo to give compound <b>7c</b> (553.7 mg, 99% yield). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.73 (m, 3H), 7.46 (m, 3H), 7.13 (d, <i>J</i> = 8.7 Hz, 1H), 4.83 (brs, 2H, NH<sub>2</sub>), 2.73 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 154.5, 147.7, 145.3, 140.0, 138.6, 135.7, 129.3 (2C), 128.8, 128.2 (2C), 127.4, 120.9, 102.9, 23.3. MS (ESI) <i>m</i>/<i>z</i>: 314 (<sup>79</sup>Br), 316 (<sup>81</sup>Br) ([M + H]<sup>+</sup>, 70), 336 (<sup>79</sup>Br), 338 (<sup>81</sup>Br) ([M + Na]<sup>+</sup>, 80), 651 ([2M + Na]<sup>+</sup>, 100). HRMS (ESI) calcd <i>m</i>/<i>z</i> for [M + H]<sup>+</sup> C<sub>15</sub>H<sub>13</sub>N<sub>3</sub>Br 314.0291, found 314.0293.</div></div><div id="sec4_1_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 5-Chloro-2-methyl-3-phenyl-6-aminoquinoxaline (<b>8c</b>)</h4><div class="NLM_p last">To a solution of compound <b>5c</b> (280.0 mg, 0.89 mmol, 1 equiv) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) was added <i>N</i>-chlorosuccinimide (118.0 mg, 1.07 mmol, 1.2 equiv) at room temperature, and the reaction mixture was heated at reflux overnight. After cooling, the reaction mixture was hydrolyzed by a solution of NaOH at 5%, and then extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layer were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and then concentrated under nitrogen to give compound <b>8c</b> (279.0 mg, 99% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.71 (dd, <i>J</i> = 8.6, 1.3 Hz, 2H), 7.48 (m, 3H), 7.45 (d, <i>J</i> = 9.2 Hz, 1H). 7.19 (d, <i>J</i> = 9.2 Hz, 1H), 4.60 (brs, 2H, NH<sub>2</sub>), 2.73 (s, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 154.6, 148.3, 143.6, 139.1, 139.0, 136.4, 129.3 (2C), 128.9, 128.3 (2C), 127.3, 120.8, 111.1, 23.7. MS (ESI) <i>m</i>/<i>z</i>: 270.2 ([<sup>35</sup>Cl – M + H]<sup>+</sup>, 25), 272.2 ([<sup>37</sup>Cl – M + H]<sup>+</sup>, 7.5). HRMS (ESI) calcd <i>m</i>/<i>z</i> for [M + H]<sup>+</sup> C<sub>15</sub>H<sub>13</sub>N<sub>3</sub>Cl 270.0798, found 270.0798.</div></div><div id="sec4_1_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 5-Chloro-7-bromo-2-methyl-3-phenyl-6-aminoquinoxaline (<b>9c</b>)</h4><div class="NLM_p last">To a solution of compound <b>8c</b> (50.0 mg, 0.186 mmol, 1 equiv) in AcOH (3 mL) was added Br<sub>2</sub> (100 μL, 0.809 mmol, 4.4 equiv) at room temperature. After 2 h of mixing, the reaction mixture was neutralized by the addition of 10 mL of a solution of NaOH 10% followed by a solution of Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> 10% (10 mL). The reaction mixture was extracted with ethyl acetate, dried on Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The residue was then purified by flash chromatography on silica gel (cyclohexane:ethyl acetate, 9:1 to 7:3) to give of compound <b>9c</b> (553.7 mg, 31% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.15 (s, 1H), 7.53–7.54 (m, 3H), 7.72 (dd, <i>J</i> = 8.0, 1.5 Hz, 2H), 5.01 (brs, 2H, NH<sub>2</sub>), 2.74 (s, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 155.1, 149.6, 141.5, 138.8, 138.2, 135.7, 130.0, 129.3 (2C), 129.1, 128.4 (2C), 114.6, 111.7, 23.9. MS (ESI) <i>m</i>/<i>z</i>: 348 ([M + H]<sup>+</sup>, 80), 350 ([M + H]<sup>+</sup>, 100), 352 ([M + H]<sup>+</sup>, 20). HRMS (ESI) calcd <i>m</i>/<i>z</i> for [M + H]<sup>+</sup> C<sub>15</sub>H<sub>12</sub>N<sub>3</sub><sup>35</sup>Br<sup>79</sup>Cl 347.9903, found 347.9903; calcd <i>m</i>/<i>z</i> for [M + H]<sup>+</sup> C<sub>15</sub>H<sub>12</sub>N<sub>3</sub><sup>35</sup>Br<sup>81</sup>Cl 349.9884, found 349.9883; calcd <i>m</i>/<i>z</i> for [M + H]<sup>+</sup> C<sub>15</sub>H<sub>12</sub>N<sub>3</sub><sup>37</sup>Br<sup>81</sup>Cl 351.9861, found 351.9853.</div></div><div id="sec4_1_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 3-Phenyl-<i>N</i>-propargyl-6-aminoquinoxaline (<b>10c</b>)</h4><div class="NLM_p last">To a suspension 3-phenyl-6-aminoquinoxaline <b>4c</b> (500 mg, 2.262 mmol, 1 equiv) and K<sub>2</sub>CO<sub>3</sub> (469 mg, 3.39 mmol, 1.5 equiv) in dry DMF (5 mL) was added propargyl bromide (380 μL, 3.39 mmol, 1.5 equiv, 80% in toluene), and the reaction mixture was heated at 80 °C for 18 h. The reaction mixture was then allowed to cool down to rt, quenched with water, and was extracted with EtOAc. The combined organic layers were washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified by chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>:EtOAc, 90:10 to 80:20) to give yellow crystals (290 mg, 49% yield). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 9.04 (s, 1H), 8.15 (dd, <i>J</i> = 8.0, 1.5 Hz, 2H), 7.90 (d, <i>J</i> = 8.5 Hz, 1H), 7.60–7.66 (m, 3H), 7.16 (s, 1H), 7.15 (m, 1H), 4.43 (brs, 1H, NH), 4.11 (brm, 2H), 2.29 (t, <i>J</i> = 2.5 Hz, 1H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 152.1, 148.1, 144.4, 141.1, 139.4, 136.9, 129.9, 129.8, 129.0 (2C), 127.5 (2C), 121.5, 105.5, 79.8, 72.0, 33.5. HRMS (ESI) calcd <i>m</i>/<i>z</i> for [M + H]<sup>+</sup> C<sub>17</sub>H<sub>14</sub>N<sub>3</sub> 260.1183, found 260.1188. Purity (HPLC/UV λ at 254 nm): 93%.</div></div><div id="sec4_1_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 3-(4-Fluorophenyl)-<i>N</i>-propargyl-6-aminoquinoxaline (<b>10e</b>)</h4><div class="NLM_p last">For experimental protocol, see compound <b>10c</b>. Yield: 41% (18.0 mg). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.99 (s, 1H), 8.15 (dd, <i>J</i> = 8.8, 5.6 Hz, 2H), 7.89 (d, <i>J</i> = 9.5 Hz, 1H), 7.21 (t, <i>J</i> = 9.0 Hz, 2H), 7.14 (dd, <i>J</i> = 9.5, 2.5 Hz, 2H), 7.12 (brs, 1H), 4.48 (brs, 1H, NH<sub>2</sub>), 4.11 (brs, 2H), 2.29 (t, <i>J</i> = 2.0 Hz, 1H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 164.0 (d, <i>J</i><sub>C–F</sub> = 250.3 Hz), 151.0, 148.2, 144.4, 138.9, 136.8, 133.5, 129.7 (d, <i>J</i><sub>C–F</sub> = 31.8 Hz, 2C), 129.4, 121.7, 116.1 (d, <i>J</i><sub>C–F</sub> = 21.7 Hz, 2C), 105.3, 79.8, 72.1, 33.5. HRMS (ESI) calcd <i>m</i>/<i>z</i> for [M + H]<sup>+</sup> C<sub>17</sub>H<sub>13</sub>N<sub>3</sub>F 278.1095, found 278.1094.</div></div><div id="sec4_1_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 2-Methyl-3-phenyl-<i>N</i>-propargyl-6-aminoquinoxaline (<b>11c</b>)</h4><div class="NLM_p last">To a solution of 2-methyl-3-phenyl-6-aminoquinoxaline <b>5c</b> (200 mg, 0.85 mmol, 1 equiv), K<sub>2</sub>CO<sub>3</sub> (118.0 mg, 0.85 mmol, 1 equiv), and KI (141 mg, 0,85 mmol, 1 equiv) in anhydrous DMF (23 mL) under inert atmosphere was added propargyl bromide (0.2 mL, 1.7 mmol, 2 equiv) dropwise. The mixture was heated at 70 °C for 24 h, then cooled down to rt, hydrolyzed by saturated aqueous solution of NH<sub>4</sub>Cl, and extracted with ethyl acetate. The combined organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was then purified by flash chromatography on silica gel (cyclohexane:EtOAc, 7:3 to 6:4) to give dipropargylated product <b>11c′</b> (14 mg, 5%, not described) followed by monopropargylated product <b>11c</b> (90.1 mg, 40% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.81 (d, <i>J</i> = 8.8 Hz, 1H), 7.61 (dd, <i>J</i> = 8.8, 1.6 Hz, 2H), 7.50 (m, 3H), 7.43–7.12 (d, <i>J</i> = 2.6 Hz, 1H), 7.09 (dd, <i>J</i> = 8.8, 2.6 Hz, 1H), 4.56 (brs, 1H, NH), 4.01 (brs, 2H), 2.67 (s, 3H), 2.23 (t, <i>J</i> = 2.4 Hz, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 154.6, 147.9, 147.3, 142.8, 139.4, 136.3, 128.9, 128.8 (2C), 128.6, 128.3 (2C), 121.6, 105.2, 79.9, 71.7, 33.3, 23.6. HRMS (ESI) calcd <i>m</i>/<i>z</i> for [M + H]<sup>+</sup> C<sub>18</sub>H<sub>16</sub>N<sub>3</sub> 274.1344, found 274.1342.</div></div><div id="sec4_1_1_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 2-Methyl-3-(4-methoxyphenyl)-<i>N</i>-propargyl-6-aminoquinoxaline (<b>11d</b>)</h4><div class="NLM_p last">For experimental protocol, see compound <b>11c</b>. Yield: 71% (280.0 mg). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.81 (d, <i>J</i> = 8.7 Hz, 1H), 7.60 (d, <i>J</i> = 8.7 Hz, 2H), 7.12 (d, <i>J</i> = 2.5 Hz, 1H), 7.02 (d, <i>J</i> = 8.7 Hz, 2H), 7.09 (dd, <i>J</i> = 8.7, 2.5 Hz, 1H), 4.44 (brs, 1H, NH), 4.03 (d, <i>J</i> = 2.4 Hz, 2H), 3.86 (s, 3H), 2.70 (s, 3H), 2.24 (t, <i>J</i> = 2.4 Hz, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 160.0, 154.4, 148.1, 147.2, 142.9, 136.1, 131.9, 130.4 (2C), 128.9, 121.4, 113.8 (2C), 105.3, 80.0, 71.8, 55.3, 33.4, 23.9. HRMS (ESI) calcd <i>m</i>/<i>z</i> for [M + H]<sup>+</sup> C<sub>19</sub>H<sub>18</sub>N<sub>3</sub>O 304.1450, found 304.1458.</div></div><div id="sec4_1_1_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 2-Methyl-3-(4-fluorophenyl)-<i>N</i>-propargyl-6-aminoquinoxaline (<b>11e</b>)</h4><div class="NLM_p last">For experimental protocol, see compound <b>11c</b>. Yield: 28% (74.0 mg). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.97 (d, <i>J</i> = 9.2 Hz, 2H), 7.64 (dd, <i>J</i> = 8.8, 5.6 Hz, 1H), 7.51 (dd, <i>J</i> = 9.2, 2.7 Hz, 1H), 7.42 (d, <i>J</i> = 2.7 Hz, 1H), 7.20 (t, <i>J</i> = 8.8 Hz, 2H), 4.27 (s, 1H, NH), 4.27 (d, <i>J</i> = 2.5 Hz, 2H), 2.71 (s, 3H), 2.26 (t, <i>J</i> = 2.5 Hz, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 163.1 (d, <i>J</i><sub>C–F</sub> = 248.0 Hz), 154.0, 148.8, 148.2, 142.9, 136.5, 135.6 (d, <i>J</i><sub>C–F</sub> = 2.0 Hz), 130.9 (d, <i>J</i><sub>C–F</sub> = 8.5 Hz, 2C), 128.9, 121.8, 115.5 (d, <i>J</i><sub>C–F</sub> = 22.4 Hz, 2C), 109.9, 80.0, 73.1, 40.4, 23.8. HRMS (ESI) calcd <i>m</i>/<i>z</i> for [M + H]<sup>+</sup> C<sub>18</sub>H<sub>15</sub>N<sub>3</sub>F 292.1250, found 292.1250. Purity (HPLC/UV λ at 260 nm): 94%.</div></div><div id="sec4_1_1_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 2-Methyl-3-(4-chlorophenyl)-<i>N</i>-propargyl-6-aminoquinoxaline (<b>11f</b>)</h4><div class="NLM_p last">For experimental protocol, see compound <b>11c</b>. Yield: 34% (160.0 mg). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.83 (d, <i>J</i> = 8.7 Hz, 1H), 7.58 (d, <i>J</i> = 8.4 Hz, 2H), 7.48 (d, <i>J</i> = 8.4 Hz, 2H), 7.13 (dd, <i>J</i> = 8.7, 2.5 Hz, 1H), 4.10 (d, <i>J</i> = 2.5 Hz, 1H), 7.44 (brs, 1H, NH), 4.05 (brs, 2H), 2.68 (s, 3H), 2.25 (t, <i>J</i> = 2.5 Hz, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 153.5, 147.7, 147.4, 142.9, 137.9, 136.5, 134.9, 130.3 (2C), 129.1, 128.7 (2C), 121.9, 105.2, 79.9, 71.9, 33.4, 23.7. HRMS (ESI) calcd <i>m</i>/<i>z</i> for [M + H]<sup>+</sup> C<sub>18</sub>H<sub>15</sub>ClN<sub>3</sub> 308.0955, found 308.0959.</div></div><div id="sec4_1_1_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 2-Methyl-3-<i>p</i>-tolyl-<i>N</i>-propargyl-6-aminoquinoxaline (<b>11g</b>)</h4><div class="NLM_p last">For experimental protocol, see compound <b>11c</b>. Yield: 40% (207.0 mg). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.81 (d, <i>J</i> = 8.9 Hz, 1H), 7.53 (d, <i>J</i> = 8.0 Hz, 2H), 7.30 (d, <i>J</i> = 8.0 Hz, 2H), 7.12 (d, <i>J</i> = 2.5 Hz, 1H), 7.10 (dd, <i>J</i> = 8.9 and 2.5 Hz, 1H), 4.48 (brs, 1H, NH), 4.02 (brs, 2H), 2.69 (s, 3H), 2.42 (s, 3H), 2.23 (t, <i>J</i> = 2.5 Hz, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 154.8, 148.1, 147.2, 142.9, 138.6, 136.6, 136.3, 129.1 (2C), 128.9, 128.8 (2C), 121.5, 105.4, 80.0, 71.8, 33.4, 23.8, 21.3. HRMS (ESI) calcd <i>m</i>/<i>z</i> for [M + H]<sup>+</sup> C<sub>19</sub>H<sub>18</sub>N<sub>3</sub> 288.1501, found 288.1501.</div></div><div id="sec4_1_1_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> 2-Methyl-3-(naphthalen-2-yl)-<i>N</i>-propargyl-6-aminoquinoxaline (<b>11h</b>)</h4><div class="NLM_p last">For experimental protocol, see compound <b>11c</b>. Yield: 28% (80.5 mg). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.11 (s, 1H), 7.97 (d, <i>J</i> = 8.4 Hz, 1H), 7.92 (t, <i>J</i> = 4.7 Hz, 2H), 7.86 (d, <i>J</i> = 8.5 Hz, 1H), 7.75 (dd, <i>J</i> = 8.5, 1.7 Hz, 1H), 7.51–7.57 (m, 2H), 7.17 (d, <i>J</i> = 2.5 Hz, 1H), 7.12 (dd, <i>J</i> = 9.0, 2.5 Hz, 1H), 4.48 (t, <i>J</i> = 5.5 Hz, 1H), 4.04 (dd, <i>J</i> = 5.5, 2.5 Hz, 2H), 2.74 (s, 3H), 2.25 (t, <i>J</i> = 2.5 Hz, 1H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 154.6, 148.1, 147.3, 142.9, 136.8, 136.4, 133.1, 133.0, 129.0, 128.5, 128.4, 128.1, 127.7, 126.6, 126.4 (2C), 121.7, 105.3, 79.9, 71.8, 33.4, 23.8. HRMS (ESI) calcd <i>m</i>/<i>z</i> for [M + H]<sup>+</sup> C<sub>22</sub>H<sub>18</sub>N<sub>3</sub> 324.1501, found 324.1472. Purity (HPLC/UV λ at 220 nm): 90%.</div></div><div id="sec4_1_1_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 2-Methyl-3-(3,4-dichlorophenyl)-<i>N</i>-propargyl-6-aminoquinoxaline (<b>11n</b>)</h4><div class="NLM_p last">For experimental protocol, see compound <b>11c</b>. Yield: 50% (196.0 mg). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.85 (d, <i>J</i> = 9.0 Hz, 1H), 7.77 (d, <i>J</i> = 2.0 Hz, 1H), 7.59 (d, <i>J</i> = 8.2 Hz, 1H), 7.49 (dd, <i>J</i> = 8.2 and 2.0 Hz, 1H), 7.17 (dd, <i>J</i> = 9.0, 2.5 Hz, 1H), 7.10 (d, <i>J</i> = 2.5 Hz, 1H), 4.40 (t, <i>J</i> = 5.7 Hz, 1H, NH), 4.07 (dd, <i>J</i> = 5.7, 2.5 Hz, 2H), 2.70 (s, 3H), 2.27 (t, <i>J</i> = 2.5 Hz, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 152.1, 147.5, 147.4, 142.9, 139.4, 136.8, 133.1, 132.8, 131.1, 130.4, 129.2, 128.3, 122.3, 105.1, 79.8, 72.0, 33.5, 23.7. HRMS (ESI) calcd <i>m</i>/<i>z</i> for [M + H]<sup>+</sup> C<sub>18</sub>H<sub>14</sub>Cl<sub>2</sub>N<sub>3</sub> 342.0565, found 342.0565. Purity (HPLC/UV λ at 264 nm): 94%.</div></div><div id="sec4_1_1_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 2-Methyl-3-(3,4,5-trimethoxyphenyl)-<i>N</i>-propargyl-6-aminoquinoxaline (<b>11r</b>)</h4><div class="NLM_p last">For experimental protocol, see compound <b>11c</b>. Yield: 42% (118.7 mg). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.78 (d, <i>J</i> = 9.6 Hz, 1H), 7.08–7.11 (m, 2H), 6.80 (s, 2H), 4.64 (brs, 1H, NH), 4.00 (brs, 2H), 3.87 (s, 9H), 2.67 (s, 3H), 2.21 (t, <i>J</i> = 2.5 Hz, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 154.4, 153.1 (2C), 147.7, 147.4, 142.6, 138.5, 136.3, 134.9, 128.8, 121.7, 106.2 (2C), 104.9, 79.9, 71.6, 60.8, 56.1 (2C), 33.2, 23.6. HRMS (ESI) calcd <i>m</i>/<i>z</i> for [M + H]<sup>+</sup> C<sub>21</sub>H<sub>22</sub>N<sub>3</sub>O<sub>3</sub> 364.1661, found 364.1659. Purity (HPLC/UV λ at 254 nm): 93%.</div></div><div id="sec4_1_1_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 5-Bromo-2-methyl-3-phenyl-<i>N</i>-propargyl-6-aminoquinoxaline (<b>13c</b>)</h4><div class="NLM_p last">For experimental protocol, see compound <b>11c</b>. Yield: 14% (62.0 mg). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.94 (d, <i>J</i> = 9.1 Hz, 1H), 7.75 (dd, <i>J</i> = 8.0, 1.5 Hz, 2H), 7.48–7.54 (m, 3H), 7.39 (d, <i>J</i> = 9.1 Hz, 1H), 5.24 (t, <i>J</i> = 5.9 Hz, 1H, NH), 4.19 (dd, <i>J</i> = 5.9, 2.3 Hz, 2H), 2.29 (t, <i>J</i> = 2.5 Hz, 1H), 2.77 (s, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 155.0, 148.7, 144.8, 139.8, 139.0, 136.2, 129.5 (2C), 128.4 (2C), 129.0, 128.2, 116.9, 105.2, 79.9, 72.1, 33.6, 23.8. MS (ESI) <i>m</i>/<i>z</i>: 352.1 (<sup>79</sup>Br) et 354.1 (<sup>81</sup>Br) ([M + H]<sup>+</sup>, 65 et 70), [2M(<sup>79</sup>Br)Na]<sup>+</sup>: 727 ([M + H]<sup>+</sup>, 100). HRMS (ESI) calcd <i>m</i>/<i>z</i> for [M + H]<sup>+</sup> C<sub>18</sub>H<sub>15</sub>N<sub>3</sub>Br 352.0447, found 352.0449.</div></div><div id="sec4_1_1_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> 2-Methyl-3-phenyl-<i>N</i>-(2,2-dimethyl)-propargyl-6-aminoquinoxaline (<b>12c</b>)</h4><div class="NLM_p last">To a solution of 2-methyl-3-phenyl-6-aminoquinoxaline (<b>5c</b>) (500.0 mg, 2.13 mmol, 1 equiv) in a mixture of THF/water (10.5/1 mL) with CuCl (20 mg) under inert atmosphere was added triethylamine (0.41 mL, 2.98 mmol, 1.4 equiv) and of 3-chloro-3-methyl-1-butyne (0.34 mL, 2.98 mmol, 1.4 equiv). The mixture was stirred at room temperature during 12 h, hydrolyzed by a saturated aqueous solution of K<sub>2</sub>CO<sub>3</sub>, and then extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and then concentrated in vacuo. The residue was purified by flash chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>:EtOAc, 85:15) to obtain compound <b>12c</b>. Yield: 65% (414.0 mg). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.81 (d, <i>J</i> = 9.0 Hz, 1H), 7.61 (d, <i>J</i> = 8.3 Hz, 2H), 7.56 (d, <i>J</i> = 2.5 Hz, 1H), 7.41–7.50 (m, 3H), 7.16 (dd, <i>J</i> = 9.0, 2.5 Hz, 1H), 4.32 (brs, 1H, NH), 2.66 (s, 3H), 2.40 (s, 1H), 1.68 (s, 6H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 154.6, 147.8, 145.8, 142.6, 139.6, 136.1, 128.8 (2C), 128.6, 128.5, 128.4 (2C), 123.2, 108.0, 86.4, 71.2, 47.8, 30.0 (2C), 23.6. HRMS (ESI) calcd <i>m</i>/<i>z</i> for [M + H]<sup>+</sup> C<sub>20</sub>H<sub>20</sub>N<sub>3</sub> 302.1657, found 302.1656.</div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> Biological Assays</h3><div id="sec5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> Ethic Statement</h4><div class="NLM_p last">Animals were housed, handled, and cared for in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health (NIH publication no. 85-23, revised 1996) and with the European Union Council Directives (86/609/CEE). The protocol was approved by the Committee on the Ethics of Animal Experiments Charles Darwin no. 5 (reference no. 5012099-A). Animals were manipulated according to protocols that have been validated by the scientific community; sacrifice was performed under sodium pentobarbital anesthesia and all efforts were made to minimize suffering. Animals were housed and maintained at a constant temperature (22 ± 1 °C) and in a humidity-controlled (55 ± 20%) environment. A 12 h/12 h light–dark cycle was kept constant, with lights turned on at 08:00 a.m. During the acclimatization period (3 days) and throughout all the study, the animals had free access to food and water.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> Paradigms of DA Cell Death in Midbrain Cultures</h4><div class="NLM_p">At gestational day 15.5, embryos were collected from the uterine horns of Sprague–Dawley female rats (Janvier LABORATORIES, Le Genest St. Isle, France) that had been deeply anesthetized and then decerebrated. The ventral mesencephalon was dissected out, and cultures were prepared using N5 medium and 1 mg/mL polyethylenimine as a coating as previously described.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Under these conditions, the loss of DA neurons is spontaneous and selective.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> When needed, some sets of cultures were also maintained with 20 ng/mL of the trophic peptide GDNF until 10 DIV to postpone neurodegeneration. Then these cultures were deprived of GDNF until 15 DIV to evaluate neuroprotection.</div><div class="NLM_p last">To study the antioxidant potential of test compounds, mesencephalic cells were seeded in a culture medium consisting of equal volumes of Dulbecco’s Minimal Essential Medium and Ham’s F12 nutrient mixture (DMEM-F12, Life Technologies, Saint Aubin, France) as previously described.<a onclick="showRef(event, 'ref12 ref22'); return false;" href="javascript:void(0);" class="ref ref12 ref22">(12, 22)</a> The presence of trace amounts of ferrous iron in the culture medium generates a Fenton-type reaction that is causing progressively the death of DA neurons.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> Treatments of the Cultures</h4><div class="NLM_p last">When using spontaneous DA cell death paradigms in either N5 or DMEM-F12 culture media, test treatments were applied after culture plating and then every day after 3 DIV until completion of the cultures. When using the GDNF deprivation model, midbrain cultures were maintained initially with the trophic peptide at 20 ng/mL for 10 DIV, and then substitutive treatments were applied each day between 11 and 15 DIV. Treatments were renewed by exchanging 70% of the culture medium.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> TH Immunolabeling</h4><div class="NLM_p last">To detect DA neurons, TH immunofluorescence was used. After fixation with a 4% formaldehyde solution in Dulbecco’s Phosphate Buffered Saline medium (PBS) for 12 min, cultured cells were washed three times with PBS and incubated overnight at 4 °C with a mouse anti-TH monoclonal antibody (1:5000, Euromedex, Souffelweyersheim, France). Subsequent incubations were performed, at rt, with a secondary antimouse IgG Alexa Fluor 488 (1:500, Life Technologies, Paisley, UK). Images were acquired with the HCI software (Hamamatsu Corporation, Bridgewater, NJ) using an inverted fluorescent microscope (TE-300, Nikon, Tokyo, Japan) coupled to an ORCA-ER digital camera from Hamamatsu. TH<sup>+</sup> cells were uniquely DA neurons in our culture conditions<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> and represented ∼2–3% of the total number of neurons present in these cultures at the time of plating.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Cell counting was performed at 200× magnification using a 20× objective matched with a 10× ocular. The number of TH<sup>+</sup> neurons in each culture well was estimated after counting all visual fields distributed along the <i>x</i>- and <i>y</i>-axes.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> Vimentin Immunolabeling</h4><div class="NLM_p last">Vimentin immunofluorescence was used to detect astrocytic cells. After fixation with a 4% formaldehyde solution in PBS medium for 12 min, cultured cells were washed three times with PBS and incubated overnight at 4 °C with a mouse antivimentin monoclonal antibody (1:100, Sigma, Saint Quentin Fallavier, France). Subsequent incubations were performed, at rt, with a secondary antimouse IgG Alexa Fluor 555 (1:500, Life Technologies, Paisley, UK). Semiquantitative scoring of the effects of test compounds on glial cell density and differentiation was performed by visual inspection of the fluorescent signal (20× objective) in treated and untreated cultures.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> Uptake of [2,5,6-<sup>3</sup>H]-DA</h4><div class="NLM_p last">The integrity and synaptic function of DA neurons were evaluated by their ability to accumulate tritiated DA.<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(44, 45)</a> Uptake was initiated by addition of 50 nM [2,5,6-<sup>3</sup>H]-DA (40 Ci/mmol) (PerkinElmer, Boston, USA) to cultures maintained at 37 °C in 500 mL of PBS containing 5 mM glucose. Blanks values were obtained by treating some cultures with 1 μM of GBR-12909 (Sigma-Aldrich, Saint Quentin Fallavier, France), a selective inhibitor of the DA transporter. Uptake was stopped after 20 min by removing the incubation mixture, followed by two rapid washes with ice-cold PBS. Then, cells were scraped off culture wells using 500 mL of distilled water and the radioactivity accumulated by DA neurons assessed by liquid scintillation spectrometry.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> Incorporation of [Methyl-<sup>3</sup>H]-thymidine</h4><div class="NLM_p last">A marker of DNA synthesis, [methyl-<sup>3</sup>H]-thymidine (PerkinElmer, Boston, USA), was used to measure glial cell proliferation in the spontaneous DA cell death paradigm with N5 medium.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Note that the proliferation rate was quantified after 8 DIV, i.e., at a stage where DA cell death is still ongoing in this experimental setting. Briefly, midbrain cultures were washed once with PBS and then incubated in N5 medium lacking serum supplementation. Then, 1 μCi [methyl-<sup>3</sup>H]-thymidine (84.4 Ci/mmol) was added to each culture well and the incubation was carried out at 37 °C for 2 h. Blanks values were obtained by treating some of the cultures with 1 mM unlabeled thymidine. Finally, the incubation mixture was removed and after two rapid washes with PBS. Cells were then scraped off culture wells using 500 μL of distilled water and the radioactivity accumulated by dividing cells assessed by liquid scintillation spectrometry.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> Subchronic MPTP Mouse Model of PD</h4><div class="NLM_p">C57BL/6 male mice (Janvier laboratories, Le Genest-Saint-Isle, France, 22–28 g) were divided into four groups (<i>n</i> = 12/group) for testing the effects of compound <b>4c</b> in vivo. One group received MPTP hydrochloride (20 mg/kg, ip; once daily) injected for 5 consecutive days, a treatment which was followed by a washout period of 4 days. Two groups received MPTP together with <b>4c</b>, administrated per os in 1% carboxymethylcellulose and 0.5% of Tween 80 (2 × 25 or 2 × 50 mg/kg/day; 10 mL/kg), the administration starting 3 days before initiation of MPTP treatment and continuing until sacrifice time. The control group received vehicles used for MPTP and <b>4c</b> administration, and the MPTP group the vehicle used for <b>4c</b> treatment only. Six hours after the last administration of <b>4c</b> or vehicle, all mice were sacrificed by cervical dislocation. The striatums were dissected out, weighed, and snap frozen separately. Tissues samples were stored at −80 °C and used for HPLC analysis of DA and its metabolites.</div><div class="NLM_p last">The caudal part of the brain (containing the SN) was placed in PFA 4% (in 0.1 M PBS pH 7.4) for 5 days and then transferred to 20% sucrose (20% in 0.1 M PBS) for cryoprotection. Tissues were stored at −80 °C until processing for TH<sup>+</sup> immunohistochemistry.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> HPLC Measurement of Striatal DA and Its Metabolites</h4><div class="NLM_p">The extent of striatal DA depletion was assessed by measuring levels of DA, DOPAC, and HVA in the striatum, using HPLC with an electrochemical detection system. The system consisted of a MD 150 mm × 3.2 mm 3 μm C18 column (ESA) and a dual electrode 5014B microdialysis cell (ESA) with the electrode potentials set at −150 mV and +375 mV. DA and its metabolites were detected at the second electrode combined with a CoulArray detector (ESA). A 5020 guard cell (ESA) with a potential of +350 mV was placed before the autosampler. The mobile phase contained 90 mM sodium dihydrogen phosphate, 50 mM citric acid, 1.7 mM 1-octanesulfonic acid, 50 μM EDTA, and 10% acetonitrile, pH 3.0, at a flow rate of 0.5 mL/min.</div><div class="NLM_p">The striatums from the left hemispheres (stored at −80 °C) were weighted and homogenized (Bandelin UW70 ultrasonic probe) in 10 volumes (w/v) of 0.1 N perchloric acid. Homogenates were centrifuged at 15000 rpm for 7 min at 0 °C before 10 μL of supernatant (or calibration standard) was injected into the HPLC-ECD system.</div><div class="NLM_p last">The calibration standards contained DA (Sigma-Aldrich, Saint Quentin Fallavier, France), DOPAC (Sigma-Aldrich, Saint Quentin Fallavier, France), and HVA (Sigma-Aldrich, Saint Quentin Fallavier, France). A calibration curve was created from a range of standards (24.4–1562.5 ng/mL).</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> TH<sup>+</sup> Immunohistochemistry of SN</h4><div class="NLM_p last">First 20 μm coronal sections of the mesencephalon were obtained with a freezing microtome and collected in 10 regularly spaced series. Then all sections were stored in PBS/0.4% sodium azide solution at 4 °C until use. For TH<sup>+</sup> immunohistochemistry, the sections were rinsed in PBS 0.1M, treated with 0.3% H<sub>2</sub>O<sub>2</sub>/PBS for 30 min to remove endogenous peroxide activity, and blocked in 5% goat serum (Sigma-Aldrich, Saint Quentin Fallavier, France) in PBS/0.15% Triton X-100 (PBST) for 1 h. Sections were incubated with the following primary antibodies for 24 h at 4 °C: mouse anti-TH (1/500; US Biologicals, Salem, USA) antibodies. After incubation with appropriate antimouse secondary antibodies diluted 1/250 (Vector Laboratories, Burlingame, USA) for 1 h, the antibodies were revealed by the ABC method according to manufacturer’s instructions (Vector Laboratories, Burlingame, USA) with DAB (Sigma-Aldrich, Saint Quentin Fallavier, France) as the peroxidase substrate.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> Quantification of SN DA Neurons</h4><div class="NLM_p last">Quantification of DA cell loss was done stereologically on regularly spaced DAB-stained sections covering the whole mesencephalon from the rostral pole of the SN to the caudal part of the structure as previously reported.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> High-resolution bright-field digital images of the labeled sections were acquired using a NanoZoomer digital scanner (Hamamatsu Photonics France, Massy, France, objective ×40) equipped with the NDP software (Hamamatsu Photonics France, Massy, France.). One side of the SN was delineated at ×4 magnification for each section. TH<sup>+</sup> cell bodies were subsequently quantified stereologically in magnified images (×20) of the selected regions using the ImageJ software (W. S. Rasband, ImageJ, US National Institutes of Health, Bethesda, MD, USA). Total cell numbers were estimated by integration along the rostrocaudal extent of the structures.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> The quantification was performed by an experimenter blinded to the treatment groups. The total number of SN TH<sup>+</sup> neurons in one hemisphere varied from 4850 to 5535 in saline-treated mice.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> Assessment of MAO-B Inhibition</h4><div class="NLM_p last">The potential of <b>4c</b> to inhibit MAO-B activity was assessed using a modification of a protocol published by Scorza and colleagues.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Briefly, <b>4c</b> or the reference MAO-B inhibitor selegiline were added to an ammonium acetate buffer solution (pH 7.4) containing a crude rat brain mitochondrial extract, the MAO-B specific substrate 4-dimethylaminophenethylamine, aldehyde dehydrogenase, and the pyridine nucleotide cofactor β-NAD. After 30 min of incubation at 37 °C, HClO<sub>4</sub> was added to stop the reaction and the supernatant recovered by centrifugation for the dosage of the reaction product 4-dimethylaminophenylacetic acid using HPLC-HRMS.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> Data Analysis</h4><div class="NLM_p last">All statistical analyses were performed using SigmaPlot 11.0. All data are presented as mean ± the standard error of the mean (SEM). For in vitro experiment, experimental values expressed as mean ± SEM were derived from at least triplicates of three independent experiments. Multiple comparisons against a single reference group were made by one-way analysis of variance (ANOVA) followed by Dunnett’s or Bonferroni’s posthoc tests. A <i>P</i> value of less than 0.05 was considered significant.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i86"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00297">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18032" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18032" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b00297" class="ext-link">10.1021/acs.jmedchem.6b00297</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings and the associated biological data (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00297/suppl_file/jm6b00297_si_001.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00297/suppl_file/jm6b00297_si_001.csv">jm6b00297_si_001.csv (2.89 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b00297" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11802" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11802" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrick P. Michel</span> - <span class="hlFld-Affiliation affiliation">Institut
du Cerveau et de la Moelle Epinière, Sorbonne Universités, Université Pierre et Marie Curie
Paris 06, INSERM U1127, CNRS UMR7225, 75013 Paris, France</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#700011040219131b5d0019150202155e1d191318151c3005001d135e1602"><span class="__cf_email__" data-cfemail="1c6c7d686e757f77316c75796e6e793271757f7479705c696c717f327a6e">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bruno Figadère</span> - <span class="hlFld-Affiliation affiliation">BioCIS,
Université Paris-Sud, CNRS, Université
Paris-Saclay, 92290 Châtenay-Malabry, France</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#0b69797e6564256d626c6a6f6e796e4b7e267b787e6f256d79"><span class="__cf_email__" data-cfemail="a5c7d7d0cbca8bc3ccc2c4c1c0d7c0e5d088d5d6d0c18bc3d7">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gael Le Douaron</span> - <span class="hlFld-Affiliation affiliation">BioCIS,
Université Paris-Sud, CNRS, Université
Paris-Saclay, 92290 Châtenay-Malabry, France</span>; 
    <span class="hlFld-Affiliation affiliation">Institut
du Cerveau et de la Moelle Epinière, Sorbonne Universités, Université Pierre et Marie Curie
Paris 06, INSERM U1127, CNRS UMR7225, 75013 Paris, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laurent Ferrié</span> - <span class="hlFld-Affiliation affiliation">BioCIS,
Université Paris-Sud, CNRS, Université
Paris-Saclay, 92290 Châtenay-Malabry, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Julia E. Sepulveda-Diaz</span> - <span class="hlFld-Affiliation affiliation">Institut
du Cerveau et de la Moelle Epinière, Sorbonne Universités, Université Pierre et Marie Curie
Paris 06, INSERM U1127, CNRS UMR7225, 75013 Paris, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Majid Amar</span> - <span class="hlFld-Affiliation affiliation">BioCIS,
Université Paris-Sud, CNRS, Université
Paris-Saclay, 92290 Châtenay-Malabry, France</span>; 
    <span class="hlFld-Affiliation affiliation">Institut
du Cerveau et de la Moelle Epinière, Sorbonne Universités, Université Pierre et Marie Curie
Paris 06, INSERM U1127, CNRS UMR7225, 75013 Paris, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Abha Harfouche</span> - <span class="hlFld-Affiliation affiliation">BioCIS,
Université Paris-Sud, CNRS, Université
Paris-Saclay, 92290 Châtenay-Malabry, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Blandine Séon-Méniel</span> - <span class="hlFld-Affiliation affiliation">BioCIS,
Université Paris-Sud, CNRS, Université
Paris-Saclay, 92290 Châtenay-Malabry, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rita Raisman-Vozari</span> - <span class="hlFld-Affiliation affiliation">Institut
du Cerveau et de la Moelle Epinière, Sorbonne Universités, Université Pierre et Marie Curie
Paris 06, INSERM U1127, CNRS UMR7225, 75013 Paris, France</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>G.L.D., L.F., and B.F. designed the chemistry synthesis; G.L.D., P.P.M., and R.R.V. designed the biological research; G.L.D., L.F., and B.S.M. performed the chemistry synthesis; G.L.D., M.A., J.E.S.D., and A.H. performed the biological research; G.L.D., L.F., P.P.M., R.R.V., and B.F., wrote the paper. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e6092-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i88">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33113" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33113" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Motac for the in vivo experiments. We thank Alexis Genin, director of research applications at ICM, for his help in the valorization of our compounds. We thank Prof. T. Morton (UCR, Riverside, USA) for fruitful discussions and proofreading our manuscript. We gratefully thank the Instituts Carnot and the LERMIT LabEx for the financial support of part of this study. This work was also supported by ANR through the ANTIPARK (ANR-201-EMMA-006) program and by Medicen. The research leading to these results has received further funding from the program “Investissements d’avenir” ANR-10-IAIHU-06 and from ANR (ANR-10-LABX-33).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i89" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i89"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i90" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i90"> Abbreviations Used</h2><tr><td class="NLM_term">Ar</td><td class="NLM_def"><p class="first last">aryl</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">ω-CON</td><td class="NLM_def"><p class="first last">ω-conotoxin MVIIA</p></td></tr><tr><td class="NLM_term">DA</td><td class="NLM_def"><p class="first last">dopamine or dopaminergic</p></td></tr><tr><td class="NLM_term">DAB</td><td class="NLM_def"><p class="first last">3,3-diaminobenzidine</p></td></tr><tr><td class="NLM_term">DAN</td><td class="NLM_def"><p class="first last">dantrolene</p></td></tr><tr><td class="NLM_term">dbcAMP</td><td class="NLM_def"><p class="first last"><i>N</i>-(6),2′-<i>O</i>-dibutyryladenosine 3′:5′ cyclic monophosphate</p></td></tr><tr><td class="NLM_term">Desf</td><td class="NLM_def"><p class="first last">desferrioxamine</p></td></tr><tr><td class="NLM_term">DIV</td><td class="NLM_def"><p class="first last">day in vitro</p></td></tr><tr><td class="NLM_term">DOPAC</td><td class="NLM_def"><p class="first last">3,4-dihydroxyphenylacetic acid</p></td></tr><tr><td class="NLM_term">EtOH</td><td class="NLM_def"><p class="first last">ethanol</p></td></tr><tr><td class="NLM_term">GDNF</td><td class="NLM_def"><p class="first last">glial cell line-derived neurotrophic factor</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-performance liquid chromatography</p></td></tr><tr><td class="NLM_term">HVA</td><td class="NLM_def"><p class="first last">homovanillic acid</p></td></tr><tr><td class="NLM_term">MALDI-TOF</td><td class="NLM_def"><p class="first last">matrix-assisted laser desorption/ionization/time-of-flight</p></td></tr><tr><td class="NLM_term">MPAQ</td><td class="NLM_def"><p class="first last">2-methyl-3-phenyl-6-aminoquinoxaline</p></td></tr><tr><td class="NLM_term">MIDA</td><td class="NLM_def"><p class="first last"><i>N</i>-methyliminodiacetic acid</p></td></tr><tr><td class="NLM_term">MPP<sup>+</sup></td><td class="NLM_def"><p class="first last">1-methyl-4-phenylpyridinium</p></td></tr><tr><td class="NLM_term">MPTP</td><td class="NLM_def"><p class="first last">1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</p></td></tr><tr><td class="NLM_term">NBS</td><td class="NLM_def"><p class="first last"><i>N</i>-bromosuccinimide</p></td></tr><tr><td class="NLM_term">NCS</td><td class="NLM_def"><p class="first last"><i>N</i>-chlorosuccinimide</p></td></tr><tr><td class="NLM_term">NIF</td><td class="NLM_def"><p class="first last">nifedipine</p></td></tr><tr><td class="NLM_term">NS</td><td class="NLM_def"><p class="first last">no significant</p></td></tr><tr><td class="NLM_term">PBS</td><td class="NLM_def"><p class="first last">Dulbecco’s Phosphate Buffered Saline</p></td></tr><tr><td class="NLM_term">PAQ</td><td class="NLM_def"><p class="first last">3-phenyl-6-aminoquinoxaline</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">Parkinson’s disease</p></td></tr><tr><td class="NLM_term">QSARs</td><td class="NLM_def"><p class="first last">quantitative structure–activity relationship</p></td></tr><tr><td class="NLM_term">rt</td><td class="NLM_def"><p class="first last">room temperature</p></td></tr><tr><td class="NLM_term">RyRs</td><td class="NLM_def"><p class="first last">ryanodine receptor channels</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SN</td><td class="NLM_def"><p class="first last">substantia nigra</p></td></tr><tr><td class="NLM_term">TH</td><td class="NLM_def"><p class="first last">tyrosine hydroxylase</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">TMS</td><td class="NLM_def"><p class="first last">tetramethylsilane</p></td></tr><tr><td class="NLM_term">Veh</td><td class="NLM_def"><p class="first last">vehicle</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i91">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62651" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62651" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 48 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Hirsch, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Przedborski, S.</span><span> </span><span class="NLM_article-title">Pathogenesis of Parkinson’s disease</span> <span class="citation_source-journal">Mov. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">24</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span><span class="refDoi"> DOI: 10.1002/mds.25032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1002%2Fmds.25032" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2013&pages=24-30&author=E.+C.+Hirschauthor=P.+Jennerauthor=S.+Przedborski&title=Pathogenesis+of+Parkinson%E2%80%99s+disease&doi=10.1002%2Fmds.25032"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1002%2Fmds.25032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmds.25032%26sid%3Dliteratum%253Aachs%26aulast%3DHirsch%26aufirst%3DE.%2BC.%26aulast%3DJenner%26aufirst%3DP.%26aulast%3DPrzedborski%26aufirst%3DS.%26atitle%3DPathogenesis%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DMov.%2520Disord.%26date%3D2013%26volume%3D28%26spage%3D24%26epage%3D30%26doi%3D10.1002%2Fmds.25032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Kincses, Z. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vecsei, L.</span><span> </span><span class="NLM_article-title">Pharmacological therapy in Parkinson’s disease: focus on neuroprotection</span> <span class="citation_source-journal">CNS Neurosci. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">345</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span><span class="refDoi"> DOI: 10.1111/j.1755-5949.2010.00150.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1111%2Fj.1755-5949.2010.00150.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=20438581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlOntL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=345-367&author=Z.+T.+Kincsesauthor=L.+Vecsei&title=Pharmacological+therapy+in+Parkinson%E2%80%99s+disease%3A+focus+on+neuroprotection&doi=10.1111%2Fj.1755-5949.2010.00150.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological therapy in Parkinson's disease: focus on neuroprotection</span></div><div class="casAuthors">Kincses, Zsigmond Tamas; Vecsei, Laszlo</div><div class="citationInfo"><span class="NLM_cas:title">CNS Neuroscience & Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">345-367</span>CODEN:
                <span class="NLM_cas:coden">CNTNAB</span>;
        ISSN:<span class="NLM_cas:issn">1755-5930</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Although the no. of available therapeutic approaches in Parkinson's disease (PD) is steadily increasing the search for effective neuroprotective agent is continuing.  Such research is directed at influencing the key steps in the pathomechanism: the mitochondrial dysfunction, the oxidative stress, the neuroinflammatory processes and the final common apoptotic pathway.  Earlier-developed symptomatic therapies were implicated to be neuroprotective, and promising novel disease modifying approaches were brought into the focus of interest.  The current review presents a survey of our current knowledge relating to the pathomechanism of PD and discusses the putative neuroprotective therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZSn1474-6xrVg90H21EOLACvtfcHk0lgEIIpgv03REw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlOntL7F&md5=7ca54cfb2c220fe48a00922b2c9bee54</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1111%2Fj.1755-5949.2010.00150.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1755-5949.2010.00150.x%26sid%3Dliteratum%253Aachs%26aulast%3DKincses%26aufirst%3DZ.%2BT.%26aulast%3DVecsei%26aufirst%3DL.%26atitle%3DPharmacological%2520therapy%2520in%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520focus%2520on%2520neuroprotection%26jtitle%3DCNS%2520Neurosci.%2520Ther.%26date%3D2011%26volume%3D17%26spage%3D345%26epage%3D367%26doi%3D10.1111%2Fj.1755-5949.2010.00150.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Hirsch, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunot, S.</span><span> </span><span class="NLM_article-title">Neuroinflammation in Parkinson’s disease: a target for neuroprotection?</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">382</span><span class="NLM_x">–</span> <span class="NLM_lpage">397</span><span class="refDoi"> DOI: 10.1016/S1474-4422(09)70062-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1016%2FS1474-4422%2809%2970062-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=19296921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=1%3ACAS%3A528%3ADC%252BD1MXks1Sis70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=382-397&author=E.+C.+Hirschauthor=S.+Hunot&title=Neuroinflammation+in+Parkinson%E2%80%99s+disease%3A+a+target+for+neuroprotection%3F&doi=10.1016%2FS1474-4422%2809%2970062-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroinflammation in Parkinson's disease: a target for neuroprotection?</span></div><div class="casAuthors">Hirsch, Etienne C.; Hunot, Stephane</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">382-397</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease is characterised by a slow and progressive degeneration of dopaminergic neurons in the substantia nigra.  Despite intensive research, the cause of the neuronal loss in Parkinson's disease is poorly understood.  Neuroinflammatory mechanisms might contribute to the cascade of events leading to neuronal degeneration.  In this Review, we describe the evidence for neuroinflammatory processes from post-mortem and in vivo studies in Parkinson's disease.  We further identify the cellular and mol. events assocd. with neuroinflammation that are involved in the degeneration of dopaminergic neurons in animal models of the disease.  Overall, available data support the importance of non-cell-autonomous pathol. mechanisms in Parkinson's disease, which are mostly mediated by activated glial and peripheral immune cells.  This cellular response to neurodegeneration triggers deleterious events (eg, oxidative stress and cytokine-receptor-mediated apoptosis), which might eventually lead to dopaminergic cell death and hence disease progression.  Finally, we highlight possible therapeutic strategies (including immunomodulatory drugs and therapeutic immunization) aimed at downregulating these inflammatory processes that might be important to slow the progression of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonuJZ2LO_DMrVg90H21EOLACvtfcHk0lg1dE9IrrEi1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXks1Sis70%253D&md5=0a49309a0821bf5589e19de971efb0f7</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2809%2970062-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252809%252970062-6%26sid%3Dliteratum%253Aachs%26aulast%3DHirsch%26aufirst%3DE.%2BC.%26aulast%3DHunot%26aufirst%3DS.%26atitle%3DNeuroinflammation%2520in%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520a%2520target%2520for%2520neuroprotection%253F%26jtitle%3DLancet%2520Neurol.%26date%3D2009%26volume%3D8%26spage%3D382%26epage%3D397%26doi%3D10.1016%2FS1474-4422%2809%2970062-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Michel, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez-Fischer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerreiro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hild, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, E. C.</span><span> </span><span class="NLM_article-title">Role of activity-dependent mechanisms in the control of dopaminergic neuron survival</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">289</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span><span class="refDoi"> DOI: 10.1111/j.1471-4159.2006.04424.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1111%2Fj.1471-4159.2006.04424.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=17402966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltVKitr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2007&pages=289-297&author=P.+P.+Michelauthor=D.+Alvarez-Fischerauthor=S.+Guerreiroauthor=A.+Hildauthor=A.+Hartmannauthor=E.+C.+Hirsch&title=Role+of+activity-dependent+mechanisms+in+the+control+of+dopaminergic+neuron+survival&doi=10.1111%2Fj.1471-4159.2006.04424.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Role of activity-dependent mechanisms in the control of dopaminergic neuron survival</span></div><div class="casAuthors">Michel, Patrick P.; Alvarez-Fischer, Daniel; Guerreiro, Serge; Hild, Audrey; Hartmann, Andreas; Hirsch, Etienne C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">289-297</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Dopaminergic neurons that constitute the nigrostriatal pathway are characterized by singular elec. properties that allow them to discharge in vivo spontaneously in a spectrum of patterns ranging from pacemaker to random and bursting modes.  These electrophysiol. features allow dopaminergic neurons to optimize the release of dopamine in their terminal fields.  However, there is emerging evidence indicating that elec. activity might also participate in the control of dopaminergic neuron survival, not only during development, but also in the adult brain, thus raising the possibility that alterations in ionic currents could contribute actively to the demise of these neurons in Parkinson disease.  This review focuses on the mechanisms by which activity-dependent mechanisms might modulate dopaminergic cell survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz_cYB0Mi9K7Vg90H21EOLACvtfcHk0lg1dE9IrrEi1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltVKitr0%253D&md5=3a5ea28280a268d10dafe504443b8ea2</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.04424.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.04424.x%26sid%3Dliteratum%253Aachs%26aulast%3DMichel%26aufirst%3DP.%2BP.%26aulast%3DAlvarez-Fischer%26aufirst%3DD.%26aulast%3DGuerreiro%26aufirst%3DS.%26aulast%3DHild%26aufirst%3DA.%26aulast%3DHartmann%26aufirst%3DA.%26aulast%3DHirsch%26aufirst%3DE.%2BC.%26atitle%3DRole%2520of%2520activity-dependent%2520mechanisms%2520in%2520the%2520control%2520of%2520dopaminergic%2520neuron%2520survival%26jtitle%3DJ.%2520Neurochem.%26date%3D2007%26volume%3D101%26spage%3D289%26epage%3D297%26doi%3D10.1111%2Fj.1471-4159.2006.04424.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Connolly, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, A. E.</span><span> </span><span class="NLM_article-title">Pharmacological treatment of Parkinson disease: a review</span> <span class="citation_source-journal">JAMA</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">311</span><span class="NLM_x">, </span> <span class="NLM_fpage">1670</span><span class="NLM_x">–</span> <span class="NLM_lpage">1683</span><span class="refDoi"> DOI: 10.1001/jama.2014.3654</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1001%2Fjama.2014.3654" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=24756517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFems7rP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=311&publication_year=2014&pages=1670-1683&author=B.+S.+Connollyauthor=A.+E.+Lang&title=Pharmacological+treatment+of+Parkinson+disease%3A+a+review&doi=10.1001%2Fjama.2014.3654"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological treatment of Parkinson disease: a review</span></div><div class="casAuthors">Connolly, Barbara S.; Lang, Anthony E.</div><div class="citationInfo"><span class="NLM_cas:title">JAMA, the Journal of the American Medical Association</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">311</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1670-1683, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">JAMAAP</span>;
        ISSN:<span class="NLM_cas:issn">1538-3598</span>.
    
            (<span class="NLM_cas:orgname">American Medical Association</span>)
        </div><div class="casAbstract">A review.  Importance: Parkinson disease is the second most common neurodegenerative disease worldwide.  Although no available therapies alter the underlying neurodegenerative process, symptomatic therapies can improve patient quality of life.  Objective: To provide an evidence-based review of the initial pharmacol. management of the classic motor symptoms of Parkinson disease; describe management of medication-related motor complications (such as motor fluctuations and dyskinesia), and other medication adverse effects (nausea, psychosis, and impulse control disorders and related behaviors); and discuss the management of selected nonmotor symptoms of Parkinson disease, including rapid eye movement sleep behavior disorder, cognitive impairment, depression, orthostatic hypotension, and sialorrhea.  Evidence Review: Refs. were identified using searches of PubMed between Jan. 1985 and Feb. 2014 for English-language human studies and the full database of the Cochrane Library.  The classification of studies by quality (classes I-IV) was assessed using the levels of evidence guidelines from the American Academy of Neurol. and the highest-quality data for each topic.  Results: Although levodopa is the most effective medication available for treating the motor symptoms of Parkinson disease, in certain instances (eg, mild symptoms, tremor as the only or most prominent symptom, aged <60 years) other medications (eg, monoamine oxidase type B inhibitors [MAOBIs], amantadine, anticholinergics, β-blockers, or dopamine agonists) may be initiated first to avoid levodopa-related motor complications.  Motor fluctuations may be managed by modifying the levodopa dosing regimen or by adding several other medications, such as MAOBIs, catechol-O-methyltransferase inhibitors, or dopamine agonists.  Impulse control disorders are typically managed by reducing or withdrawing dopaminergic medication, particularly dopamine agonists.  Evidence-based management of some nonmotor symptoms is limited by a paucity of high-quality pos. studies.  Conclusions and Relevance: Strong evidence supports using levodopa and dopamine agonists for motor symptoms at all stages of Parkinson disease.  Dopamine agonists and drugs that block dopamine metab. are effective for motor fluctuations and clozapine is effective for hallucinations.  Cholinesterase inhibitors may improve symptoms of dementia and antidepressants and pramipexole may improve depression.  Evidence supporting other therapies for motor and nonmotor features is less well established.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq4bHOyyI7XrVg90H21EOLACvtfcHk0ljVIWa20UFhKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFems7rP&md5=a3faf879f5febdfc11a8992db89f2e67</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1001%2Fjama.2014.3654&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.2014.3654%26sid%3Dliteratum%253Aachs%26aulast%3DConnolly%26aufirst%3DB.%2BS.%26aulast%3DLang%26aufirst%3DA.%2BE.%26atitle%3DPharmacological%2520treatment%2520of%2520Parkinson%2520disease%253A%2520a%2520review%26jtitle%3DJAMA%26date%3D2014%26volume%3D311%26spage%3D1670%26epage%3D1683%26doi%3D10.1001%2Fjama.2014.3654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Tracy, H. M.</span><span> </span><span class="NLM_article-title">Parkinson’s</span>.  <span class="citation_source-journal">Neuroperspective</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">190</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=190&publication_year=2011&pages=3-24&author=H.+M.+Tracy&title=Parkinson%E2%80%99s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTracy%26aufirst%3DH.%2BM.%26atitle%3DParkinson%25E2%2580%2599s%26jtitle%3DNeuroperspective%26date%3D2011%26volume%3D190%26spage%3D3%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Stocchi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olanow, C. W.</span><span> </span><span class="NLM_article-title">Obstacles to the development of a neuroprotective therapy for Parkinson’s disease</span> <span class="citation_source-journal">Mov. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">7</span><span class="refDoi"> DOI: 10.1002/mds.25337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1002%2Fmds.25337" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2013&pages=3-7&author=F.+Stocchiauthor=C.+W.+Olanow&title=Obstacles+to+the+development+of+a+neuroprotective+therapy+for+Parkinson%E2%80%99s+disease&doi=10.1002%2Fmds.25337"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2Fmds.25337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmds.25337%26sid%3Dliteratum%253Aachs%26aulast%3DStocchi%26aufirst%3DF.%26aulast%3DOlanow%26aufirst%3DC.%2BW.%26atitle%3DObstacles%2520to%2520the%2520development%2520of%2520a%2520neuroprotective%2520therapy%2520for%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DMov.%2520Disord.%26date%3D2013%26volume%3D28%26spage%3D3%26epage%3D7%26doi%3D10.1002%2Fmds.25337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Schmidt, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Champy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Séon-Méniel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franck, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raisman-Vozari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figadère, B.</span><span> </span><span class="NLM_article-title">Chemicals possessing a neurotrophin-like activity on dopaminergic neurons in primary culture</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">e6215</span><span class="refDoi"> DOI: 10.1371/journal.pone.0006215</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1371%2Fjournal.pone.0006215" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=19593444" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=e6215&author=F.+Schmidtauthor=P.+Champyauthor=B.+S%C3%A9on-M%C3%A9nielauthor=X.+Franckauthor=R.+Raisman-Vozariauthor=B.+Figad%C3%A8re&title=Chemicals+possessing+a+neurotrophin-like+activity+on+dopaminergic+neurons+in+primary+culture&doi=10.1371%2Fjournal.pone.0006215"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0006215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0006215%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DF.%26aulast%3DChampy%26aufirst%3DP.%26aulast%3DS%25C3%25A9on-M%25C3%25A9niel%26aufirst%3DB.%26aulast%3DFranck%26aufirst%3DX.%26aulast%3DRaisman-Vozari%26aufirst%3DR.%26aulast%3DFigad%25C3%25A8re%26aufirst%3DB.%26atitle%3DChemicals%2520possessing%2520a%2520neurotrophin-like%2520activity%2520on%2520dopaminergic%2520neurons%2520in%2520primary%2520culture%26jtitle%3DPLoS%2520One%26date%3D2009%26volume%3D4%26spage%3De6215%26doi%3D10.1371%2Fjournal.pone.0006215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Schmidt, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Douaron, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Champy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Séon-Méniel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raisman-Vozari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figadère, B.</span><span> </span><span class="NLM_article-title">Tryptamine-derived alkaloids from Annonaceae exerting neurotrophin-like properties on primary dopaminergic neurons</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5103</span><span class="NLM_x">–</span> <span class="NLM_lpage">5113</span><span class="refDoi"> DOI: 10.1016/j.bmc.2010.05.067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1016%2Fj.bmc.2010.05.067" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=5103-5113&author=F.+Schmidtauthor=G.+Le+Douaronauthor=P.+Champyauthor=M.+Amarauthor=B.+S%C3%A9on-M%C3%A9nielauthor=R.+Raisman-Vozariauthor=B.+Figad%C3%A8re&title=Tryptamine-derived+alkaloids+from+Annonaceae+exerting+neurotrophin-like+properties+on+primary+dopaminergic+neurons&doi=10.1016%2Fj.bmc.2010.05.067"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.05.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.05.067%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DF.%26aulast%3DLe%2BDouaron%26aufirst%3DG.%26aulast%3DChampy%26aufirst%3DP.%26aulast%3DAmar%26aufirst%3DM.%26aulast%3DS%25C3%25A9on-M%25C3%25A9niel%26aufirst%3DB.%26aulast%3DRaisman-Vozari%26aufirst%3DR.%26aulast%3DFigad%25C3%25A8re%26aufirst%3DB.%26atitle%3DTryptamine-derived%2520alkaloids%2520from%2520Annonaceae%2520exerting%2520neurotrophin-like%2520properties%2520on%2520primary%2520dopaminergic%2520neurons%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D5103%26epage%3D5113%26doi%3D10.1016%2Fj.bmc.2010.05.067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Mayo, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sainz, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, D. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antolín, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiter, R. J.</span><span> </span><span class="NLM_article-title">Melatonin and Parkinson’s disease</span> <span class="citation_source-journal">Endocr. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">178</span><span class="refDoi"> DOI: 10.1385/ENDO:27:2:169</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1385%2FENDO%3A27%3A2%3A169" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2005&pages=169-178&author=J.+C.+Mayoauthor=R.+M.+Sainzauthor=D.+X.+Tanauthor=I.+Antol%C3%ADnauthor=C.+Rodr%C3%ADguezauthor=R.+J.+Reiter&title=Melatonin+and+Parkinson%E2%80%99s+disease&doi=10.1385%2FENDO%3A27%3A2%3A169"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1385%2FENDO%3A27%3A2%3A169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252FENDO%253A27%253A2%253A169%26sid%3Dliteratum%253Aachs%26aulast%3DMayo%26aufirst%3DJ.%2BC.%26aulast%3DSainz%26aufirst%3DR.%2BM.%26aulast%3DTan%26aufirst%3DD.%2BX.%26aulast%3DAntol%25C3%25ADn%26aufirst%3DI.%26aulast%3DRodr%25C3%25ADguez%26aufirst%3DC.%26aulast%3DReiter%26aufirst%3DR.%2BJ.%26atitle%3DMelatonin%2520and%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DEndocr.%2520J.%26date%3D2005%26volume%3D27%26spage%3D169%26epage%3D178%26doi%3D10.1385%2FENDO%3A27%3A2%3A169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Cao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span> </span><span class="NLM_article-title">Effects of docosahexaenoic acid on the survival and neurite outgrowth of rat cortical neurons in primary cultures</span> <span class="citation_source-journal">J. Nutr. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">538</span><span class="NLM_x">–</span> <span class="NLM_lpage">546</span><span class="refDoi"> DOI: 10.1016/j.jnutbio.2005.02.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1016%2Fj.jnutbio.2005.02.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=16115542" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsVWiu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2005&pages=538-546&author=D.+Caoauthor=R.+Xueauthor=J.+Xuauthor=Z.+Liu&title=Effects+of+docosahexaenoic+acid+on+the+survival+and+neurite+outgrowth+of+rat+cortical+neurons+in+primary+cultures&doi=10.1016%2Fj.jnutbio.2005.02.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of docosahexaenoic acid on the survival and neurite outgrowth of rat cortical neurons in primary cultures</span></div><div class="casAuthors">Cao, Dehua; Xue, Renhao; Xu, Jun; Liu, Zhili</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nutritional Biochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">538-546</span>CODEN:
                <span class="NLM_cas:coden">JNBIEL</span>;
        ISSN:<span class="NLM_cas:issn">0955-2863</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Effects of docosahexaenoic acid (DHA) on survival and neurite outgrowth were investigated in primary cultures of rat cortical neurons.  Cell cultures were prepd. from cortex on embryonic day 18 (E-18) for treatment with a series of DHA concns. (12.5, 25, 50, 75, 100 and 200 μM).  Docosahexaenoic acid (25-50 μM) significantly enhanced neuronal viability, but lower concn. of DHA (12.5 μM) did not show an obvious effect.  In contrast, higher concns. of DHA (100-200 μM) exerted the significant opposite effects by decreasing neuronal viability.  Furthermore, treatment with 25 μM DHA significantly prevented the neurons from death after different culture days in vitro (DIV).  Moreover, measurements from the cultures exposed to 25 μM DHA immediately after plating showed significant increases in the percentage of cells with neurites, the mean no. of neurite branches, the total neuritic length per cell and the length of the longest neurite in each cell after 24 and 48 h in vitro (HIV).  The DHA-treated neurons had greater growth-assocd. protein-43 (GAP-43) immunoactivity and higher phosphatidylserine (PS) and phosphatidylethanolamine (PE) contents, but lower phosphatidylcholine (PC) content than control neurons.  The significant increased DHA contents were also obsd. in both PE and PS in the treated neurons.  These findings suggest that optimal DHA (25 μM) may have pos. effects on the survival and the neurite outgrowth of the cultured fetal rat cortical neurons, and the effects probably are related to DHA-stimulating neuron-specific protein synthesis and its enhancing the discrete phospholipid (PL) content through enrichment of DHA in the PL species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovQscmVZruy7Vg90H21EOLACvtfcHk0lhNcp6M3dP6ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsVWiu7o%253D&md5=b36c888f3dfbf42d9cd2da52b088861d</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.jnutbio.2005.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jnutbio.2005.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DD.%26aulast%3DXue%26aufirst%3DR.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DZ.%26atitle%3DEffects%2520of%2520docosahexaenoic%2520acid%2520on%2520the%2520survival%2520and%2520neurite%2520outgrowth%2520of%2520rat%2520cortical%2520neurons%2520in%2520primary%2520cultures%26jtitle%3DJ.%2520Nutr.%2520Biochem.%26date%3D2005%26volume%3D16%26spage%3D538%26epage%3D546%26doi%3D10.1016%2Fj.jnutbio.2005.02.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Le Douaron, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadar, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debortoli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Séon-Méniel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrié, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michel, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Touboul, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunelle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raisman-Vozari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figadère, B.</span><span> </span><span class="NLM_article-title">Neuroprotective effects of a brain permeant 6-aminoquinoxaline derivative in cell culture conditions that model the loss of dopaminergic neurons in Parkinson disease</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">467</span><span class="NLM_x">–</span> <span class="NLM_lpage">479</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.10.067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1016%2Fj.ejmech.2014.10.067" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2015&pages=467-479&author=G.+Le+Douaronauthor=F.+Schmidtauthor=M.+Amarauthor=H.+Kadarauthor=L.+Debortoliauthor=A.+Latiniauthor=B.+S%C3%A9on-M%C3%A9nielauthor=L.+Ferri%C3%A9author=P.+P.+Michelauthor=D.+Touboulauthor=A.+Brunelleauthor=R.+Raisman-Vozariauthor=B.+Figad%C3%A8re&title=Neuroprotective+effects+of+a+brain+permeant+6-aminoquinoxaline+derivative+in+cell+culture+conditions+that+model+the+loss+of+dopaminergic+neurons+in+Parkinson+disease&doi=10.1016%2Fj.ejmech.2014.10.067"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.10.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.10.067%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BDouaron%26aufirst%3DG.%26aulast%3DSchmidt%26aufirst%3DF.%26aulast%3DAmar%26aufirst%3DM.%26aulast%3DKadar%26aufirst%3DH.%26aulast%3DDebortoli%26aufirst%3DL.%26aulast%3DLatini%26aufirst%3DA.%26aulast%3DS%25C3%25A9on-M%25C3%25A9niel%26aufirst%3DB.%26aulast%3DFerri%25C3%25A9%26aufirst%3DL.%26aulast%3DMichel%26aufirst%3DP.%2BP.%26aulast%3DTouboul%26aufirst%3DD.%26aulast%3DBrunelle%26aufirst%3DA.%26aulast%3DRaisman-Vozari%26aufirst%3DR.%26aulast%3DFigad%25C3%25A8re%26aufirst%3DB.%26atitle%3DNeuroprotective%2520effects%2520of%2520a%2520brain%2520permeant%25206-aminoquinoxaline%2520derivative%2520in%2520cell%2520culture%2520conditions%2520that%2520model%2520the%2520loss%2520of%2520dopaminergic%2520neurons%2520in%2520Parkinson%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D89%26spage%3D467%26epage%3D479%26doi%3D10.1016%2Fj.ejmech.2014.10.067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Adlard, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherny, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finkelstein, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gautier, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robb, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volitakis, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laughton, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolazzo, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkins, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deleva, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kok, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritchie, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanzi, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masters, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnham, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, A. I.</span><span> </span><span class="NLM_article-title">Rapid restoration of cognition in Alzheimer’s transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Ab</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span><span class="refDoi"> DOI: 10.1016/j.neuron.2008.06.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1016%2Fj.neuron.2008.06.018" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2008&pages=43-55&author=P.+A.+Adlardauthor=R.+A.+Chernyauthor=D.+I.+Finkelsteinauthor=E.+Gautierauthor=E.+Robbauthor=M.+Cortesauthor=I.+Volitakisauthor=X.+Liuauthor=J.+P.+Smithauthor=K.+Perezauthor=K.+Laughtonauthor=Q.-X.+Liauthor=S.+A.+Charmanauthor=J.+A.+Nicolazzoauthor=S.+Wilkinsauthor=K.+Delevaauthor=T.+Lynchauthor=G.+Kokauthor=C.+W.+Ritchieauthor=R.+E.+Tanziauthor=R.+Cappaiauthor=C.+L.+Mastersauthor=K.+J.+Barnhamauthor=A.+I.+Bush&title=Rapid+restoration+of+cognition+in+Alzheimer%E2%80%99s+transgenic+mice+with+8-hydroxy+quinoline+analogs+is+associated+with+decreased+interstitial+Ab&doi=10.1016%2Fj.neuron.2008.06.018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2008.06.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2008.06.018%26sid%3Dliteratum%253Aachs%26aulast%3DAdlard%26aufirst%3DP.%2BA.%26aulast%3DCherny%26aufirst%3DR.%2BA.%26aulast%3DFinkelstein%26aufirst%3DD.%2BI.%26aulast%3DGautier%26aufirst%3DE.%26aulast%3DRobb%26aufirst%3DE.%26aulast%3DCortes%26aufirst%3DM.%26aulast%3DVolitakis%26aufirst%3DI.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DSmith%26aufirst%3DJ.%2BP.%26aulast%3DPerez%26aufirst%3DK.%26aulast%3DLaughton%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DQ.-X.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DNicolazzo%26aufirst%3DJ.%2BA.%26aulast%3DWilkins%26aufirst%3DS.%26aulast%3DDeleva%26aufirst%3DK.%26aulast%3DLynch%26aufirst%3DT.%26aulast%3DKok%26aufirst%3DG.%26aulast%3DRitchie%26aufirst%3DC.%2BW.%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26aulast%3DCappai%26aufirst%3DR.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DBarnham%26aufirst%3DK.%2BJ.%26aulast%3DBush%26aufirst%3DA.%2BI.%26atitle%3DRapid%2520restoration%2520of%2520cognition%2520in%2520Alzheimer%25E2%2580%2599s%2520transgenic%2520mice%2520with%25208-hydroxy%2520quinoline%2520analogs%2520is%2520associated%2520with%2520decreased%2520interstitial%2520Ab%26jtitle%3DNeuron%26date%3D2008%26volume%3D59%26spage%3D43%26epage%3D55%26doi%3D10.1016%2Fj.neuron.2008.06.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Mandel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinreb, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amit, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span> </span><span class="NLM_article-title">Mechanism of neuroprotective action of the anti-Parkinson drug rasagiline and its derivatives</span> <span class="citation_source-journal">Brain Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">379</span><span class="NLM_x">–</span> <span class="NLM_lpage">387</span><span class="refDoi"> DOI: 10.1016/j.brainresrev.2004.12.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1016%2Fj.brainresrev.2004.12.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=15850677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjs1Clsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=379-387&author=S.+Mandelauthor=O.+Weinrebauthor=T.+Amitauthor=M.+B.+H.+Youdim&title=Mechanism+of+neuroprotective+action+of+the+anti-Parkinson+drug+rasagiline+and+its+derivatives&doi=10.1016%2Fj.brainresrev.2004.12.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of neuroprotective action of the anti-Parkinson drug rasagiline and its derivatives</span></div><div class="casAuthors">Mandel, Silvia; Weinreb, Orly; Amit, Tamar; Youdim, Moussa B. H.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">379-387</span>CODEN:
                <span class="NLM_cas:coden">BRERD2</span>;
        ISSN:<span class="NLM_cas:issn">0165-0173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The mitochondria are directly involved in cell survival and death.  Drugs that protect mitochondria viability and prevent apoptotic cascade mechanisms involved in mitochondrial permeability transition pore (MPTp) will be cytoprotective.  Rasagiline (N-propargyl-1R-aminoindan) is a novel, highly potent irreversible monoamine oxidase (MAO) B inhibitor, anti-Parkinson drug.  Unlike selegiline, rasagiline is not derived from amphetamine, is not metabolized to neurotoxic l-methamphetamine deriv., nor does it have sympathomimetic activity.  Rasagiline is effective as monotherapy or adjunct to L-dopa for patients with early and late Parkinson's disease (PD), and adverse events do not occur with greater frequency in subjects receiving rasagiline than those on placebo.  Controlled studies indicate that it might have a disease-modifying effect in PD that may be related to neuroprotection.  Its S-isomer, TVP1022, is a relatively inactive MAO inhibitor.  However, both drugs have similar neuroprotective activities in neuronal cell cultures in response to various neurotoxins and in vivo (global ischemia, neurotrauma, head injury, anoxia, etc.), indicating that MAO inhibition is not a pre-requisite for neuroprotection.  Structure activity studies have shown that the neuroprotective activity is assocd. with the propargyl moiety of rasagiline which protects mitochondrial viability and MPTp by activating Bcl-2 and protein kinase C (PKC), and down regulating pro-apoptotic FAS and Bax.  Rasagiline and its derivs. also process amyloid precursor protein (APP) to the neuroprotective-neurotrophic sol. APP alpha (sAPPα) by PKC and MAP kinase-dependent activation of α-secretase.  The neuroprotective activity of propargylamine has led us to develop novel bifunctional neuroprotective iron-chelating MAO-inhibiting drugs possessing propargyl moiety for the treatment of other neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqo-jzsUjjFfbVg90H21EOLACvtfcHk0lhVoTldGKpQkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjs1Clsr0%253D&md5=7defa497360ae91d0d8bea6f1e1ee6b0</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.brainresrev.2004.12.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainresrev.2004.12.027%26sid%3Dliteratum%253Aachs%26aulast%3DMandel%26aufirst%3DS.%26aulast%3DWeinreb%26aufirst%3DO.%26aulast%3DAmit%26aufirst%3DT.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26atitle%3DMechanism%2520of%2520neuroprotective%2520action%2520of%2520the%2520anti-Parkinson%2520drug%2520rasagiline%2520and%2520its%2520derivatives%26jtitle%3DBrain%2520Res.%2520Rev.%26date%3D2005%26volume%3D48%26spage%3D379%26epage%3D387%26doi%3D10.1016%2Fj.brainresrev.2004.12.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Weinreb, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amit, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Am, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span> </span><span class="NLM_article-title">Rasagiline: a novel anti-Parkinsonian monoamine oxidase-B inhibitor with neuroprotective activity</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">330</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span><span class="refDoi"> DOI: 10.1016/j.pneurobio.2010.06.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1016%2Fj.pneurobio.2010.06.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=20600573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVWmt7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2010&pages=330-344&author=O.+Weinrebauthor=T.+Amitauthor=O.+Bar-Amauthor=M.+B.+H.+Youdim&title=Rasagiline%3A+a+novel+anti-Parkinsonian+monoamine+oxidase-B+inhibitor+with+neuroprotective+activity&doi=10.1016%2Fj.pneurobio.2010.06.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Rasagiline: A novel anti-Parkinsonian monoamine oxidase-B inhibitor with neuroprotective activity</span></div><div class="casAuthors">Weinreb, Orly; Amit, Tamar; Bar-Am, Orit; Youdim, Moussa B. H.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">330-344</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Rasagiline (N-propargyl-1-(R)-aminoindan) is a novel, highly potent irreversible monoamine oxidase (MAO)-B inhibitor, anti-Parkinsonian drug.  Rasagiline is effective as monotherapy or adjunct to L-Dopa for patients with early and late Parkinson's disease (PD).  Its S-isomer, TVP1022 is thousand times less potent as an MAO-B inhibitor.  However, both compds. have similar mol. mechanisms of neuroprotection in neuronal cell cultures and animal neurodegenerative models, indicating that the neuroprotective effect of rasagiline does not depend on inhibition of MAO-B, but rather is assocd. with the N-propargyl moiety, which promotes mitochondrial viability and stabilizes permeability transition by regulating Bcl-2 family proteins.  Novel findings demonstrated that the major metabolite of rasagiline, 1-(R)-aminoindan has antioxidant and neuroprotective capabilities and thus, may contribute to the overt activity of its parent compd., rasagiline.  This paper will review the earlier and present studies in the development of rasagiline for treatment of PD and discuss its pharmacol. and applicable mechanism of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSUYfAZtuEY7Vg90H21EOLACvtfcHk0lhrfa9wCvcgvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVWmt7%252FL&md5=02539198de5f5360d2d458de7a44bfe4</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2010.06.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2010.06.008%26sid%3Dliteratum%253Aachs%26aulast%3DWeinreb%26aufirst%3DO.%26aulast%3DAmit%26aufirst%3DT.%26aulast%3DBar-Am%26aufirst%3DO.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26atitle%3DRasagiline%253A%2520a%2520novel%2520anti-Parkinsonian%2520monoamine%2520oxidase-B%2520inhibitor%2520with%2520neuroprotective%2520activity%26jtitle%3DProg.%2520Neurobiol.%26date%3D2010%26volume%3D92%26spage%3D330%26epage%3D344%26doi%3D10.1016%2Fj.pneurobio.2010.06.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Guerreiro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toulorge, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marien, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sokoloff, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michel, P. P.</span><span> </span><span class="NLM_article-title">Paraxanthine, the primary metabolite of caffeine, provides protection against dopaminergic cell death via stimulation of ryanodine receptor channels</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">980</span><span class="NLM_x">–</span> <span class="NLM_lpage">989</span><span class="refDoi"> DOI: 10.1124/mol.108.048207</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1124%2Fmol.108.048207" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2008&pages=980-989&author=S.+Guerreiroauthor=D.+Toulorgeauthor=E.+Hirschauthor=M.+Marienauthor=P.+Sokoloffauthor=P.+P.+Michel&title=Paraxanthine%2C+the+primary+metabolite+of+caffeine%2C+provides+protection+against+dopaminergic+cell+death+via+stimulation+of+ryanodine+receptor+channels&doi=10.1124%2Fmol.108.048207"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1124%2Fmol.108.048207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.108.048207%26sid%3Dliteratum%253Aachs%26aulast%3DGuerreiro%26aufirst%3DS.%26aulast%3DToulorge%26aufirst%3DD.%26aulast%3DHirsch%26aufirst%3DE.%26aulast%3DMarien%26aufirst%3DM.%26aulast%3DSokoloff%26aufirst%3DP.%26aulast%3DMichel%26aufirst%3DP.%2BP.%26atitle%3DParaxanthine%252C%2520the%2520primary%2520metabolite%2520of%2520caffeine%252C%2520provides%2520protection%2520against%2520dopaminergic%2520cell%2520death%2520via%2520stimulation%2520of%2520ryanodine%2520receptor%2520channels%26jtitle%3DMol.%2520Pharmacol.%26date%3D2008%26volume%3D74%26spage%3D980%26epage%3D989%26doi%3D10.1124%2Fmol.108.048207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Xu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarzschild, M. A.</span><span> </span><span class="NLM_article-title">Neuroprotection by caffeine: time course and role of its metabolites in the MPTP model of Parkinson’s disease</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">167</span><span class="NLM_x">, </span> <span class="NLM_fpage">475</span><span class="NLM_x">–</span> <span class="NLM_lpage">481</span><span class="refDoi"> DOI: 10.1016/j.neuroscience.2010.02.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1016%2Fj.neuroscience.2010.02.020" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2010&pages=475-481&author=K.+Xuauthor=Y.+H.+Xuauthor=J.+F.+Chenauthor=M.+A.+Schwarzschild&title=Neuroprotection+by+caffeine%3A+time+course+and+role+of+its+metabolites+in+the+MPTP+model+of+Parkinson%E2%80%99s+disease&doi=10.1016%2Fj.neuroscience.2010.02.020"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2010.02.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2010.02.020%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DK.%26aulast%3DXu%26aufirst%3DY.%2BH.%26aulast%3DChen%26aufirst%3DJ.%2BF.%26aulast%3DSchwarzschild%26aufirst%3DM.%2BA.%26atitle%3DNeuroprotection%2520by%2520caffeine%253A%2520time%2520course%2520and%2520role%2520of%2520its%2520metabolites%2520in%2520the%2520MPTP%2520model%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNeuroscience%26date%3D2010%26volume%3D167%26spage%3D475%26epage%3D481%26doi%3D10.1016%2Fj.neuroscience.2010.02.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Hinsberg, O.</span><span> </span><span class="NLM_article-title">Ueber chinoxaline</span> <span class="citation_source-journal">Ber. Dtsch. Chem. Ges.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1884</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">318</span><span class="NLM_x">–</span> <span class="NLM_lpage">323</span><span class="refDoi"> DOI: 10.1002/cber.18840170193</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1002%2Fcber.18840170193" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1884&pages=318-323&author=O.+Hinsberg&title=Ueber+chinoxaline&doi=10.1002%2Fcber.18840170193"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fcber.18840170193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcber.18840170193%26sid%3Dliteratum%253Aachs%26aulast%3DHinsberg%26aufirst%3DO.%26atitle%3DUeber%2520chinoxaline%26jtitle%3DBer.%2520Dtsch.%2520Chem.%2520Ges.%26date%3D1884%26volume%3D17%26spage%3D318%26epage%3D323%26doi%3D10.1002%2Fcber.18840170193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Hui, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fakhfakh, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franck, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figadère, B.</span><span> </span><span class="NLM_article-title">A new preparation of 2-substituted-7-aminoquinoxalines and 2,3-disubstituted-7-aminoquinoxalines</span> <span class="citation_source-journal">Heterocycles</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">361</span><span class="refDoi"> DOI: 10.3987/COM-06-S(K)19</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.3987%2FCOM-06-S%28K%2919" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2007&pages=353-361&author=X.+Huiauthor=F.+Schmidtauthor=M.+A.+Fakhfakhauthor=X.+Franckauthor=B.+Figad%C3%A8re&title=A+new+preparation+of+2-substituted-7-aminoquinoxalines+and+2%2C3-disubstituted-7-aminoquinoxalines&doi=10.3987%2FCOM-06-S%28K%2919"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.3987%2FCOM-06-S%28K%2919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3987%252FCOM-06-S%2528K%252919%26sid%3Dliteratum%253Aachs%26aulast%3DHui%26aufirst%3DX.%26aulast%3DSchmidt%26aufirst%3DF.%26aulast%3DFakhfakh%26aufirst%3DM.%2BA.%26aulast%3DFranck%26aufirst%3DX.%26aulast%3DFigad%25C3%25A8re%26aufirst%3DB.%26atitle%3DA%2520new%2520preparation%2520of%25202-substituted-7-aminoquinoxalines%2520and%25202%252C3-disubstituted-7-aminoquinoxalines%26jtitle%3DHeterocycles%26date%3D2007%26volume%3D72%26spage%3D353%26epage%3D361%26doi%3D10.3987%2FCOM-06-S%28K%2919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Deng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span> </span><span class="NLM_article-title">Design and synthesis of small molecule RhoA inhibitors: a new promising therapy for cardiovascular diseases?</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">4508</span><span class="NLM_x">–</span> <span class="NLM_lpage">4522</span><span class="refDoi"> DOI: 10.1021/jm200161c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200161c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4508-4522&author=J.+Dengauthor=E.+G.+Fengauthor=S.+Maauthor=Y.+Zhangauthor=X.+F.+Liuauthor=H.+L.+Liauthor=H.+Huangauthor=J.+Zhuauthor=W.+L.+Zhuauthor=X.+Shenauthor=L.+Y.+Miaoauthor=H.+Liuauthor=H.+L.+Jiangauthor=J.+Li&title=Design+and+synthesis+of+small+molecule+RhoA+inhibitors%3A+a+new+promising+therapy+for+cardiovascular+diseases%3F&doi=10.1021%2Fjm200161c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm200161c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200161c%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DJ.%26aulast%3DFeng%26aufirst%3DE.%2BG.%26aulast%3DMa%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DX.%2BF.%26aulast%3DLi%26aufirst%3DH.%2BL.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DW.%2BL.%26aulast%3DShen%26aufirst%3DX.%26aulast%3DMiao%26aufirst%3DL.%2BY.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DH.%2BL.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520small%2520molecule%2520RhoA%2520inhibitors%253A%2520a%2520new%2520promising%2520therapy%2520for%2520cardiovascular%2520diseases%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D4508%26epage%3D4522%26doi%3D10.1021%2Fjm200161c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Holman, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, A. D.</span><span> </span><span class="NLM_article-title">Preparation and cyclization of some N-(2,2-dimethylpropargyl) homo- and heteroaromatic amines and the synthesis of some pyrido[2,3-d]pyrimidines</span> <span class="citation_source-journal">Aust. J. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">368</span><span class="NLM_x">–</span> <span class="NLM_lpage">374</span><span class="refDoi"> DOI: 10.1071/CH04260</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1071%2FCH04260" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2005&pages=368-374&author=M.+A.+Holmanauthor=N.+M.+Williamsonauthor=A.+D.+Ward&title=Preparation+and+cyclization+of+some+N-%282%2C2-dimethylpropargyl%29+homo-+and+heteroaromatic+amines+and+the+synthesis+of+some+pyrido%5B2%2C3-d%5Dpyrimidines&doi=10.1071%2FCH04260"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1071%2FCH04260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1071%252FCH04260%26sid%3Dliteratum%253Aachs%26aulast%3DHolman%26aufirst%3DM.%2BA.%26aulast%3DWilliamson%26aufirst%3DN.%2BM.%26aulast%3DWard%26aufirst%3DA.%2BD.%26atitle%3DPreparation%2520and%2520cyclization%2520of%2520some%2520N-%25282%252C2-dimethylpropargyl%2529%2520homo-%2520and%2520heteroaromatic%2520amines%2520and%2520the%2520synthesis%2520of%2520some%2520pyrido%255B2%252C3-d%255Dpyrimidines%26jtitle%3DAust.%2520J.%2520Chem.%26date%3D2005%26volume%3D58%26spage%3D368%26epage%3D374%26doi%3D10.1071%2FCH04260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Rousseau, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michel, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, E. C.</span><span> </span><span class="NLM_article-title">The iron-binding protein lactoferrin protects vulnerable dopamine neurons from degeneration by preserving mitochondrial calcium homeostasis</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">888</span><span class="NLM_x">–</span> <span class="NLM_lpage">898</span><span class="refDoi"> DOI: 10.1124/mol.113.087965</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1124%2Fmol.113.087965" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2013&pages=888-898&author=E.+Rousseauauthor=P.+P.+Michelauthor=E.+C.+Hirsch&title=The+iron-binding+protein+lactoferrin+protects+vulnerable+dopamine+neurons+from+degeneration+by+preserving+mitochondrial+calcium+homeostasis&doi=10.1124%2Fmol.113.087965"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1124%2Fmol.113.087965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.113.087965%26sid%3Dliteratum%253Aachs%26aulast%3DRousseau%26aufirst%3DE.%26aulast%3DMichel%26aufirst%3DP.%2BP.%26aulast%3DHirsch%26aufirst%3DE.%2BC.%26atitle%3DThe%2520iron-binding%2520protein%2520lactoferrin%2520protects%2520vulnerable%2520dopamine%2520neurons%2520from%2520degeneration%2520by%2520preserving%2520mitochondrial%2520calcium%2520homeostasis%26jtitle%3DMol.%2520Pharmacol.%26date%3D2013%26volume%3D84%26spage%3D888%26epage%3D898%26doi%3D10.1124%2Fmol.113.087965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Toulorge, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerreiro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hild, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maskos, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michel, P. P.</span><span> </span><span class="NLM_article-title">Neuroprotection of midbrain dopamine neurons by nicotine is gated by cytoplasmic Ca<sub>2</sub>+</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">2563</span><span class="NLM_x">–</span> <span class="NLM_lpage">2573</span><span class="refDoi"> DOI: 10.1096/fj.11-182824</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1096%2Ffj.11-182824" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=2563-2573&author=D.+Toulorgeauthor=S.+Guerreiroauthor=A.+Hildauthor=U.+Maskosauthor=E.+C.+Hirschauthor=P.+P.+Michel&title=Neuroprotection+of+midbrain+dopamine+neurons+by+nicotine+is+gated+by+cytoplasmic+Ca2%2B&doi=10.1096%2Ffj.11-182824"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1096%2Ffj.11-182824&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.11-182824%26sid%3Dliteratum%253Aachs%26aulast%3DToulorge%26aufirst%3DD.%26aulast%3DGuerreiro%26aufirst%3DS.%26aulast%3DHild%26aufirst%3DA.%26aulast%3DMaskos%26aufirst%3DU.%26aulast%3DHirsch%26aufirst%3DE.%2BC.%26aulast%3DMichel%26aufirst%3DP.%2BP.%26atitle%3DNeuroprotection%2520of%2520midbrain%2520dopamine%2520neurons%2520by%2520nicotine%2520is%2520gated%2520by%2520cytoplasmic%2520Ca2%252B%26jtitle%3DFASEB%2520J.%26date%3D2011%26volume%3D25%26spage%3D2563%26epage%3D2573%26doi%3D10.1096%2Ffj.11-182824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Michel, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agid, Y.</span><span> </span><span class="NLM_article-title">Chronic activation of the cyclic AMP signaling pathway promotes development and long-term survival of mesencephalic dopaminergic neurons</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">1633</span><span class="NLM_x">–</span> <span class="NLM_lpage">1642</span><span class="refDoi"> DOI: 10.1046/j.1471-4159.1996.67041633.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1046%2Fj.1471-4159.1996.67041633.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=8858948" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=1%3ACAS%3A528%3ADyaK28XmtVWitb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=1996&pages=1633-1642&author=P.+P.+Michelauthor=Y.+Agid&title=Chronic+activation+of+the+cyclic+AMP+signaling+pathway+promotes+development+and+long-term+survival+of+mesencephalic+dopaminergic+neurons&doi=10.1046%2Fj.1471-4159.1996.67041633.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic activation of the cyclic AMP signaling pathway promotes development and long-term survival of mesencephalic dopaminergic neurons</span></div><div class="casAuthors">Michel, Patrick P.; Agid, Yves</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1633-1642</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott-Raven</span>)
        </div><div class="casAbstract">Di-Bu cAMP (dbcAMP), a permeant analog of cAMP, prevented, for at least 3 wk, the death of tyrosine hydroxylase (TH)-immunopos. dopaminergic neurons, which occurred spontaneously by apoptosis in mesencephalic cultures.  Treatment with the cyclic nucleotide analog also led to a significant increase in the uptake of [3H]dopamine, attesting that the rescued TH+ neurons were fully functional and differentiated, dbcAMP was most effective when added immediately after plating, but delayed treatment could still arrest the ongoing degenerative process.  Trophic/survival effects were long-lasting, declining only progressively after withdrawal of dbcAMP from the culture medium.  They were independent of cell d. and still detectable in the absence of serum proteins.  The effects of dbcAMP were mimicked by depolarizing concns. of potassium and by agents that increase endogenous prodn. of cAMP, such as forskolin or 3-isobutyl-1-methylxanthine, but not by native cAMP, which cannot cross cell membranes.  Elimination of glial cells by arabinoside-C did not reduce the activity of dbcAMP.  GABAergic neurons, also present in these cultures, were much less dependent on the cyclic nucleotide analog for their survival, and serotoninergic cells were not dependent at all.  Therefore, cAMP-dependent signaling may be particularly crucial for the maturation and long-term survival of mesencephalic dopaminergic neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8wVJwOPv_7rVg90H21EOLACvtfcHk0lgBf9hF7xSyGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmtVWitb0%253D&md5=f976dd63e117454712bdc1811357e2f1</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.1996.67041633.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.1996.67041633.x%26sid%3Dliteratum%253Aachs%26aulast%3DMichel%26aufirst%3DP.%2BP.%26aulast%3DAgid%26aufirst%3DY.%26atitle%3DChronic%2520activation%2520of%2520the%2520cyclic%2520AMP%2520signaling%2520pathway%2520promotes%2520development%2520and%2520long-term%2520survival%2520of%2520mesencephalic%2520dopaminergic%2520neurons%26jtitle%3DJ.%2520Neurochem.%26date%3D1996%26volume%3D67%26spage%3D1633%26epage%3D1642%26doi%3D10.1046%2Fj.1471-4159.1996.67041633.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Michel, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agid, Y.</span><span> </span><span class="NLM_article-title">Rescue of mesencephalic dopamine neurons by anticancer drug cytosine arabinoside</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">1499</span><span class="NLM_x">–</span> <span class="NLM_lpage">1507</span><span class="refDoi"> DOI: 10.1046/j.1471-4159.1997.69041499.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1046%2Fj.1471-4159.1997.69041499.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=9326279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=1%3ACAS%3A528%3ADyaK2sXmsVCksLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=1997&pages=1499-1507&author=P.+P.+Michelauthor=M.+Rubergauthor=Y.+Agid&title=Rescue+of+mesencephalic+dopamine+neurons+by+anticancer+drug+cytosine+arabinoside&doi=10.1046%2Fj.1471-4159.1997.69041499.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Rescue of mesencephalic dopamine neurons by anticancer drug cytosine arabinoside</span></div><div class="casAuthors">Michel, Patrick P.; Ruberg, Merle; Agid, Yves</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1499-1507</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott-Raven</span>)
        </div><div class="casAbstract">Nanomolar concns. of cytosine arabinoside (ara-C), a structural analog of 2'-deoxycytidine (2'dC) used in the chemotherapy of cancer, proved to be highly effective in preventing the death of postmitotic dopaminergic neurons that occurs spontaneously by apoptosis in mesencephalic cultures.  The rescued cells were totally functional and highly differentiated.  The trophic/neuroprotective effects of ara-C were (1) specific for dopaminergic neurons; (2) long-lived, remaining detectable several days after withdrawal of the nucleoside analog from the culture medium; (3) still obsd. when the treatment was delayed after plating; (4) abolished by an excess of 2'dC or dCTP, or by exposure to the neurotoxin 1-methyl-4-phenylpyridinium; and (5) mimicked by ara-CTP, 5-fluoro-2'-deoxyuridine, and aphidicolin.  Autoradiog. studies revealed that ara-C was incorporated exclusively into astrocyte nuclei, suggesting that the dopaminotrophic activity was indirect and resulted from the antiproliferative action of the modified nucleoside on glial cells at concns. that were not neurotoxic.  No evidence was found for putative deleterious or trophic mols. secreted by proliferating or ara-C-treated astrocytes, resp., suggesting that neuroglial contact may play a role.  Our results suggest a possible mechanism underlying neurodegeneration in Parkinson's disease, where selective loss of dopaminergic neurons in the mesencephalon is accompanied by astrogliosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-6-ya9PGverVg90H21EOLACvtfcHk0lgBf9hF7xSyGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmsVCksLo%253D&md5=6097a5c963f110e6ff7b927b152d4b52</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.1997.69041499.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.1997.69041499.x%26sid%3Dliteratum%253Aachs%26aulast%3DMichel%26aufirst%3DP.%2BP.%26aulast%3DRuberg%26aufirst%3DM.%26aulast%3DAgid%26aufirst%3DY.%26atitle%3DRescue%2520of%2520mesencephalic%2520dopamine%2520neurons%2520by%2520anticancer%2520drug%2520cytosine%2520arabinoside%26jtitle%3DJ.%2520Neurochem.%26date%3D1997%26volume%3D69%26spage%3D1499%26epage%3D1507%26doi%3D10.1046%2Fj.1471-4159.1997.69041499.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Tian, D.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, D.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Z.-y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, M.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span> </span><span class="NLM_article-title">Attenuation of astrogliosis by suppressing of microglial proliferation with the cell cycle inhibitor olomoucine in rat spinal cord injury model</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">1154</span><span class="NLM_x">, </span> <span class="NLM_fpage">206</span><span class="NLM_x">–</span> <span class="NLM_lpage">214</span><span class="refDoi"> DOI: 10.1016/j.brainres.2007.04.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1016%2Fj.brainres.2007.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=17482149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmt1ynsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1154&publication_year=2007&pages=206-214&author=D.-S.+Tianauthor=Q.+Dongauthor=D.-J.+Panauthor=Y.+Heauthor=Z.-y.+Yuauthor=M.-J.+Xieauthor=W.+Wang&title=Attenuation+of+astrogliosis+by+suppressing+of+microglial+proliferation+with+the+cell+cycle+inhibitor+olomoucine+in+rat+spinal+cord+injury+model&doi=10.1016%2Fj.brainres.2007.04.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Attenuation of astrogliosis by suppressing of microglial proliferation with the cell cycle inhibitor olomoucine in rat spinal cord injury model</span></div><div class="casAuthors">Tian, Dai-shi; Dong, Qiang; Pan, Deng-ji; He, Yi; Yu, Zhi-yuan; Xie, Min-jie; Wang, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1154</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">206-214</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Microglial activation/proliferation and reactive astrogliosis are commonly obsd. and have been considered to be closely relevant pathol. processes during spinal cord injury (SCI).  However, the mol. mechanisms underlying this microglial-astroglial interaction are still poorly understood.  We showed recently that the continuous injection of the cell cycle inhibitor olomoucine not only markedly suppressed microglial proliferation and assocd. release of pro-inflammatory cytokines, but also attenuated astroglial scar formation and the lesion cavity and mitigated the functional deficits in rat SCI animal model.  In this study, we asked whether microglial activation/proliferation plays an initial role and also necessary in maintaining astrogliosis in SCI model.  Our results showed that traumatic induced microglial activation/proliferation precedes astrogliosis, and the up-regulated GFAP expression at both mRNA and protein levels was temporally posterior to the microglial activation.  Furthermore, when the cell cycle inhibitor olomoucine was administered only once 1 h post-SCI that should selectively suppress microglial proliferation, the subsequent SCI induced increase in GFAP expression at 1, 2 and 4 wk was significantly attenuated, suggesting that microglial activation/proliferation played an important role for the later onset astrogliosis after SCI.  Consistent with the results that microglial proliferation always precedes astroglial proliferation and there is at present no evidence of other astroglial precursors, which as always does not mean that they will not be uncovered by further searching, and in view of the fact that microglial-derived pro-inflammatory cytokines promote astrogliosis as we reported recently, these findings together suggest that by release of cytokines and other sol. products, the early onset microglial activation/proliferation can significantly influence the subsequent development of reactive astrogliosis and glial scar formation in SCI animal model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSNS9ziTBd8bVg90H21EOLACvtfcHk0lgBf9hF7xSyGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmt1ynsb8%253D&md5=5781b79baf8cac74cd121bef0974f5c0</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2007.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2007.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DTian%26aufirst%3DD.-S.%26aulast%3DDong%26aufirst%3DQ.%26aulast%3DPan%26aufirst%3DD.-J.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DZ.-y.%26aulast%3DXie%26aufirst%3DM.-J.%26aulast%3DWang%26aufirst%3DW.%26atitle%3DAttenuation%2520of%2520astrogliosis%2520by%2520suppressing%2520of%2520microglial%2520proliferation%2520with%2520the%2520cell%2520cycle%2520inhibitor%2520olomoucine%2520in%2520rat%2520spinal%2520cord%2520injury%2520model%26jtitle%3DBrain%2520Res.%26date%3D2007%26volume%3D1154%26spage%3D206%26epage%3D214%26doi%3D10.1016%2Fj.brainres.2007.04.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Hailer, N. P.</span><span> </span><span class="NLM_article-title">Immunosuppression after traumatic or ischemic CNS damage: It is neuroprotective and illuminates the role of microglial cells</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">233</span><span class="refDoi"> DOI: 10.1016/j.pneurobio.2007.12.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1016%2Fj.pneurobio.2007.12.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=18262323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitlektbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2008&pages=211-233&author=N.+P.+Hailer&title=Immunosuppression+after+traumatic+or+ischemic+CNS+damage%3A+It+is+neuroprotective+and+illuminates+the+role+of+microglial+cells&doi=10.1016%2Fj.pneurobio.2007.12.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Immunosuppression after traumatic or ischemic CNS damage: It is neuroprotective and illuminates the role of microglial cells</span></div><div class="casAuthors">Hailer, Nils P.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">211-233</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Acute traumatic and ischemic events in the central nervous system (CNS) invariably result in activation of microglial cells as local representatives of the immune system.  It is still under debate whether activated microglia promote neuronal survival, or whether they exacerbate the original extent of neuronal damage.  Protagonists of the view that microglial cells cause secondary damage have proposed that inhibition of microglial activation by immunosuppression is beneficial after acute CNS damage.  It is the aim of this review to analyze the effects of immunosuppressants on isolated microglial cells and neurons, and to scrutinize the effects of immunosuppression in different in vivo models of acute CNS trauma or ischemia.  It is found that the immunosuppressants cytosine-arabinoside, different steroids, cyclosporin A, FK506, rapamycin, mycophenolate mofetil, and minocycline all have direct inhibitory effects on microglial cells.  These effects are mainly exerted by inhibiting microglial proliferation or microglial secretion of neurotoxic substances such as proinflammatory cytokines and nitric oxide.  Furthermore, immunosuppression after acute CNS trauma or ischemia results in improved structure preservation and, mostly, in enhanced function.  However, all investigated immunosuppressants also have direct effects on neurons, and some immunosuppressants affect other glial cells such as astrocytes.  In summary, it is safe to conclude that immunosuppression after acute CNS trauma or ischemia is neuroprotective.  Furthermore, circumferential evidence indicates that microglial activation after traumatic or ischemic CNS damage is not beneficial to adjacent neurons in the immediate aftermath of such acute lesions.  Further expts. with more specific agents or genetic approaches that specifically inhibit microglial cells are needed in order to fully answer the question of whether microglial activation is "good or bad".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV7s6ccRvs77Vg90H21EOLACvtfcHk0lhQhLOZ965bvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitlektbk%253D&md5=9c3cb72eae0057051102e54a47bab58c</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2007.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2007.12.001%26sid%3Dliteratum%253Aachs%26aulast%3DHailer%26aufirst%3DN.%2BP.%26atitle%3DImmunosuppression%2520after%2520traumatic%2520or%2520ischemic%2520CNS%2520damage%253A%2520It%2520is%2520neuroprotective%2520and%2520illuminates%2520the%2520role%2520of%2520microglial%2520cells%26jtitle%3DProg.%2520Neurobiol.%26date%3D2008%26volume%3D84%26spage%3D211%26epage%3D233%26doi%3D10.1016%2Fj.pneurobio.2007.12.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Mourlevat, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troadec, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michel, P. P.</span><span> </span><span class="NLM_article-title">Prevention of dopaminergic neuronal death by cyclic AMP in mixed neuronal/Glial mesencephalic cultures requires the repression of presumptive astrocytes</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">578</span><span class="NLM_x">–</span> <span class="NLM_lpage">586</span><span class="refDoi"> DOI: 10.1124/mol.64.3.578</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1124%2Fmol.64.3.578" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2003&pages=578-586&author=S.+Mourlevatauthor=J.+D.+Troadecauthor=M.+Rubergauthor=P.+P.+Michel&title=Prevention+of+dopaminergic+neuronal+death+by+cyclic+AMP+in+mixed+neuronal%2FGlial+mesencephalic+cultures+requires+the+repression+of+presumptive+astrocytes&doi=10.1124%2Fmol.64.3.578"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1124%2Fmol.64.3.578&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.64.3.578%26sid%3Dliteratum%253Aachs%26aulast%3DMourlevat%26aufirst%3DS.%26aulast%3DTroadec%26aufirst%3DJ.%2BD.%26aulast%3DRuberg%26aufirst%3DM.%26aulast%3DMichel%26aufirst%3DP.%2BP.%26atitle%3DPrevention%2520of%2520dopaminergic%2520neuronal%2520death%2520by%2520cyclic%2520AMP%2520in%2520mixed%2520neuronal%252FGlial%2520mesencephalic%2520cultures%2520requires%2520the%2520repression%2520of%2520presumptive%2520astrocytes%26jtitle%3DMol.%2520Pharmacol.%26date%3D2003%26volume%3D64%26spage%3D578%26epage%3D586%26doi%3D10.1124%2Fmol.64.3.578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Ciliax, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heilman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demchyshyn, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pristupa, Z. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ince, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hersch, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niznik, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levey, A. I.</span><span> </span><span class="NLM_article-title">The dopamine transporter: immunochemical characterization and localization in brain</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1714</span><span class="NLM_x">–</span> <span class="NLM_lpage">1723</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1523%2FJNEUROSCI.15-03-01714.1995" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=7534339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=1%3ACAS%3A528%3ADyaK2MXksVegu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1995&pages=1714-1723&author=B.+J.+Ciliaxauthor=C.+Heilmanauthor=L.+L.+Demchyshynauthor=Z.+B.+Pristupaauthor=E.+Inceauthor=S.+M.+Herschauthor=H.+B.+Niznikauthor=A.+I.+Levey&title=The+dopamine+transporter%3A+immunochemical+characterization+and+localization+in+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The dopamine transporter: immunochemical characterization and localization in brain</span></div><div class="casAuthors">Ciliax, Brian J.; Heilman, Craig; Demchyshyn, Lidia L.; Pristupa, Zdenek B.; Ince, Ernesto; Hersch, Steven M.; Niznik, Hyman B.; Levey, Allan I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3, Pt. 1</span>),
    <span class="NLM_cas:pages">1714-23</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Antibodies specific for the dopamine transporter (DAT) were developed and characterized by immunoblot anal., immunopptn., and immunocytochem., and used for immunolocalization of transporter protein in rat brain at the light microscopic level.  Antibodies targeting the N-terminus, the second extracellular loop, and the C-terminus were generated from fusion proteins contg. amino acid sequences from these resp. regions.  Immunoblot anal. demonstrated that N-terminus and loop antibodies were specific for expressed cloned DAT, recognized transporter protein in rat and human striatal membranes, and were sensitive to preabsorption with excess homologs fusion protein.  Immunopptn. studies demonstrated that anti-DAT antisera recognized solubilized, radiolabeled DAT protein in a concn.-dependent manner.  DAT immunocytochem. with these antibodies were also sensitive to preabsorption with fusion protein and to lesions of dopaminergic mesostriatal and mesocorticolimbic pathways.  Regional distribution of DAT coincided with established dopaminergic innervation of several regions, including ventral mesencephalon, medial forebrain bundle, and dorsal and ventral striatum.  However, certain mismatches between immunocytochem. distributions of DAT and tyrosine hydroxylase were apparent, indicating that dopaminergic systems are heterogeneous and may use independent mechanisms for the regulation of dopamine levels in brain.  The generation of specific DAT antibodies will permit further characterization of the cellular and subcellular localization of DAT protein, and of dopaminergic circuits in neurol. and psychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfjjVCGF3sKbVg90H21EOLACvtfcHk0lhlY1cf35li7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXksVegu7w%253D&md5=8da0687e1226112c5e21eed4f90ed095</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.15-03-01714.1995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.15-03-01714.1995%26sid%3Dliteratum%253Aachs%26aulast%3DCiliax%26aufirst%3DB.%2BJ.%26aulast%3DHeilman%26aufirst%3DC.%26aulast%3DDemchyshyn%26aufirst%3DL.%2BL.%26aulast%3DPristupa%26aufirst%3DZ.%2BB.%26aulast%3DInce%26aufirst%3DE.%26aulast%3DHersch%26aufirst%3DS.%2BM.%26aulast%3DNiznik%26aufirst%3DH.%2BB.%26aulast%3DLevey%26aufirst%3DA.%2BI.%26atitle%3DThe%2520dopamine%2520transporter%253A%2520immunochemical%2520characterization%2520and%2520localization%2520in%2520brain%26jtitle%3DJ.%2520Neurosci.%26date%3D1995%26volume%3D15%26spage%3D1714%26epage%3D1723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Toulorge, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerreiro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michel, P. P.</span><span> </span><span class="NLM_article-title">KATP channel blockade protects midbrain dopamine neurons by repressing a glia-to-neuron signaling cascade that ultimately disrupts mitochondrial calcium homeostasis</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">553</span><span class="NLM_x">–</span> <span class="NLM_lpage">564</span><span class="refDoi"> DOI: 10.1111/j.1471-4159.2010.06785.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1111%2Fj.1471-4159.2010.06785.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=20456014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=1%3ACAS%3A528%3ADC%252BC3cXovFKitr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2010&pages=553-564&author=D.+Toulorgeauthor=S.+Guerreiroauthor=E.+C.+Hirschauthor=P.+P.+Michel&title=KATP+channel+blockade+protects+midbrain+dopamine+neurons+by+repressing+a+glia-to-neuron+signaling+cascade+that+ultimately+disrupts+mitochondrial+calcium+homeostasis&doi=10.1111%2Fj.1471-4159.2010.06785.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">KATP channel blockade protects midbrain dopamine neurons by repressing a glia-to-neuron signaling cascade that ultimately disrupts mitochondrial calcium homeostasis</span></div><div class="casAuthors">Toulorge, Damien; Guerreiro, Serge; Hirsch, Etienne C.; Michel, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">553-564</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">While KATP channels serve primarily as metabolic gatekeepers in excitable cells, they might also participate in other important cellular functions.  Here, we demonstrate that KATP channel blockade with the sulfonylurea deriv. glibenclamide provided robust protection to dopamine neurons undergoing spontaneous and selective degeneration in midbrain cultures.  Unexpectedly, glibenclamide operated not by a direct effect on dopamine neurons but instead by halting the proliferation of a population of immature glial cells lacking astrocytic and microglial markers.  The antimitotic effect of glibenclamide appeared essential to unmask a pro-survival phosphoinositide 3-kinase (PI3K)/Akt-dependent signaling pathway that controlled shuttling of calcium from endoplasmic reticulum to mitochondria in dopamine neurons.  Preventing integrin-ligand interactions with a decoy ligand, the Arg-Gly-Asp-Ser sequence peptide, reproduced survival promotion by glibenclamide via a mechanism that also required PI3K/Akt-dependent regulation of mitochondrial calcium.  Noticeably, Arg-Gly-Asp-Ser did not cause a redn. in glial cell nos. indicating that it prevented the death process downstream of the level at which glibenclamide intervenes.  Based on these results, we propose that KATP channel blockade protected dopamine neurons by inhibiting a glia-to-neuron signaling pathway that propagates through integrin/ ligand interactions and ultimately disrupts PI3K/Akt-dependent signaling and mitochondrial calcium homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7LYz6Qevl3bVg90H21EOLACvtfcHk0lhlY1cf35li7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXovFKitr8%253D&md5=df2d7ae94cf5e264d22d6430f8fd3896</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2010.06785.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2010.06785.x%26sid%3Dliteratum%253Aachs%26aulast%3DToulorge%26aufirst%3DD.%26aulast%3DGuerreiro%26aufirst%3DS.%26aulast%3DHirsch%26aufirst%3DE.%2BC.%26aulast%3DMichel%26aufirst%3DP.%2BP.%26atitle%3DKATP%2520channel%2520blockade%2520protects%2520midbrain%2520dopamine%2520neurons%2520by%2520repressing%2520a%2520glia-to-neuron%2520signaling%2520cascade%2520that%2520ultimately%2520disrupts%2520mitochondrial%2520calcium%2520homeostasis%26jtitle%3DJ.%2520Neurochem.%26date%3D2010%26volume%3D114%26spage%3D553%26epage%3D564%26doi%3D10.1111%2Fj.1471-4159.2010.06785.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Fill, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copello, J. A.</span><span> </span><span class="NLM_article-title">Ryanodine receptor calcium release channels</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">893</span><span class="NLM_x">–</span> <span class="NLM_lpage">922</span><span class="refDoi"> DOI: 10.1152/physrev.00013.2002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1152%2Fphysrev.00013.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=12270947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=1%3ACAS%3A528%3ADC%252BD38Xot1Ggurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2002&pages=893-922&author=M.+Fillauthor=J.+A.+Copello&title=Ryanodine+receptor+calcium+release+channels&doi=10.1152%2Fphysrev.00013.2002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Ryanodine receptor calcium release channels</span></div><div class="casAuthors">Fill, Michael; Copello, Julio A.</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">893-922</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  The ryanodine receptors (RyRs) are a family of Ca2+ release channels found on intracellular Ca2+ storage/release organelles.  The RyR channels are ubiquitously expressed in many types of cells and participate in a variety of important Ca2+ signaling phenomena (neurotransmission, secretion, etc.).  In striated muscle, the RyR channels represent the primary pathway for Ca2+ release during the excitation-contraction coupling process.  In general, the signals that activate the RyR channels are known (e.g., sarcolemmal Ca2+ influx or depolarization), but the specific mechanisms involved are still being debated.  The signals that modulate and/or turn off the RyR channels remain ambiguous and the mechanisms involved unclear.  Over the last decade, studies of RyR-mediated Ca2+ release have taken many forms and have steadily advanced investigators' knowledge.  This robust field, however, is not without controversial ideas and contradictory results.  Controversies surrounding the complex Ca2+ regulation of single RyR channels receive particular attention here.  In addn., a large body of information is synthesized into a focused perspective of single RyR channel function.  The present status of the single RyR channel field and its likely future directions are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5A5-cHXQNgLVg90H21EOLACvtfcHk0lhWM6Au_NHJqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xot1Ggurk%253D&md5=5bc6b275c4a2f4876b29d89d2ffee8a7</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00013.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00013.2002%26sid%3Dliteratum%253Aachs%26aulast%3DFill%26aufirst%3DM.%26aulast%3DCopello%26aufirst%3DJ.%2BA.%26atitle%3DRyanodine%2520receptor%2520calcium%2520release%2520channels%26jtitle%3DPhysiol.%2520Rev.%26date%3D2002%26volume%3D82%26spage%3D893%26epage%3D922%26doi%3D10.1152%2Fphysrev.00013.2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Verkhratsky, A.</span><span> </span><span class="NLM_article-title">Physiology and pathophysiology of the calcium store in the endoplasmic reticulum of neurons</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">279</span><span class="refDoi"> DOI: 10.1152/physrev.00004.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1152%2Fphysrev.00004.2004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2005&pages=201-279&author=A.+Verkhratsky&title=Physiology+and+pathophysiology+of+the+calcium+store+in+the+endoplasmic+reticulum+of+neurons&doi=10.1152%2Fphysrev.00004.2004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00004.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00004.2004%26sid%3Dliteratum%253Aachs%26aulast%3DVerkhratsky%26aufirst%3DA.%26atitle%3DPhysiology%2520and%2520pathophysiology%2520of%2520the%2520calcium%2520store%2520in%2520the%2520endoplasmic%2520reticulum%2520of%2520neurons%26jtitle%3DPhysiol.%2520Rev.%26date%3D2005%26volume%3D85%26spage%3D201%26epage%3D279%26doi%3D10.1152%2Fphysrev.00004.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Lin, L.-F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lile, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bektesh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, F.</span><span> </span><span class="NLM_article-title">GDNF: a glial cell line derived neurotrophic factor for midbrain dopaminergic neurons</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">260</span><span class="NLM_x">, </span> <span class="NLM_fpage">1130</span><span class="NLM_x">–</span> <span class="NLM_lpage">1132</span><span class="refDoi"> DOI: 10.1126/science.8493557</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1126%2Fscience.8493557" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=260&publication_year=1993&pages=1130-1132&author=L.-F.+H.+Linauthor=D.+H.+Dohertyauthor=J.+D.+Lileauthor=S.+Bekteshauthor=F.+Collins&title=GDNF%3A+a+glial+cell+line+derived+neurotrophic+factor+for+midbrain+dopaminergic+neurons&doi=10.1126%2Fscience.8493557"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1126%2Fscience.8493557&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.8493557%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DL.-F.%2BH.%26aulast%3DDoherty%26aufirst%3DD.%2BH.%26aulast%3DLile%26aufirst%3DJ.%2BD.%26aulast%3DBektesh%26aufirst%3DS.%26aulast%3DCollins%26aufirst%3DF.%26atitle%3DGDNF%253A%2520a%2520glial%2520cell%2520line%2520derived%2520neurotrophic%2520factor%2520for%2520midbrain%2520dopaminergic%2520neurons%26jtitle%3DScience%26date%3D1993%26volume%3D260%26spage%3D1130%26epage%3D1132%26doi%3D10.1126%2Fscience.8493557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Cipriani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desjardins, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burdett, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarzschild, M. A.</span><span> </span><span class="NLM_article-title">Urate and its transgenic depletion modulate neuronal vulnerability in a cellular model of Parkinson’s disease</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e37331</span><span class="refDoi"> DOI: 10.1371/journal.pone.0037331</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1371%2Fjournal.pone.0037331" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e37331&author=S.+Ciprianiauthor=C.+A.+Desjardinsauthor=T.+C.+Burdettauthor=Y.+Xuauthor=K.+Xuauthor=M.+A.+Schwarzschild&title=Urate+and+its+transgenic+depletion+modulate+neuronal+vulnerability+in+a+cellular+model+of+Parkinson%E2%80%99s+disease&doi=10.1371%2Fjournal.pone.0037331"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0037331&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0037331%26sid%3Dliteratum%253Aachs%26aulast%3DCipriani%26aufirst%3DS.%26aulast%3DDesjardins%26aufirst%3DC.%2BA.%26aulast%3DBurdett%26aufirst%3DT.%2BC.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DK.%26aulast%3DSchwarzschild%26aufirst%3DM.%2BA.%26atitle%3DUrate%2520and%2520its%2520transgenic%2520depletion%2520modulate%2520neuronal%2520vulnerability%2520in%2520a%2520cellular%2520model%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De37331%26doi%3D10.1371%2Fjournal.pone.0037331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Troadec, J.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marien, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darios, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colpaert, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michel, P. P.</span><span> </span><span class="NLM_article-title">Noradrenaline provides long-term protection to dopaminergic neurons by reducing oxidative stress</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">200</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span><span class="refDoi"> DOI: 10.1046/j.1471-4159.2001.00556.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1046%2Fj.1471-4159.2001.00556.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=11595772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnsV2isbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2001&pages=200-210&author=J.-D.+Troadecauthor=M.+Marienauthor=F.+Dariosauthor=A.+Hartmannauthor=M.+Rubergauthor=F.+Colpaertauthor=P.+P.+Michel&title=Noradrenaline+provides+long-term+protection+to+dopaminergic+neurons+by+reducing+oxidative+stress&doi=10.1046%2Fj.1471-4159.2001.00556.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Noradrenaline provides long-term protection to dopaminergic neurons by reducing oxidative stress</span></div><div class="casAuthors">Troadec, Jean-Denis; Marien, Marc; Darios, Frederic; Hartmann, Andreas; Ruberg, Merle; Colpaert, Francis; Michel, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">200-210</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">To better understand the neurotrophic function of the neurotransmitter noradrenaline, the authors have developed a model of mesencephalic cultures in which the authors find low concns. (0.3-10 μM) of noradrenaline to be remarkably effective in promoting long-term survival and function of dopaminergic neurons.  This protective action reproduced the effect of caspase inhibition.  It was atypical in that it occurred independently of adrenoceptor activation and was mimicked by some antioxidants, redox metal chelators and the hydroxyl radical detoxifying enzyme catalase.  Interestingly, intracellular reactive oxygen species (ROS) were drastically reduced by treatment with noradrenaline, indicating that the neurotransmitter itself acted as an antioxidant.  Prevention of oxidative stress was, however, independent of the glutathione antioxidant defense system.  Chem. analogs of noradrenaline bearing two free hydroxyl groups in the ortho position of the arom. ring (o-catechols), as well as o-catechol itself, mimicked the survival promoting effects of the neurotransmitter, suggesting that this diphenolic structure was crit. for both neuroprotection and redn. of ROS prodn.  Paradoxically, the autoxidn. of noradrenaline and the ensuing prodn. of quinone metabolites may be required for both effects, as the neurotransmitter was spontaneously and rapidly degraded over time in the culture medium.  These results support the concept that central noradrenergic mechanisms have a neuroprotective role, perhaps in part by reducing oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr_rqtGZFPa7Vg90H21EOLACvtfcHk0lhWM6Au_NHJqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnsV2isbY%253D&md5=56ef166f3fe786abcfaed5a696294da4</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2001.00556.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2001.00556.x%26sid%3Dliteratum%253Aachs%26aulast%3DTroadec%26aufirst%3DJ.-D.%26aulast%3DMarien%26aufirst%3DM.%26aulast%3DDarios%26aufirst%3DF.%26aulast%3DHartmann%26aufirst%3DA.%26aulast%3DRuberg%26aufirst%3DM.%26aulast%3DColpaert%26aufirst%3DF.%26aulast%3DMichel%26aufirst%3DP.%2BP.%26atitle%3DNoradrenaline%2520provides%2520long-term%2520protection%2520to%2520dopaminergic%2520neurons%2520by%2520reducing%2520oxidative%2520stress%26jtitle%3DJ.%2520Neurochem.%26date%3D2001%26volume%3D79%26spage%3D200%26epage%3D210%26doi%3D10.1046%2Fj.1471-4159.2001.00556.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Miller, M. J.</span><span> </span><span class="NLM_article-title">Syntheses and therapeutic potential of hydroxamic acid based siderophores and analogues</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">1563</span><span class="NLM_x">–</span> <span class="NLM_lpage">1579</span><span class="refDoi"> DOI: 10.1021/cr00097a011</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr00097a011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1989&pages=1563-1579&author=M.+J.+Miller&title=Syntheses+and+therapeutic+potential+of+hydroxamic+acid+based+siderophores+and+analogues&doi=10.1021%2Fcr00097a011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fcr00097a011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr00097a011%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DM.%2BJ.%26atitle%3DSyntheses%2520and%2520therapeutic%2520potential%2520of%2520hydroxamic%2520acid%2520based%2520siderophores%2520and%2520analogues%26jtitle%3DChem.%2520Rev.%26date%3D1989%26volume%3D89%26spage%3D1563%26epage%3D1579%26doi%3D10.1021%2Fcr00097a011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Von Bonsdorff, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindeberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nyman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harju, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkkinen, J.</span><span> </span><span class="NLM_article-title">Development of a pharmaceutical apotransferrin product for iron binding therapy</span> <span class="citation_source-journal">Biologicals</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">37</span><span class="refDoi"> DOI: 10.1006/biol.2001.0273</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1006%2Fbiol.2001.0273" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=11482890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlsFyns7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2001&pages=27-37&author=L.+Von+Bonsdorffauthor=H.+Toloauthor=E.+Lindebergauthor=T.+Nymanauthor=A.+Harjuauthor=J.+Parkkinen&title=Development+of+a+pharmaceutical+apotransferrin+product+for+iron+binding+therapy&doi=10.1006%2Fbiol.2001.0273"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Pharmaceutical Apotransferrin Product for Iron Binding Therapy</span></div><div class="casAuthors">von Bonsdorff, Leni; Tolo, Hannele; Lindeberg, Enni; Nyman, Tuula; Harju, Anna; Parkkinen, Jaakko</div><div class="citationInfo"><span class="NLM_cas:title">Biologicals</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">27-37</span>CODEN:
                <span class="NLM_cas:coden">BILSEC</span>;
        ISSN:<span class="NLM_cas:issn">1045-1056</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">High-dose chemotherapy of patients with hematol. malignancies results in extracellular iron accumulation and appearance of non-transferrin-bound iron, which is thought to predispose the patients to septic infections and contribute to organ toxicity.  We describe the development of a human plasma-derived apotransferrin product for iron binding therapy.  The product is purified from Cohn fraction IV of human plasma by two ion exchange chromatog. steps and ultrafiltration.  The process comprises solvent detergent treatment as the main virus inactivation step and 15 nm virus filtration and polyethylene glycol pptn. as removal steps for physico-chem. resistant infectious agents.  Product characterization by electrospray and MALDI-TOF mass spectrometry indicated no other chem. modifications than N-linked glycan chains and disulfide bonds, except minor oxidn.  The purity of the product was more than 98%, main impurities being IgG, IgA and hemopexin.  The product had intact iron binding capacity and native conformation.  A stable liq. formulation for the finished product was developed.  The product has proved safe and well tolerated in early clin. trials in iron binding therapy.  (c) 2001 The International Association of Biological Standardization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodrpZmf7RmJbVg90H21EOLACvtfcHk0ljALAFvP4Hdug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlsFyns7s%253D&md5=261cd593c924e385b27e566b52516e41</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1006%2Fbiol.2001.0273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbiol.2001.0273%26sid%3Dliteratum%253Aachs%26aulast%3DVon%2BBonsdorff%26aufirst%3DL.%26aulast%3DTolo%26aufirst%3DH.%26aulast%3DLindeberg%26aufirst%3DE.%26aulast%3DNyman%26aufirst%3DT.%26aulast%3DHarju%26aufirst%3DA.%26aulast%3DParkkinen%26aufirst%3DJ.%26atitle%3DDevelopment%2520of%2520a%2520pharmaceutical%2520apotransferrin%2520product%2520for%2520iron%2520binding%2520therapy%26jtitle%3DBiologicals%26date%3D2001%26volume%3D29%26spage%3D27%26epage%3D37%26doi%3D10.1006%2Fbiol.2001.0273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Bové, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Przedborski, S.</span><span> </span><span class="NLM_article-title">Toxin-induced models of Parkinson’s disease</span> <span class="citation_source-journal">NeuroRx</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">484</span><span class="NLM_x">–</span> <span class="NLM_lpage">494</span><span class="refDoi"> DOI: 10.1602/neurorx.2.3.484</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1602%2Fneurorx.2.3.484" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=484-494&author=J.+Bov%C3%A9author=D.+Prouauthor=C.+Perierauthor=S.+Przedborski&title=Toxin-induced+models+of+Parkinson%E2%80%99s+disease&doi=10.1602%2Fneurorx.2.3.484"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1602%2Fneurorx.2.3.484&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1602%252Fneurorx.2.3.484%26sid%3Dliteratum%253Aachs%26aulast%3DBov%25C3%25A9%26aufirst%3DJ.%26aulast%3DProu%26aufirst%3DD.%26aulast%3DPerier%26aufirst%3DC.%26aulast%3DPrzedborski%26aufirst%3DS.%26atitle%3DToxin-induced%2520models%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNeuroRx%26date%3D2005%26volume%3D2%26spage%3D484%26epage%3D494%26doi%3D10.1602%2Fneurorx.2.3.484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Smeyne, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson-Lewis, V.</span><span> </span><span class="NLM_article-title">The MPTP model of Parkinson’s disease</span> <span class="citation_source-journal">Mol. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">66</span><span class="refDoi"> DOI: 10.1016/j.molbrainres.2004.09.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1016%2Fj.molbrainres.2004.09.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=15790530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisFGmu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2005&pages=57-66&author=R.+J.+Smeyneauthor=V.+Jackson-Lewis&title=The+MPTP+model+of+Parkinson%E2%80%99s+disease&doi=10.1016%2Fj.molbrainres.2004.09.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">The MPTP model of Parkinson's disease</span></div><div class="casAuthors">Smeyne, Richard Jay; Jackson-Lewis, Vernice</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Brain Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-66</span>CODEN:
                <span class="NLM_cas:coden">MBREE4</span>;
        ISSN:<span class="NLM_cas:issn">0169-328X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The biochem. and cellular changes that occur following administration of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) are remarkably similar to that seen in idiopathic Parkinson's disease (PD).  In this review, we detail the mol. activities of this compd. from peripheral intoxication through its various biotransformations.  In addn., we detail the interplay that occurs between the different cellular compartments (neurons and glia) that eventually consort to kill substantia nigra pars compacta (SNpc) neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrE6gdfZbJXHLVg90H21EOLACvtfcHk0lhM-X2NwEob3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisFGmu70%253D&md5=b89c5ca3ec56aea5bba5529bb86a8ea4</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.molbrainres.2004.09.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molbrainres.2004.09.017%26sid%3Dliteratum%253Aachs%26aulast%3DSmeyne%26aufirst%3DR.%2BJ.%26aulast%3DJackson-Lewis%26aufirst%3DV.%26atitle%3DThe%2520MPTP%2520model%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DMol.%2520Brain%2520Res.%26date%3D2005%26volume%3D134%26spage%3D57%26epage%3D66%26doi%3D10.1016%2Fj.molbrainres.2004.09.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Kuroiwa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araki, T.</span><span> </span><span class="NLM_article-title">Biochemical alterations of the striatum in an MPTP-treated mouse model of Parkinson’s disease</span> <span class="citation_source-journal">Metab. Brain Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">177</span><span class="NLM_x">–</span> <span class="NLM_lpage">183</span><span class="refDoi"> DOI: 10.1007/s11011-010-9195-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1007%2Fs11011-010-9195-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=20431930" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=1%3ACAS%3A280%3ADC%252BC3czpsFaqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2010&pages=177-183&author=H.+Kuroiwaauthor=H.+Yokoyamaauthor=H.+Kimotoauthor=H.+Katoauthor=T.+Araki&title=Biochemical+alterations+of+the+striatum+in+an+MPTP-treated+mouse+model+of+Parkinson%E2%80%99s+disease&doi=10.1007%2Fs11011-010-9195-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical alterations of the striatum in an MPTP-treated mouse model of Parkinson's disease</span></div><div class="casAuthors">Kuroiwa Hayato; Yokoyama Hironori; Kimoto Hiroki; Kato Hiroyuki; Araki Tsutomu</div><div class="citationInfo"><span class="NLM_cas:title">Metabolic brain disease</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">177-83</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">We investigated the biochemical alterations of the striatum of mice subjected to seven experimental schedules with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride (MPTP) treatment.  The mice were treated intraperitoneally (i.p.) with MPTP (20 mg/kg in saline) four times a day at 2-hr intervals showed severe and persistent depletions of dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) in the striatum, as compared with those (1) treated with MPTP (15 mg/kg in saline, i.p.) once a day for 14 consecutive days; (2)MPTP (30 mg/kg in saline, i.p.) twice a day for 5 consecutive days; (3) MPTP (10 mg/kg in saline, i.p.) four times a day at 1-hr intervals for 2 consecutive days; (4) MPTP (20 mg/kg in saline, i.p.) once a day for 4 consecutive days; (5) MPTP (20 mg/kg in saline, i.p.) twice a day for 2 consecutive days; (6) MPTP (20 mg/kg in saline, i.p.) twice a day for 4 consecutive days.  In our Western blot analysis, furthermore, the mice that received MPTP (20 mg/kg in saline) four times a day at 2-hr intervals showed a severe decrease of the striatal tyrosine hydroxylase (TH) protein levels and a significant increase of the striatal glial fibrillary acidic protein (GFAP) levels.  These results demonstrate that the model with acute MPTP treatment can cause severe neuronal damage in the mouse striatum, as compared to the model with continuous treatment with MPTP.  Thus our findings may support the validity of acute MPTP treatment model for unraveling in the neurodegenerative processes in PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQk1VQNiZGs08ERNNga7KD-fW6udTcc2eYQ-u0HeOa_Cbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3czpsFaqtQ%253D%253D&md5=f4185a28a783039e1df56713da1d84ce</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1007%2Fs11011-010-9195-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11011-010-9195-9%26sid%3Dliteratum%253Aachs%26aulast%3DKuroiwa%26aufirst%3DH.%26aulast%3DYokoyama%26aufirst%3DH.%26aulast%3DKimoto%26aufirst%3DH.%26aulast%3DKato%26aufirst%3DH.%26aulast%3DAraki%26aufirst%3DT.%26atitle%3DBiochemical%2520alterations%2520of%2520the%2520striatum%2520in%2520an%2520MPTP-treated%2520mouse%2520model%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DMetab.%2520Brain%2520Dis.%26date%3D2010%26volume%3D25%26spage%3D177%26epage%3D183%26doi%3D10.1007%2Fs11011-010-9195-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Dehmer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heneka, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sastre, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dichgans, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, J. B.</span><span> </span><span class="NLM_article-title">Protection by pioglitazone in the MPTP model of Parkinson’s disease correlates with IkBα induction and block of NFKB and iNOS activation</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">494</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span><span class="refDoi"> DOI: 10.1046/j.1471-4159.2003.02210.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1046%2Fj.1471-4159.2003.02210.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=14690537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntlWjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2004&pages=494-501&author=T.+Dehmerauthor=M.+T.+Henekaauthor=M.+Sastreauthor=J.+Dichgansauthor=J.+B.+Schulz&title=Protection+by+pioglitazone+in+the+MPTP+model+of+Parkinson%E2%80%99s+disease+correlates+with+IkB%CE%B1+induction+and+block+of+NFKB+and+iNOS+activation&doi=10.1046%2Fj.1471-4159.2003.02210.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with IκBα induction and block of NFκB and iNOS activation</span></div><div class="casAuthors">Dehmer, Thomas; Heneka, Michael T.; Sastre, Magdalena; Dichgans, Johannes; Schulz, Joerg B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">494-501</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Inflammation has been implicated in the pathogenesis of Parkinson's disease (PD).  In the chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model of PD, inducible NO synthase (iNOS) derived nitric oxide (NO) is an important mediator of dopaminergic cell death.  Ligands of the peroxisome proliferator-activated receptor (PPAR) exert anti-inflammatory effects.  We here investigated whether pioglitazone, a PPARγ agonist, protected mice from MPTP-induced dopaminergic cell loss, glial activation, and loss of catecholamines in the striatum.  As shown by western blot, PPARγ was expressed in the striatum and the substantia nigra of vehicle- and MPTP-treated mice.  Oral administration of 20 mg/(kg day) of pioglitazone protected tyrosine hydroxylase (TH)-pos. substantia nigra neurons from death induced by 5×30 mg/kg MPTP.  However, the decrease of dopamine in the striatum was only partially prevented.  In mice treated with pioglitazone, there were a reduced activation of microglia, reduced induction of iNOS-pos. cells and less glial fibrillary acidic protein pos. cells in both striatum and substantia nigra pars compacta.  In addn., treatment with pioglitazone almost completely blocked staining of TH-pos. neurons for nitrotyrosine, a marker of NO-mediated cell damage.  Because an increase in inhibitory protein-κ-Bα (IκBα) expression and inhibition of translocation of the nuclear factor kappaB (NFκB) subunit p65 to the nucleus in dopaminergic neurons, glial cells and astrocytes correlated with the protective effects of pioglitazone, our results suggest that pioglitazone sequentially acts through PPARγ activation, IκBα induction, block of NFκB activation, iNOS induction and NO-mediated toxicity.  In conclusion, treatment with pioglitazone may offer a treatment opportunity in PD to slow the progression of disease that is mediated by inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnWWHNApdYerVg90H21EOLACvtfcHk0ljPNzVc26q53Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntlWjug%253D%253D&md5=c95ad2e413d42738e73d25096a1aaff9</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2003.02210.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2003.02210.x%26sid%3Dliteratum%253Aachs%26aulast%3DDehmer%26aufirst%3DT.%26aulast%3DHeneka%26aufirst%3DM.%2BT.%26aulast%3DSastre%26aufirst%3DM.%26aulast%3DDichgans%26aufirst%3DJ.%26aulast%3DSchulz%26aufirst%3DJ.%2BB.%26atitle%3DProtection%2520by%2520pioglitazone%2520in%2520the%2520MPTP%2520model%2520of%2520Parkinson%25E2%2580%2599s%2520disease%2520correlates%2520with%2520IkB%25CE%25B1%2520induction%2520and%2520block%2520of%2520NFKB%2520and%2520iNOS%2520activation%26jtitle%3DJ.%2520Neurochem.%26date%3D2004%26volume%3D88%26spage%3D494%26epage%3D501%26doi%3D10.1046%2Fj.1471-4159.2003.02210.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Michel, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez-Fischer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerreiro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hild, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, E. C.</span><span> </span><span class="NLM_article-title">Role of activity-dependent mechanisms in the control of dopaminergic neuron survival</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">289</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span><span class="refDoi"> DOI: 10.1111/j.1471-4159.2006.04424.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1111%2Fj.1471-4159.2006.04424.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=17402966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltVKitr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2007&pages=289-297&author=P.+P.+Michelauthor=D.+Alvarez-Fischerauthor=S.+Guerreiroauthor=A.+Hildauthor=A.+Hartmannauthor=E.+C.+Hirsch&title=Role+of+activity-dependent+mechanisms+in+the+control+of+dopaminergic+neuron+survival&doi=10.1111%2Fj.1471-4159.2006.04424.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Role of activity-dependent mechanisms in the control of dopaminergic neuron survival</span></div><div class="casAuthors">Michel, Patrick P.; Alvarez-Fischer, Daniel; Guerreiro, Serge; Hild, Audrey; Hartmann, Andreas; Hirsch, Etienne C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">289-297</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Dopaminergic neurons that constitute the nigrostriatal pathway are characterized by singular elec. properties that allow them to discharge in vivo spontaneously in a spectrum of patterns ranging from pacemaker to random and bursting modes.  These electrophysiol. features allow dopaminergic neurons to optimize the release of dopamine in their terminal fields.  However, there is emerging evidence indicating that elec. activity might also participate in the control of dopaminergic neuron survival, not only during development, but also in the adult brain, thus raising the possibility that alterations in ionic currents could contribute actively to the demise of these neurons in Parkinson disease.  This review focuses on the mechanisms by which activity-dependent mechanisms might modulate dopaminergic cell survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz_cYB0Mi9K7Vg90H21EOLACvtfcHk0ljPNzVc26q53Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltVKitr0%253D&md5=3a5ea28280a268d10dafe504443b8ea2</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.04424.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.04424.x%26sid%3Dliteratum%253Aachs%26aulast%3DMichel%26aufirst%3DP.%2BP.%26aulast%3DAlvarez-Fischer%26aufirst%3DD.%26aulast%3DGuerreiro%26aufirst%3DS.%26aulast%3DHild%26aufirst%3DA.%26aulast%3DHartmann%26aufirst%3DA.%26aulast%3DHirsch%26aufirst%3DE.%2BC.%26atitle%3DRole%2520of%2520activity-dependent%2520mechanisms%2520in%2520the%2520control%2520of%2520dopaminergic%2520neuron%2520survival%26jtitle%3DJ.%2520Neurochem.%26date%3D2007%26volume%3D101%26spage%3D289%26epage%3D297%26doi%3D10.1111%2Fj.1471-4159.2006.04424.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Traver, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marien, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michel, P. P.</span><span> </span><span class="NLM_article-title">The phenotypic differentiation of locus ceruleus noradrenergic neurons mediated by brain derived neurotrophic factor is enhanced by corticotropin releasing factor through the activation of a cAMP-dependent signaling pathway</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">30</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span><span class="refDoi"> DOI: 10.1124/mol.106.022715</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1124%2Fmol.106.022715" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=30-40&author=S.+Traverauthor=M.+Marienauthor=E.+Martinauthor=E.+C.+Hirschauthor=P.+P.+Michel&title=The+phenotypic+differentiation+of+locus+ceruleus+noradrenergic+neurons+mediated+by+brain+derived+neurotrophic+factor+is+enhanced+by+corticotropin+releasing+factor+through+the+activation+of+a+cAMP-dependent+signaling+pathway&doi=10.1124%2Fmol.106.022715"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1124%2Fmol.106.022715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.106.022715%26sid%3Dliteratum%253Aachs%26aulast%3DTraver%26aufirst%3DS.%26aulast%3DMarien%26aufirst%3DM.%26aulast%3DMartin%26aufirst%3DE.%26aulast%3DHirsch%26aufirst%3DE.%2BC.%26aulast%3DMichel%26aufirst%3DP.%2BP.%26atitle%3DThe%2520phenotypic%2520differentiation%2520of%2520locus%2520ceruleus%2520noradrenergic%2520neurons%2520mediated%2520by%2520brain%2520derived%2520neurotrophic%2520factor%2520is%2520enhanced%2520by%2520corticotropin%2520releasing%2520factor%2520through%2520the%2520activation%2520of%2520a%2520cAMP-dependent%2520signaling%2520pathway%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D70%26spage%3D30%26epage%3D40%26doi%3D10.1124%2Fmol.106.022715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Michel, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marien, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colpaert, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agid, Y.</span><span> </span><span class="NLM_article-title">Adenosine prevents the death of mesencephalic dopaminergic neurons by a mechanism that involves astrocytes</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">2074</span><span class="NLM_x">–</span> <span class="NLM_lpage">2082</span><span class="refDoi"> DOI: 10.1046/j.1471-4159.1999.0722074.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1046%2Fj.1471-4159.1999.0722074.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10217287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=1%3ACAS%3A528%3ADyaK1MXis12lt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1999&pages=2074-2082&author=P.+P.+Michelauthor=M.+Marienauthor=M.+Rubergauthor=F.+Colpaertauthor=Y.+Agid&title=Adenosine+prevents+the+death+of+mesencephalic+dopaminergic+neurons+by+a+mechanism+that+involves+astrocytes&doi=10.1046%2Fj.1471-4159.1999.0722074.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine prevents the death of mesencephalic dopaminergic neurons by a mechanism that involves astrocytes</span></div><div class="casAuthors">Michel, Patrick P.; Marien, Marc; Ruberg, Merle; Colpaert, Francis; Agid, Yves</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2074-2082</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The purinergic nucleoside adenosine effectively prevented the death of dopaminergic neurons that occurs spontaneously and progressively in cultures of rat mesencephalon.  Adenosine also significantly increased dopamine uptake, attesting to the state of differentiation and functional integrity of the neurons that were rescued.  The effects of adenosine were (a) specific to the dopaminergic neurons in these cultures, (b) long-lived, (c) still obsd. when the treatment was delayed after plating, (d) potentiated by inhibition of adenosine deaminase, and (e) abolished when this enzyme was added in excess to the culture medium.  The action of adenosine was mimicked by 5'-(N-ethylcarboxamido)adenosine and dibutyryl-cAMP, but not by CGS-21680, suggesting the possible involvement of A2B subtype purinergic receptors.  ATP was also neuroprotective, but its action resulted principally from conversion to adenosine by ectonucleotidases.  Several anticancer drugs, including cytosine arabinoside, have been shown previously to prevent apoptosis in cultured dopaminergic neurons by a mechanism that requires the inhibition of proliferating astrocytes.  In the presence of adenosine, astrocytes were more differentiated, and their proliferation rate was significantly reduced, suggesting that the neurotrophic effect of the adenine nucleoside resulted also from the repression of the astroglial cells.  The authors did not find evidence of a trophic intermediary in adenosine-treated cultures, however, leading to the hypothesis that limitation of astrocyte replication in itself and/or ensuing changes in the glial phenotype were crucial.  The authors' results suggest that mols. that modulate adenine nucleotide/nucleoside release may be useful for the treatment of chronic neurodegenerative conditions affecting dopaminergic neurons, such as Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoka4zRCdtAiLVg90H21EOLACvtfcHk0lilZE2jGMd3Xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXis12lt7c%253D&md5=88526bb957f28033481b0619f0e64709</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.1999.0722074.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.1999.0722074.x%26sid%3Dliteratum%253Aachs%26aulast%3DMichel%26aufirst%3DP.%2BP.%26aulast%3DMarien%26aufirst%3DM.%26aulast%3DRuberg%26aufirst%3DM.%26aulast%3DColpaert%26aufirst%3DF.%26aulast%3DAgid%26aufirst%3DY.%26atitle%3DAdenosine%2520prevents%2520the%2520death%2520of%2520mesencephalic%2520dopaminergic%2520neurons%2520by%2520a%2520mechanism%2520that%2520involves%2520astrocytes%26jtitle%3DJ.%2520Neurochem.%26date%3D1999%26volume%3D72%26spage%3D2074%26epage%3D2082%26doi%3D10.1046%2Fj.1471-4159.1999.0722074.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Rougé-Pont, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrous, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Moal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piazza, P. V.</span><span> </span><span class="NLM_article-title">Release of endogenous dopamine in cultured mesencephalic neurons: influence of dopaminergic agonists and glucocorticoid antagonists</span> <span class="citation_source-journal">Eur. J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">2343</span><span class="NLM_x">–</span> <span class="NLM_lpage">2350</span><span class="refDoi"> DOI: 10.1046/j.1460-9568.1999.00650.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1046%2Fj.1460-9568.1999.00650.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10383623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=1%3ACAS%3A280%3ADyaK1MzhsFektw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1999&pages=2343-2350&author=F.+Roug%C3%A9-Pontauthor=D.+N.+Abrousauthor=M.+Le+Moalauthor=P.+V.+Piazza&title=Release+of+endogenous+dopamine+in+cultured+mesencephalic+neurons%3A+influence+of+dopaminergic+agonists+and+glucocorticoid+antagonists&doi=10.1046%2Fj.1460-9568.1999.00650.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Release of endogenous dopamine in cultured mesencephalic neurons: influence of dopaminergic agonists and glucocorticoid antagonists</span></div><div class="casAuthors">Rouge-Pont F; Abrous D N; Le Moal M; Piazza P V</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2343-50</span>
        ISSN:<span class="NLM_cas:issn">0953-816X</span>.
    </div><div class="casAbstract">Several electrochemical techniques allow the measurement of dopamine release in freely moving animals and brain slices.  In this report, we applied one of these techniques, coulometry, coupled to high-performance liquid chromatography (HPLC), to the study of dopamine release in primary cultures of embryonic mesencephalic dopaminergic neurons.  Between day 9 and 33 of culture, concentrations of dopamine, above the detection threshold, were found in the incubation buffer (Krebs ringer buffer, KRB).  Concentrations of dopamine in the incubation buffer reflected neuronal release as they were: (i) positively correlated with the number of tyrosine hydroxylase-positive dopamine neurons in the culture; (ii) tetrodotoxin (TTX) sensitive and Ca2+ dependent; (iii) increased by a depolarizing stimulus, e.g.  K+ (20 mM), or by the indirect dopamine agonists amphetamine and cocaine; (iv) decreased by a hyperpolarizing stimulus, e.g. the dopamine D2-like receptor agonist quinpirole.  Dopamine release in this model was also sensitive to the manipulation of glucocorticoids, potent modulators of dopamine release in vivo.  Long-term treatment of the cell cultures with RU 39305, a selective antagonist of glucocorticoid receptors (GR), but not with spironolactone, a selective antagonist of mineralocorticoid receptors (MR), dose-dependently decreased K+-stimulated dopamine release.  In conclusion, these results demonstrate an in vitro model that allows the studying of the release of endogenous dopamine in cell cultures and the effects of glucocorticoid hormones on the release dynamics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS1x0cofaq7d0PI-fCgwosgfW6udTcc2ebSzglhtQwnlLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1MzhsFektw%253D%253D&md5=1452426e00e276d8ff3d55702d3e711f</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1046%2Fj.1460-9568.1999.00650.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1460-9568.1999.00650.x%26sid%3Dliteratum%253Aachs%26aulast%3DRoug%25C3%25A9-Pont%26aufirst%3DF.%26aulast%3DAbrous%26aufirst%3DD.%2BN.%26aulast%3DLe%2BMoal%26aufirst%3DM.%26aulast%3DPiazza%26aufirst%3DP.%2BV.%26atitle%3DRelease%2520of%2520endogenous%2520dopamine%2520in%2520cultured%2520mesencephalic%2520neurons%253A%2520influence%2520of%2520dopaminergic%2520agonists%2520and%2520glucocorticoid%2520antagonists%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D1999%26volume%3D11%26spage%3D2343%26epage%3D2350%26doi%3D10.1046%2Fj.1460-9568.1999.00650.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Douhou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debeir, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murer, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dufour, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanchard, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moussaoui, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohme, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agid, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raisman-Vozari, R.</span><span> </span><span class="NLM_article-title">Effect of chronic treatment with riluzole on the nigrostriatal dopaminergic system in weaver mutant mice</span> <span class="citation_source-journal">Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">176</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">–</span> <span class="NLM_lpage">253</span><span class="refDoi"> DOI: 10.1006/exnr.2002.7935</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1006%2Fexnr.2002.7935" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=12093102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=1%3ACAS%3A528%3ADC%252BD38XkvFKrs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2002&pages=247-253&author=A.+Douhouauthor=T.+Debeirauthor=M.+G.+Murerauthor=L.+Doauthor=N.+Dufourauthor=V.+Blanchardauthor=S.+Moussaouiauthor=G.+A.+Bohmeauthor=Y.+Agidauthor=R.+Raisman-Vozari&title=Effect+of+chronic+treatment+with+riluzole+on+the+nigrostriatal+dopaminergic+system+in+weaver+mutant+mice&doi=10.1006%2Fexnr.2002.7935"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of Chronic Treatment with Riluzole on the Nigrostriatal Dopaminergic System in Weaver Mutant Mice</span></div><div class="casAuthors">Douhou, Aicha; Debeir, Thomas; Murer, Mario Gustavo; Do, Louis; Dufour, Noelle; Blanchard, Veronique; Moussaoui, Saliha; Bohme, Georg Andrees; Agid, Yves; Raisman-Vozari, Rita</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">247-253</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">The effects of a chronic treatment with the anti-glutamate and sodium channel modulating neuroprotective agent riluzole on the degeneration of dopamine-contg. neurons were studied in the brain of weaver mutant mice.  In these animals, as in Parkinson's disease, dopaminergic neurons of the nigro-striatal pathway undergo spontaneous and progressive cell death.  Homozygous weaver mice were orally treated twice a day with either 8 mg/kg riluzole or placebo for 2 mo.  Quantification of tyrosine-hydroxylase and dopamine-transporter axonal immunostaining in the striatum revealed that riluzole significantly increased the d. of striatal dopaminergic nerve terminals.  These results suggest that riluzole protects dopaminergic processes in the weaver mice and/or promotes their neuroplasticity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA720pf2gBC7Vg90H21EOLACvtfcHk0lgOoEVzj2QEdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkvFKrs74%253D&md5=d87e43c23e7d0ebb91c4ef69319afdb2</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1006%2Fexnr.2002.7935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fexnr.2002.7935%26sid%3Dliteratum%253Aachs%26aulast%3DDouhou%26aufirst%3DA.%26aulast%3DDebeir%26aufirst%3DT.%26aulast%3DMurer%26aufirst%3DM.%2BG.%26aulast%3DDo%26aufirst%3DL.%26aulast%3DDufour%26aufirst%3DN.%26aulast%3DBlanchard%26aufirst%3DV.%26aulast%3DMoussaoui%26aufirst%3DS.%26aulast%3DBohme%26aufirst%3DG.%2BA.%26aulast%3DAgid%26aufirst%3DY.%26aulast%3DRaisman-Vozari%26aufirst%3DR.%26atitle%3DEffect%2520of%2520chronic%2520treatment%2520with%2520riluzole%2520on%2520the%2520nigrostriatal%2520dopaminergic%2520system%2520in%2520weaver%2520mutant%2520mice%26jtitle%3DExp.%2520Neurol.%26date%3D2002%26volume%3D176%26spage%3D247%26epage%3D253%26doi%3D10.1006%2Fexnr.2002.7935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Höglinger, G. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrard, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michel, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medja, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombès, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friguet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, E. C.</span><span> </span><span class="NLM_article-title">Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson’s disease</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">1297</span><span class="NLM_x">–</span> <span class="NLM_lpage">1307</span><span class="refDoi"> DOI: 10.1046/j.1471-4159.2003.01952.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1046%2Fj.1471-4159.2003.01952.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=12911637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=1%3ACAS%3A280%3ADC%252BD3sznslGltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2003&pages=1297-1307&author=G.+U.+H%C3%B6glingerauthor=G.+Carrardauthor=P.+P.+Michelauthor=F.+Medjaauthor=A.+Lomb%C3%A8sauthor=M.+Rubergauthor=B.+Friguetauthor=E.+C.+Hirsch&title=Dysfunction+of+mitochondrial+complex+I+and+the+proteasome%3A+interactions+between+two+biochemical+deficits+in+a+cellular+model+of+Parkinson%E2%80%99s+disease&doi=10.1046%2Fj.1471-4159.2003.01952.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson's disease</span></div><div class="casAuthors">Hoglinger Gunter U; Carrard Geraldine; Michel Patrick P; Medja Fadia; Lombes Anne; Ruberg Merle; Friguet Bertrand; Hirsch Etienne C</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurochemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1297-307</span>
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    </div><div class="casAbstract">Two biochemical deficits have been described in the substantia nigra in Parkinson's disease, decreased activity of mitochondrial complex I and reduced proteasomal activity.  We analysed interactions between these deficits in primary mesencephalic cultures.  Proteasome inhibitors (epoxomicin, MG132) exacerbated the toxicity of complex I inhibitors [rotenone, 1-methyl-4-phenylpyridinium (MPP+)] and of the toxic dopamine analogue 6-hydroxydopamine, but not of inhibitors of mitochondrial complex II-V or excitotoxins [N-methyl-d-aspartate (NMDA), kainate].  Rotenone and MPP+ increased free radicals and reduced proteasomal activity via adenosine triphosphate (ATP) depletion. 6-hydroxydopamine also increased free radicals, but did not affect ATP levels and increased proteasomal activity, presumably in response to oxidative damage.  Proteasome inhibition potentiated the toxicity of rotenone, MPP+ and 6-hydroxydopamine at concentrations at which they increased free radical levels >/= 40% above baseline, exceeding the cellular capacity to detoxify oxidized proteins reduced by proteasome inhibition, and also exacerbated ATP depletion caused by complex I inhibition.  Consistently, both free radical scavenging and stimulation of ATP production by glucose supplementation protected against the synergistic toxicity.  In summary, proteasome inhibition increases neuronal vulnerability to normally subtoxic levels of free radicals and amplifies energy depletion following complex I inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ_GDPXA9Djz825P7XSLhESfW6udTcc2ea2uUuRH_zfybntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3sznslGltw%253D%253D&md5=31bfe804be13eb54a57f6e4374e56d6d</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2003.01952.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2003.01952.x%26sid%3Dliteratum%253Aachs%26aulast%3DH%25C3%25B6glinger%26aufirst%3DG.%2BU.%26aulast%3DCarrard%26aufirst%3DG.%26aulast%3DMichel%26aufirst%3DP.%2BP.%26aulast%3DMedja%26aufirst%3DF.%26aulast%3DLomb%25C3%25A8s%26aufirst%3DA.%26aulast%3DRuberg%26aufirst%3DM.%26aulast%3DFriguet%26aufirst%3DB.%26aulast%3DHirsch%26aufirst%3DE.%2BC.%26atitle%3DDysfunction%2520of%2520mitochondrial%2520complex%2520I%2520and%2520the%2520proteasome%253A%2520interactions%2520between%2520two%2520biochemical%2520deficits%2520in%2520a%2520cellular%2520model%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurochem.%26date%3D2003%26volume%3D86%26spage%3D1297%26epage%3D1307%26doi%3D10.1046%2Fj.1471-4159.2003.01952.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Scorza, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silveira, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zapata-Torres, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassels, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reyes-Parada, M.</span><span> </span><span class="NLM_article-title">Monoamine oxidase inhibitory properties of some methoxylated and alkylthioamphetamine derivatives: structure-activity relationships</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1361</span><span class="NLM_x">–</span> <span class="NLM_lpage">1369</span><span class="refDoi"> DOI: 10.1016/S0006-2952(97)00405-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1016%2FS0006-2952%2897%2900405-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1997&pages=1361-1369&author=M.+C.+Scorzaauthor=C.+Carrauauthor=R.+Silveiraauthor=G.+Zapata-Torresauthor=B.+K.+Casselsauthor=M.+Reyes-Parada&title=Monoamine+oxidase+inhibitory+properties+of+some+methoxylated+and+alkylthioamphetamine+derivatives%3A+structure-activity+relationships&doi=10.1016%2FS0006-2952%2897%2900405-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2FS0006-2952%2897%2900405-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-2952%252897%252900405-X%26sid%3Dliteratum%253Aachs%26aulast%3DScorza%26aufirst%3DM.%2BC.%26aulast%3DCarrau%26aufirst%3DC.%26aulast%3DSilveira%26aufirst%3DR.%26aulast%3DZapata-Torres%26aufirst%3DG.%26aulast%3DCassels%26aufirst%3DB.%2BK.%26aulast%3DReyes-Parada%26aufirst%3DM.%26atitle%3DMonoamine%2520oxidase%2520inhibitory%2520properties%2520of%2520some%2520methoxylated%2520and%2520alkylthioamphetamine%2520derivatives%253A%2520structure-activity%2520relationships%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1997%26volume%3D54%26spage%3D1361%26epage%3D1369%26doi%3D10.1016%2FS0006-2952%2897%2900405-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 15 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Aidan M. Kelly, Peng-Jui Chen, Jenna Klubnick, Daniel J. Blair, <span class="NLM_string-name hlFld-ContribAuthor">Martin D. Burke</span>. </span><span class="cited-content_cbyCitation_article-title">A Mild Method for Making MIDA Boronates. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (24)
                                     , 9408-9414. <a href="https://doi.org/10.1021/acs.orglett.0c02449" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c02449</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c02449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c02449%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DA%252BMild%252BMethod%252Bfor%252BMaking%252BMIDA%252BBoronates%26aulast%3DKelly%26aufirst%3DAidan%2BM.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D22072020%26date%3D25082020%26volume%3D22%26issue%3D24%26spage%3D9408%26epage%3D9414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Oleg V. Ardashov, Alla V. Pavlova, Arun Kumar Mahato, Yulia Sidorova, Ekaterina A. Morozova, Dina V. Korchagina, Georgi E. Salnikov, Alexander M. Genaev, Oksana S. Patrusheva, Nikolay S. Li-Zhulanov, Tat’yana
G. Tolstikova, Konstantin P. Volcho, <span class="NLM_string-name hlFld-ContribAuthor">Nariman F. Salakhutdinov</span>. </span><span class="cited-content_cbyCitation_article-title">A Novel Small Molecule Supports the Survival of Cultured Dopamine Neurons and May Restore the Dopaminergic Innervation of the Brain in the MPTP Mouse Model of Parkinson’s Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (10)
                                     , 4337-4349. <a href="https://doi.org/10.1021/acschemneuro.9b00396" title="DOI URL">https://doi.org/10.1021/acschemneuro.9b00396</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.9b00396&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.9b00396%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DA%252BNovel%252BSmall%252BMolecule%252BSupports%252Bthe%252BSurvival%252Bof%252BCultured%252BDopamine%252BNeurons%252Band%252BMay%252BRestore%252Bthe%252BDopaminergic%252BInnervation%252Bof%252Bthe%252BBrain%252Bin%252Bthe%252BMPTP%252BMouse%252BModel%252Bof%252BParkinson%2525E2%252580%252599s%252BDisease%26aulast%3DArdashov%26aufirst%3DOleg%2BV.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D15072019%26date%3D29082019%26date%3D11092019%26date%3D29082019%26volume%3D10%26issue%3D10%26spage%3D4337%26epage%3D4349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gael  Le Douaron</span>, <span class="hlFld-ContribAuthor ">Laurent  Ferrié</span>, <span class="hlFld-ContribAuthor ">Julia E.  Sepulveda-Diaz</span>, <span class="hlFld-ContribAuthor ">Blandine  Séon-Méniel</span>, <span class="hlFld-ContribAuthor ">Rita  Raisman-Vozari</span>, <span class="hlFld-ContribAuthor ">Patrick P.  Michel</span>, and <span class="hlFld-ContribAuthor ">Bruno  Figadère</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of a Novel 1,4,8-Triazaphenanthrene Derivative as a Neuroprotectant for Dopamine Neurons Vulnerable in Parkinson’s Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2017,</strong> <em>8 </em>
                                    (6)
                                     , 1222-1231. <a href="https://doi.org/10.1021/acschemneuro.6b00385" title="DOI URL">https://doi.org/10.1021/acschemneuro.6b00385</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.6b00385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.6b00385%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DIdentification%252Bof%252Ba%252BNovel%252B1%25252C4%25252C8-Triazaphenanthrene%252BDerivative%252Bas%252Ba%252BNeuroprotectant%252Bfor%252BDopamine%252BNeurons%252BVulnerable%252Bin%252BParkinson%2525E2%252580%252599s%252BDisease%26aulast%3DLe%2BDouaron%26aufirst%3DGael%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D10112016%26date%3D31012017%26date%3D15022017%26date%3D21062017%26date%3D31012017%26volume%3D8%26issue%3D6%26spage%3D1222%26epage%3D1231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hanyang  Bao</span>, <span class="hlFld-ContribAuthor ">Ziyun  Lin</span>, <span class="hlFld-ContribAuthor ">Mengshi  Jin</span>, <span class="hlFld-ContribAuthor ">Hongdou  Zhang</span>, <span class="hlFld-ContribAuthor ">Jun  Xu</span>, <span class="hlFld-ContribAuthor ">Bajin  Chen</span>, <span class="hlFld-ContribAuthor ">Wanmei  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Visible-light-induced C H arylation of quinoxalin-2(1H)-ones in H2O. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2021,</strong> <em>66 </em>, 152841. <a href="https://doi.org/10.1016/j.tetlet.2021.152841" title="DOI URL">https://doi.org/10.1016/j.tetlet.2021.152841</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2021.152841&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2021.152841%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DVisible-light-induced%252BC%252BH%252Barylation%252Bof%252Bquinoxalin-2%2525281H%252529-ones%252Bin%252BH2O%26aulast%3DBao%26aufirst%3DHanyang%26date%3D2021%26volume%3D66%26spage%3D152841" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liang  Sun</span>, <span class="hlFld-ContribAuthor ">Huafeng  Wei</span>. </span><span class="cited-content_cbyCitation_article-title">Ryanodine Receptors: A Potential Treatment Target in Various Neurodegenerative Disease. </span><span class="cited-content_cbyCitation_journal-name">Cellular and Molecular Neurobiology</span><span> <strong>2020,</strong> <em>55 </em><a href="https://doi.org/10.1007/s10571-020-00936-w" title="DOI URL">https://doi.org/10.1007/s10571-020-00936-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10571-020-00936-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10571-020-00936-w%26sid%3Dliteratum%253Aachs%26jtitle%3DCellular%2520and%2520Molecular%2520Neurobiology%26atitle%3DRyanodine%252BReceptors%25253A%252BA%252BPotential%252BTreatment%252BTarget%252Bin%252BVarious%252BNeurodegenerative%252BDisease%26aulast%3DSun%26aufirst%3DLiang%26date%3D2020%26date%3D2020%26volume%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao‐Tong  Wang</span>, <span class="hlFld-ContribAuthor ">Jia‐Lin  Song</span>, <span class="hlFld-ContribAuthor ">Mei  Zhong</span>, <span class="hlFld-ContribAuthor ">Hua‐Jie  Kang</span>, <span class="hlFld-ContribAuthor ">Hui  Xie</span>, <span class="hlFld-ContribAuthor ">Tong  Che</span>, <span class="hlFld-ContribAuthor ">Bing  Shu</span>, <span class="hlFld-ContribAuthor ">Dongming  Peng</span>, <span class="hlFld-ContribAuthor ">Luyong  Zhang</span>, <span class="hlFld-ContribAuthor ">Shang‐Shi  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Iridium‐Catalyzed [4+2] Annulations of β‐Keto Sulfoxonium Ylides and
              o
              ‐Phenylenediamines: Mild and Facile Synthesis of Quinoxaline Derivatives. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>2020 </em>
                                    (24)
                                     , 3635-3639. <a href="https://doi.org/10.1002/ejoc.202000411" title="DOI URL">https://doi.org/10.1002/ejoc.202000411</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.202000411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.202000411%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DIridium%2525E2%252580%252590Catalyzed%252B%25255B4%25252B2%25255D%252BAnnulations%252Bof%252B%2525CE%2525B2%2525E2%252580%252590Keto%252BSulfoxonium%252BYlides%252Band%252Bo%252B%2525E2%252580%252590Phenylenediamines%25253A%252BMild%252Band%252BFacile%252BSynthesis%252Bof%252BQuinoxaline%252BDerivatives%26aulast%3DWang%26aufirst%3DXiao%25E2%2580%2590Tong%26date%3D2020%26date%3D2020%26volume%3D2020%26issue%3D24%26spage%3D3635%26epage%3D3639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nadeem  Abad</span>, <span class="hlFld-ContribAuthor ">Melek  Hajji</span>, <span class="hlFld-ContribAuthor ">Youssef  Ramli</span>, <span class="hlFld-ContribAuthor ">Marwa  Belkhiria</span>, <span class="hlFld-ContribAuthor ">Salima  Moftah H. Elmgirhi</span>, <span class="hlFld-ContribAuthor ">Mohamed  A. Habib</span>, <span class="hlFld-ContribAuthor ">Taha  Guerfel</span>, <span class="hlFld-ContribAuthor ">Joel  T. Mague</span>, <span class="hlFld-ContribAuthor ">El Mokhtar  Essassi</span>. </span><span class="cited-content_cbyCitation_article-title">A newly synthesized nitrogen‐rich derivative of bicyclic quinoxaline—Structural and conceptual DFT reactivity study. </span><span class="cited-content_cbyCitation_journal-name">Journal of Physical Organic Chemistry</span><span> <strong>2020,</strong> <em>33 </em>
                                    (6)
                                     <a href="https://doi.org/10.1002/poc.4055" title="DOI URL">https://doi.org/10.1002/poc.4055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/poc.4055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fpoc.4055%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Physical%2520Organic%2520Chemistry%26atitle%3DA%252Bnewly%252Bsynthesized%252Bnitrogen%2525E2%252580%252590rich%252Bderivative%252Bof%252Bbicyclic%252Bquinoxaline%2525E2%252580%252594Structural%252Band%252Bconceptual%252BDFT%252Breactivity%252Bstudy%26aulast%3DAbad%26aufirst%3DNadeem%26date%3D2020%26date%3D2020%26volume%3D33%26issue%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Isaac N.  Pessah</span>, <span class="hlFld-ContribAuthor ">Pamela J.  Lein</span>, <span class="hlFld-ContribAuthor ">Richard F.  Seegal</span>, <span class="hlFld-ContribAuthor ">Sharon K.  Sagiv</span>. </span><span class="cited-content_cbyCitation_article-title">Neurotoxicity of polychlorinated biphenyls and related organohalogens. </span><span class="cited-content_cbyCitation_journal-name">Acta Neuropathologica</span><span> <strong>2019,</strong> <em>138 </em>
                                    (3)
                                     , 363-387. <a href="https://doi.org/10.1007/s00401-019-01978-1" title="DOI URL">https://doi.org/10.1007/s00401-019-01978-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00401-019-01978-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00401-019-01978-1%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Neuropathologica%26atitle%3DNeurotoxicity%252Bof%252Bpolychlorinated%252Bbiphenyls%252Band%252Brelated%252Borganohalogens%26aulast%3DPessah%26aufirst%3DIsaac%2BN.%26date%3D2019%26date%3D2019%26volume%3D138%26issue%3D3%26spage%3D363%26epage%3D387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yulia A.  Sidorova</span>, <span class="hlFld-ContribAuthor ">Konstantin P.  Volcho</span>, <span class="hlFld-ContribAuthor ">Nariman F.  Salakhutdinov</span>. </span><span class="cited-content_cbyCitation_article-title">Neuroregeneration in Parkinson’s Disease: From Proteins to Small Molecules. </span><span class="cited-content_cbyCitation_journal-name">Current Neuropharmacology</span><span> <strong>2019,</strong> <em>17 </em>
                                    (3)
                                     , 268-287. <a href="https://doi.org/10.2174/1570159X16666180905094123" title="DOI URL">https://doi.org/10.2174/1570159X16666180905094123</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1570159X16666180905094123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1570159X16666180905094123%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Neuropharmacology%26atitle%3DNeuroregeneration%252Bin%252BParkinson%2525E2%252580%252599s%252BDisease%25253A%252BFrom%252BProteins%252Bto%252BSmall%252BMolecules%26aulast%3DSidorova%26aufirst%3DYulia%2BA.%26date%3D2019%26volume%3D17%26issue%3D3%26spage%3D268%26epage%3D287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan-Xiao  Jiao</span>, <span class="hlFld-ContribAuthor ">Lin-Su  Wei</span>, <span class="hlFld-ContribAuthor ">Chun-Yang  Zhao</span>, <span class="hlFld-ContribAuthor ">Kai  Wei</span>, <span class="hlFld-ContribAuthor ">Dong-Liang  Mo</span>, <span class="hlFld-ContribAuthor ">Cheng-Xue  Pan</span>, <span class="hlFld-ContribAuthor ">Gui-Fa  Su</span>. </span><span class="cited-content_cbyCitation_article-title">Isobutyl Nitrite-Mediated Synthesis of Quinoxalines through Double C−H Bond Amination of
              N
              -Aryl Enamines. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2018,</strong> <em>360 </em>
                                    (22)
                                     , 4446-4451. <a href="https://doi.org/10.1002/adsc.201800928" title="DOI URL">https://doi.org/10.1002/adsc.201800928</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201800928&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201800928%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DIsobutyl%252BNitrite-Mediated%252BSynthesis%252Bof%252BQuinoxalines%252Bthrough%252BDouble%252BC%2525E2%252588%252592H%252BBond%252BAmination%252Bof%252BN%252B-Aryl%252BEnamines%26aulast%3DJiao%26aufirst%3DYan-Xiao%26date%3D2018%26date%3D2018%26volume%3D360%26issue%3D22%26spage%3D4446%26epage%3D4451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tim  Vervliet</span>. </span><span class="cited-content_cbyCitation_article-title">Ryanodine Receptors in Autophagy: Implications for Neurodegenerative Diseases?. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Cellular Neuroscience</span><span> <strong>2018,</strong> <em>12 </em><a href="https://doi.org/10.3389/fncel.2018.00089" title="DOI URL">https://doi.org/10.3389/fncel.2018.00089</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fncel.2018.00089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffncel.2018.00089%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Cellular%2520Neuroscience%26atitle%3DRyanodine%252BReceptors%252Bin%252BAutophagy%25253A%252BImplications%252Bfor%252BNeurodegenerative%252BDiseases%25253F%26aulast%3DVervliet%26aufirst%3DTim%26date%3D2018%26date%3D2018%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Islam H.  El Azab</span>, <span class="hlFld-ContribAuthor ">Nadia A. A.  Elkanzi</span>, <span class="hlFld-ContribAuthor ">Adil A.  Gobouri</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Some New Quinoxaline-Based Heterocycles. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2018,</strong> <em>55 </em>
                                    (1)
                                     , 65-76. <a href="https://doi.org/10.1002/jhet.2978" title="DOI URL">https://doi.org/10.1002/jhet.2978</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.2978&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.2978%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BSome%252BNew%252BQuinoxaline-Based%252BHeterocycles%26aulast%3DEl%2BAzab%26aufirst%3DIslam%2BH.%26date%3D2018%26date%3D2017%26volume%3D55%26issue%3D1%26spage%3D65%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jin  Wang</span>, <span class="hlFld-ContribAuthor ">Pei  Cai</span>, <span class="hlFld-ContribAuthor ">Xue-Lian  Yang</span>, <span class="hlFld-ContribAuthor ">Fan  Li</span>, <span class="hlFld-ContribAuthor ">Jia-Jia  Wu</span>, <span class="hlFld-ContribAuthor ">Ling-Yi  Kong</span>, <span class="hlFld-ContribAuthor ">Xiao-Bing  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Novel cinnamamide-dibenzylamine hybrids: Potent neurogenic agents with antioxidant, cholinergic, and neuroprotective properties as innovative drugs for Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>139 </em>, 68-83. <a href="https://doi.org/10.1016/j.ejmech.2017.07.077" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.07.077</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.07.077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.07.077%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Bcinnamamide-dibenzylamine%252Bhybrids%25253A%252BPotent%252Bneurogenic%252Bagents%252Bwith%252Bantioxidant%25252C%252Bcholinergic%25252C%252Band%252Bneuroprotective%252Bproperties%252Bas%252Binnovative%252Bdrugs%252Bfor%252BAlzheimer%252527s%252Bdisease%26aulast%3DWang%26aufirst%3DJin%26date%3D2017%26volume%3D139%26spage%3D68%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">K.  Alison Rinderspacher</span>. </span><span class="cited-content_cbyCitation_article-title">Six-Membered Ring Systems. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 441-482. <a href="https://doi.org/10.1016/B978-0-08-102310-5.00013-8" title="DOI URL">https://doi.org/10.1016/B978-0-08-102310-5.00013-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-102310-5.00013-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-102310-5.00013-8%26sid%3Dliteratum%253Aachs%26atitle%3DSix-Membered%252BRing%252BSystems%26aulast%3DAlison%2BRinderspacher%26aufirst%3DK.%26date%3D2017%26spage%3D441%26epage%3D482%26pub%3DElsevier%26date%3D2017%26volume%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ndumiso  Ndlovu</span>, <span class="hlFld-ContribAuthor ">Winston  Nxumalo</span>. </span><span class="cited-content_cbyCitation_article-title">Nucleophilic Substitution on 2-Monosubstituted Quinoxalines Giving 2,3-Disubstituted Quinoxalines: Investigating the Effect of the 2-Substituent. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2016,</strong> <em>21 </em>
                                    (10)
                                     , 1304. <a href="https://doi.org/10.3390/molecules21101304" title="DOI URL">https://doi.org/10.3390/molecules21101304</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules21101304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules21101304%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DNucleophilic%252BSubstitution%252Bon%252B2-Monosubstituted%252BQuinoxalines%252BGiving%252B2%25252C3-Disubstituted%252BQuinoxalines%25253A%252BInvestigating%252Bthe%252BEffect%252Bof%252Bthe%252B2-Substituent%26aulast%3DNdlovu%26aufirst%3DNdumiso%26date%3D2016%26date%3D2016%26volume%3D21%26issue%3D10%26spage%3D1304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/medium/jm-2016-00297a_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00297&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/medium/jm-2016-00297a_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0016.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 6-Aminoquinoxaline and 2-Substituted-6-aminoquinoxalines by Hinsberg Condensation<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00297&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) H<sub>2</sub>O, reflux; (b) H<sub>2</sub>, Pd/C in EtOH, 60 °C, then purification by flash chromatography.</p></p></figure><figure data-id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/medium/jm-2016-00297a_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0017.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 2,3-Disubstituted Quinoxalines<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00297&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) R<sub>1</sub>Li (2.5 equiv), THF, −78 °C or <i>t</i>BuLi (8 equiv), R<sub>1</sub>Br (4 equiv), −78 °C, Et<sub>2</sub>O/THF if R<sub>1</sub> is aryl; (b) MnO<sub>2</sub> (5 equiv), CHCl<sub>3</sub>, reflux.</p></p></figure><figure data-id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/medium/jm-2016-00297a_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0018.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of 3-Aryl-6-aminoquinoxalines from Quinoxalin-2-ol<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00297&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HNO<sub>3</sub> (2 equiv), acetic acid, rt; (b) POCl<sub>3</sub>, reflux; (c) SnCl<sub>2</sub>, EtOAc, reflux; (d) ArB(OH)<sub>2</sub> or ArB(MIDA) (1.3 equiv), (PPh<sub>3</sub>)<sub>2</sub>PdCl<sub>2</sub> (0.03 equiv), K<sub>2</sub>CO<sub>3</sub> (2.6 equiv), dioxane/water, reflux; (e) TMS–acetylene or 4-methoxy-phenylacetylene, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, CuI, Et<sub>3</sub>N, THF, reflux. When R = TMS subsequent basic treatment (K<sub>2</sub>CO<sub>3</sub>, MeOH, reflux 10 min) furnishes compound <b>4s</b>. MIDA = <i>N</i>-methyliminodiacetic acid.</p></p></figure><figure data-id="sch4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/medium/jm-2016-00297a_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0019.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Regioselective Halogenation of 6-Aminoquinoxaline <b>5c</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00297&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Br<sub>2</sub> (1 equiv), AcOH, rt, 1 h or NCS/NBS (1.2 equiv), DCM, rt., 2 h; (b) excess Br<sub>2</sub>, AcOH, rt, 2 h.</p></p></figure><figure data-id="sch5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/medium/jm-2016-00297a_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0020.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of <i>N</i>-Propargyl-6-aminoquinoxaline Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00297&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) propargyl bromide (1.5 equiv), KI (1 equiv), K<sub>2</sub>CO<sub>3</sub> (1 equiv), DMF, 70 °C; (b) 1,1-dimethyl-propargyl chloride (1.4 equiv), CuCl (cat.), Et<sub>3</sub>N (1,4 equiv), THF/water, rt.</p></p></figure><figure data-id="fig1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/medium/jm-2016-00297a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0004.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Screening of 6-aminoquinoxaline derivatives in a cellular system that models selective DA cell death in midbrain cultures. Number of TH<sup>+</sup> neurons surviving after 10 days in vitro (DIV) in midbrain cultures treated or not with 6-aminoquinoxalines (50 μM, except <b>5c</b> 100 μM). Note that <b>5c</b> is inactive at 50 μM.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> DbcAMP (1 mM) is used as reference protective molecule for DA neurons. Inactive 6-aminoquinoxaline derivatives (<b>4s</b>, <b>4t</b>, <b>5b</b>, <b>5d</b>, <b>5f</b>, <b>5g</b>, <b>5h</b>, <b>5i</b>, <b>5k</b>, <b>6d</b>, <b>9c</b>) are not included in the figure. A 185% increase in survival at 50 μM is our cutoff for the selection of the most active compounds (above red line). *, <i>p</i> < 0.05 vs controls.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00297&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/medium/jm-2016-00297a_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Chemical Structures of All 6-Aminoquinoxaline Derivatives Tested in the Cellular PD Model of Spontaneous DA Cell Death<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00297&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Chart a</span>Compounds having significant protective effects towards DA neurons at 50 μM are colored in purple. Protective compounds selected for further investigations (see <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a> for selection criteria) are colored in green.</p></p></figure><figure data-id="fig2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/medium/jm-2016-00297a_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0005.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Evaluation of previously selected 6-aminoquinoxaline derivatives for their efficacy at a concentration of 10 μM. Selected 6-aminoquinoxaline derivatives were applied to midbrain cultures at 10 μM, and the survival rate of DA neurons was assessed at 10 DIV. Derivatives not providing protection at 10 μM (<b>4p</b>, <b>4r</b>, <b>7c</b>) are not shown in this figure. DbcAMP (1 mM) was used as reference protective molecule for DA neurons. * <i>p</i> < 0.05 vs controls.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00297&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/medium/jm-2016-00297a_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0006.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Screening of <i>N</i>-propargyl-6-aminoquinoxaline derivatives in a cellular system that models selective DA cell death in midbrain cultures. Number of TH<sup>+</sup> neurons surviving after 10 DIV in cultures treated or not with <i>N</i>-propargyl-6-aminoquinoxaline derivatives (50 μM). DbcAMP (1 mM) is used as reference protective molecule for DA neurons. Inactive <i>N</i>-propargyl-6-aminoquinoxaline derivatives (<b>11d</b>, <b>11f</b>, <b>11g</b>, <b>11h</b>, <b>11n</b>, <b>11r</b>, <b>12c</b>) are not included in this figure. A 185% increase in survival at 50 μM is our cutoff for active compounds (above red line). *, <i>p</i> < 0.05 vs controls.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00297&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/medium/jm-2016-00297a_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. Chemical Structures of All <i>N</i>-Propargyl-6-aminoquinoxaline Derivatives Synthesized and Tested in the Cellular PD Model of Spontaneous DA Cell Death<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00297&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Chart a</span>Compounds having significant protective effects towards DA neurons at 50 μM are colored in purple. Protective compounds selected for further investigations (see <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a> for selection criteria) are colored in green.</p></p></figure><figure data-id="fig4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/medium/jm-2016-00297a_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0007.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Evaluation of previously selected <i>N</i>-propargyl-6-aminoquinoxaline derivatives for their efficacy at 10 μM. Selected <i>N</i>-propargyl-6-aminoquinoxaline derivatives were applied to midbrain cultures at 10 μM and the survival rate of DA neurons was assessed at 10 DIV. DbcAMP (1 mM) is used as reference protective molecule for DA neurons. *, <i>p</i> < 0.05 vs controls.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00297&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/medium/jm-2016-00297a_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0008.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. <b>4c</b> does not reduce glial cell proliferation in midbrain cultures. Quantification of [<sup>3</sup>H]-thymidine incorporation in 8 DIV cultures treated or not with <b>4c</b> (10–50 μM). DbcAMP at 1 mM was used as a positive control. NS: no significant effect.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00297&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/medium/jm-2016-00297a_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0009.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Neuroprotective and neuritogenic effects of <b>4c</b> onto DA neurons in midbrain cultures. (A) Number of TH<sup>+</sup> neurons, in 10 DIV cultures treated or not with <b>4c</b> (1–50 μM). (B) Illustration showing TH<sup>+</sup> neurons, in 10 DIV cultures treated or not with <b>4c</b> (10–50 μM). Illustrations of the effects of <b>4c</b> on TH<sup>+</sup> cells are presented under an inverted format. Scale bars = 60 μm. In A–D, DbcAMP (1 mM) was used as reference protective molecule. (C) Quantification of [<sup>3</sup>H]-DA uptake in 10 DIV cultures treated or not with <b>4c</b> (10–50 μM). (D) Rate of DA uptake per TH<sup>+</sup> neuron in 10 DIV cultures treated or not with <b>4c</b> (10–50 μM). *<i>P</i> < 0.05 vs control cultures.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00297&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/medium/jm-2016-00297a_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0010.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Neuroprotection by <b>4c</b> requires calcium mobilization through RyRs. Number of TH<sup>+</sup> neurons in 10 DIV cultures chronically exposed or not to <b>4c</b> (50 μM) in the presence or not of nifedipine (NIF, 20 μM), ω-conotoxin MVIIA (ω-CON, 0.5 μM), or dantrolene (DAN, 30 μM). *<i>P</i> < 0.05 vs no treated cultures. #<i>P</i> < 0.05 vs <b>4c</b> treated cultures.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00297&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/medium/jm-2016-00297a_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0011.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Protective effect of <b>4c</b> is unrelated to that of GDNF. Number of TH<sup>+</sup> neurons in 10 DIV cultures treated or not with <b>4c</b> (50 μM), in the presence or not of an anti-GDNF antibody (AB-212-NA, 10 μg/mL). GDNF at 20 ng/mL was used as a positive control. *<i>P</i> < 0.05 vs control cultures. <sup>#</sup><i>P</i> < 0.05 vs GDNF-treated cultures.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00297&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/medium/jm-2016-00297a_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0012.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Mature DA neurons dependent on GDNF for their survival can be rescued by <b>4c</b>. Rescuing effect of <b>4c</b> (10–50 μM) in midbrain cultures exposed to 20 ng/mL GDNF for 10 days and then deprived of the trophic peptide between 11 DIV and 15 DIV. Comparison to cultures maintained continuously with GDNF up to 15 DIV. *<i>P</i> < 0.05 vs GDNF-treated cultures. #<i>P</i> < 0.05 vs GDNF-deprived cultures.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00297&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/medium/jm-2016-00297a_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0013.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Antioxidant effect of <b>4c</b>. Neuroprotective effect of <b>4c</b> (1–10 μM) for DA neurons in a model system of chronic oxidative stress. Desferrioxamine (Desf 10 μM) is used as a positive control. *<i>P</i> < 0.05 vs control cultures.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00297&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/medium/jm-2016-00297a_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0014.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Neuroprotective effects of <b>4c</b> onto DA neurons in the SN of MPTP-treated mice. (A) Neuroprotective effect of 11 days of treatment with <b>4c</b> (2 × 25, 2 × 50 mg/kg/day; po) on the number of TH<sup>+</sup> neurons in the SN of MPTP-treated mice (one hemisphere analyzed by mouse). Data expressed as mean ± SEM (<i>n</i> = 9–12). *<i>P</i> < 0.05 vs vehicle + MPTP (20 mg/kg/day) (one-way ANOVA with Dunnett’s multiple comparisons). #<i>P</i> < 0.05 vs vehicle (one-way ANOVA with Dunnett’s multiple comparisons). (B) Illustration showing the impact of <b>4c</b> (2 × 25, 2 × 50 mg/kg/day; po) on the number of DA neurons in the SN of MPTP or vehicle-treated mice. High-resolution bright-field digital images of the labeled sections were acquired using a NanoZoomer digital scanner (Hamamatsu Photonics France, Massy, France. objective ×40) equipped with the NDP software (Hamamatsu Photonics France, Massy, France, magnification ×4.5). Scale bar = 1 mm. Veh: vehicle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00297&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/medium/jm-2016-00297a_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0015.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. (A–C) Effect of 11 days of treatment with <b>4c</b> (2 × 25, 2 × 50 mg/kg/day; po) on the level of DA (A) and its metabolites (DOPAC, (B); HVA, (C)) in the striatum of MPTP-treated mice. (D) Effect of 11 days of treatment with <b>4c</b> (2 × 25, 2 × 50 mg/kg/day; po) on the ratio of (DOPAC + HVA)/DA in the striatum of MPTP-treated mice. Data expressed as mean ± SEM (<i>n</i> = 9–12). *<i>P</i> < 0.05 vs vehicle + MPTP (20 mg/kg) (one-way ANOVA with Dunnett’s multiple comparisons). Veh: vehicle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00297/20160708/images/large/jm-2016-00297a_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00297&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i91">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88308" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88308" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 48 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Hirsch, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Przedborski, S.</span><span> </span><span class="NLM_article-title">Pathogenesis of Parkinson’s disease</span> <span class="citation_source-journal">Mov. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">24</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span><span class="refDoi"> DOI: 10.1002/mds.25032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1002%2Fmds.25032" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2013&pages=24-30&author=E.+C.+Hirschauthor=P.+Jennerauthor=S.+Przedborski&title=Pathogenesis+of+Parkinson%E2%80%99s+disease&doi=10.1002%2Fmds.25032"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1002%2Fmds.25032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmds.25032%26sid%3Dliteratum%253Aachs%26aulast%3DHirsch%26aufirst%3DE.%2BC.%26aulast%3DJenner%26aufirst%3DP.%26aulast%3DPrzedborski%26aufirst%3DS.%26atitle%3DPathogenesis%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DMov.%2520Disord.%26date%3D2013%26volume%3D28%26spage%3D24%26epage%3D30%26doi%3D10.1002%2Fmds.25032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Kincses, Z. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vecsei, L.</span><span> </span><span class="NLM_article-title">Pharmacological therapy in Parkinson’s disease: focus on neuroprotection</span> <span class="citation_source-journal">CNS Neurosci. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">345</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span><span class="refDoi"> DOI: 10.1111/j.1755-5949.2010.00150.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1111%2Fj.1755-5949.2010.00150.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=20438581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlOntL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=345-367&author=Z.+T.+Kincsesauthor=L.+Vecsei&title=Pharmacological+therapy+in+Parkinson%E2%80%99s+disease%3A+focus+on+neuroprotection&doi=10.1111%2Fj.1755-5949.2010.00150.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological therapy in Parkinson's disease: focus on neuroprotection</span></div><div class="casAuthors">Kincses, Zsigmond Tamas; Vecsei, Laszlo</div><div class="citationInfo"><span class="NLM_cas:title">CNS Neuroscience & Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">345-367</span>CODEN:
                <span class="NLM_cas:coden">CNTNAB</span>;
        ISSN:<span class="NLM_cas:issn">1755-5930</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Although the no. of available therapeutic approaches in Parkinson's disease (PD) is steadily increasing the search for effective neuroprotective agent is continuing.  Such research is directed at influencing the key steps in the pathomechanism: the mitochondrial dysfunction, the oxidative stress, the neuroinflammatory processes and the final common apoptotic pathway.  Earlier-developed symptomatic therapies were implicated to be neuroprotective, and promising novel disease modifying approaches were brought into the focus of interest.  The current review presents a survey of our current knowledge relating to the pathomechanism of PD and discusses the putative neuroprotective therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZSn1474-6xrVg90H21EOLACvtfcHk0liLDmhl4F85dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlOntL7F&md5=7ca54cfb2c220fe48a00922b2c9bee54</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1111%2Fj.1755-5949.2010.00150.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1755-5949.2010.00150.x%26sid%3Dliteratum%253Aachs%26aulast%3DKincses%26aufirst%3DZ.%2BT.%26aulast%3DVecsei%26aufirst%3DL.%26atitle%3DPharmacological%2520therapy%2520in%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520focus%2520on%2520neuroprotection%26jtitle%3DCNS%2520Neurosci.%2520Ther.%26date%3D2011%26volume%3D17%26spage%3D345%26epage%3D367%26doi%3D10.1111%2Fj.1755-5949.2010.00150.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Hirsch, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunot, S.</span><span> </span><span class="NLM_article-title">Neuroinflammation in Parkinson’s disease: a target for neuroprotection?</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">382</span><span class="NLM_x">–</span> <span class="NLM_lpage">397</span><span class="refDoi"> DOI: 10.1016/S1474-4422(09)70062-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1016%2FS1474-4422%2809%2970062-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=19296921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=1%3ACAS%3A528%3ADC%252BD1MXks1Sis70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=382-397&author=E.+C.+Hirschauthor=S.+Hunot&title=Neuroinflammation+in+Parkinson%E2%80%99s+disease%3A+a+target+for+neuroprotection%3F&doi=10.1016%2FS1474-4422%2809%2970062-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroinflammation in Parkinson's disease: a target for neuroprotection?</span></div><div class="casAuthors">Hirsch, Etienne C.; Hunot, Stephane</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">382-397</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease is characterised by a slow and progressive degeneration of dopaminergic neurons in the substantia nigra.  Despite intensive research, the cause of the neuronal loss in Parkinson's disease is poorly understood.  Neuroinflammatory mechanisms might contribute to the cascade of events leading to neuronal degeneration.  In this Review, we describe the evidence for neuroinflammatory processes from post-mortem and in vivo studies in Parkinson's disease.  We further identify the cellular and mol. events assocd. with neuroinflammation that are involved in the degeneration of dopaminergic neurons in animal models of the disease.  Overall, available data support the importance of non-cell-autonomous pathol. mechanisms in Parkinson's disease, which are mostly mediated by activated glial and peripheral immune cells.  This cellular response to neurodegeneration triggers deleterious events (eg, oxidative stress and cytokine-receptor-mediated apoptosis), which might eventually lead to dopaminergic cell death and hence disease progression.  Finally, we highlight possible therapeutic strategies (including immunomodulatory drugs and therapeutic immunization) aimed at downregulating these inflammatory processes that might be important to slow the progression of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonuJZ2LO_DMrVg90H21EOLACvtfcHk0liLDmhl4F85dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXks1Sis70%253D&md5=0a49309a0821bf5589e19de971efb0f7</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2809%2970062-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252809%252970062-6%26sid%3Dliteratum%253Aachs%26aulast%3DHirsch%26aufirst%3DE.%2BC.%26aulast%3DHunot%26aufirst%3DS.%26atitle%3DNeuroinflammation%2520in%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520a%2520target%2520for%2520neuroprotection%253F%26jtitle%3DLancet%2520Neurol.%26date%3D2009%26volume%3D8%26spage%3D382%26epage%3D397%26doi%3D10.1016%2FS1474-4422%2809%2970062-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Michel, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez-Fischer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerreiro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hild, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, E. C.</span><span> </span><span class="NLM_article-title">Role of activity-dependent mechanisms in the control of dopaminergic neuron survival</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">289</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span><span class="refDoi"> DOI: 10.1111/j.1471-4159.2006.04424.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1111%2Fj.1471-4159.2006.04424.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=17402966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltVKitr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2007&pages=289-297&author=P.+P.+Michelauthor=D.+Alvarez-Fischerauthor=S.+Guerreiroauthor=A.+Hildauthor=A.+Hartmannauthor=E.+C.+Hirsch&title=Role+of+activity-dependent+mechanisms+in+the+control+of+dopaminergic+neuron+survival&doi=10.1111%2Fj.1471-4159.2006.04424.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Role of activity-dependent mechanisms in the control of dopaminergic neuron survival</span></div><div class="casAuthors">Michel, Patrick P.; Alvarez-Fischer, Daniel; Guerreiro, Serge; Hild, Audrey; Hartmann, Andreas; Hirsch, Etienne C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">289-297</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Dopaminergic neurons that constitute the nigrostriatal pathway are characterized by singular elec. properties that allow them to discharge in vivo spontaneously in a spectrum of patterns ranging from pacemaker to random and bursting modes.  These electrophysiol. features allow dopaminergic neurons to optimize the release of dopamine in their terminal fields.  However, there is emerging evidence indicating that elec. activity might also participate in the control of dopaminergic neuron survival, not only during development, but also in the adult brain, thus raising the possibility that alterations in ionic currents could contribute actively to the demise of these neurons in Parkinson disease.  This review focuses on the mechanisms by which activity-dependent mechanisms might modulate dopaminergic cell survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz_cYB0Mi9K7Vg90H21EOLACvtfcHk0lhOhvoaqrDPgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltVKitr0%253D&md5=3a5ea28280a268d10dafe504443b8ea2</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.04424.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.04424.x%26sid%3Dliteratum%253Aachs%26aulast%3DMichel%26aufirst%3DP.%2BP.%26aulast%3DAlvarez-Fischer%26aufirst%3DD.%26aulast%3DGuerreiro%26aufirst%3DS.%26aulast%3DHild%26aufirst%3DA.%26aulast%3DHartmann%26aufirst%3DA.%26aulast%3DHirsch%26aufirst%3DE.%2BC.%26atitle%3DRole%2520of%2520activity-dependent%2520mechanisms%2520in%2520the%2520control%2520of%2520dopaminergic%2520neuron%2520survival%26jtitle%3DJ.%2520Neurochem.%26date%3D2007%26volume%3D101%26spage%3D289%26epage%3D297%26doi%3D10.1111%2Fj.1471-4159.2006.04424.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Connolly, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, A. E.</span><span> </span><span class="NLM_article-title">Pharmacological treatment of Parkinson disease: a review</span> <span class="citation_source-journal">JAMA</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">311</span><span class="NLM_x">, </span> <span class="NLM_fpage">1670</span><span class="NLM_x">–</span> <span class="NLM_lpage">1683</span><span class="refDoi"> DOI: 10.1001/jama.2014.3654</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1001%2Fjama.2014.3654" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=24756517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFems7rP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=311&publication_year=2014&pages=1670-1683&author=B.+S.+Connollyauthor=A.+E.+Lang&title=Pharmacological+treatment+of+Parkinson+disease%3A+a+review&doi=10.1001%2Fjama.2014.3654"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological treatment of Parkinson disease: a review</span></div><div class="casAuthors">Connolly, Barbara S.; Lang, Anthony E.</div><div class="citationInfo"><span class="NLM_cas:title">JAMA, the Journal of the American Medical Association</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">311</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1670-1683, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">JAMAAP</span>;
        ISSN:<span class="NLM_cas:issn">1538-3598</span>.
    
            (<span class="NLM_cas:orgname">American Medical Association</span>)
        </div><div class="casAbstract">A review.  Importance: Parkinson disease is the second most common neurodegenerative disease worldwide.  Although no available therapies alter the underlying neurodegenerative process, symptomatic therapies can improve patient quality of life.  Objective: To provide an evidence-based review of the initial pharmacol. management of the classic motor symptoms of Parkinson disease; describe management of medication-related motor complications (such as motor fluctuations and dyskinesia), and other medication adverse effects (nausea, psychosis, and impulse control disorders and related behaviors); and discuss the management of selected nonmotor symptoms of Parkinson disease, including rapid eye movement sleep behavior disorder, cognitive impairment, depression, orthostatic hypotension, and sialorrhea.  Evidence Review: Refs. were identified using searches of PubMed between Jan. 1985 and Feb. 2014 for English-language human studies and the full database of the Cochrane Library.  The classification of studies by quality (classes I-IV) was assessed using the levels of evidence guidelines from the American Academy of Neurol. and the highest-quality data for each topic.  Results: Although levodopa is the most effective medication available for treating the motor symptoms of Parkinson disease, in certain instances (eg, mild symptoms, tremor as the only or most prominent symptom, aged <60 years) other medications (eg, monoamine oxidase type B inhibitors [MAOBIs], amantadine, anticholinergics, β-blockers, or dopamine agonists) may be initiated first to avoid levodopa-related motor complications.  Motor fluctuations may be managed by modifying the levodopa dosing regimen or by adding several other medications, such as MAOBIs, catechol-O-methyltransferase inhibitors, or dopamine agonists.  Impulse control disorders are typically managed by reducing or withdrawing dopaminergic medication, particularly dopamine agonists.  Evidence-based management of some nonmotor symptoms is limited by a paucity of high-quality pos. studies.  Conclusions and Relevance: Strong evidence supports using levodopa and dopamine agonists for motor symptoms at all stages of Parkinson disease.  Dopamine agonists and drugs that block dopamine metab. are effective for motor fluctuations and clozapine is effective for hallucinations.  Cholinesterase inhibitors may improve symptoms of dementia and antidepressants and pramipexole may improve depression.  Evidence supporting other therapies for motor and nonmotor features is less well established.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq4bHOyyI7XrVg90H21EOLACvtfcHk0lhOhvoaqrDPgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFems7rP&md5=a3faf879f5febdfc11a8992db89f2e67</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1001%2Fjama.2014.3654&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.2014.3654%26sid%3Dliteratum%253Aachs%26aulast%3DConnolly%26aufirst%3DB.%2BS.%26aulast%3DLang%26aufirst%3DA.%2BE.%26atitle%3DPharmacological%2520treatment%2520of%2520Parkinson%2520disease%253A%2520a%2520review%26jtitle%3DJAMA%26date%3D2014%26volume%3D311%26spage%3D1670%26epage%3D1683%26doi%3D10.1001%2Fjama.2014.3654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Tracy, H. M.</span><span> </span><span class="NLM_article-title">Parkinson’s</span>.  <span class="citation_source-journal">Neuroperspective</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">190</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=190&publication_year=2011&pages=3-24&author=H.+M.+Tracy&title=Parkinson%E2%80%99s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTracy%26aufirst%3DH.%2BM.%26atitle%3DParkinson%25E2%2580%2599s%26jtitle%3DNeuroperspective%26date%3D2011%26volume%3D190%26spage%3D3%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Stocchi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olanow, C. W.</span><span> </span><span class="NLM_article-title">Obstacles to the development of a neuroprotective therapy for Parkinson’s disease</span> <span class="citation_source-journal">Mov. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">7</span><span class="refDoi"> DOI: 10.1002/mds.25337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1002%2Fmds.25337" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2013&pages=3-7&author=F.+Stocchiauthor=C.+W.+Olanow&title=Obstacles+to+the+development+of+a+neuroprotective+therapy+for+Parkinson%E2%80%99s+disease&doi=10.1002%2Fmds.25337"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2Fmds.25337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmds.25337%26sid%3Dliteratum%253Aachs%26aulast%3DStocchi%26aufirst%3DF.%26aulast%3DOlanow%26aufirst%3DC.%2BW.%26atitle%3DObstacles%2520to%2520the%2520development%2520of%2520a%2520neuroprotective%2520therapy%2520for%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DMov.%2520Disord.%26date%3D2013%26volume%3D28%26spage%3D3%26epage%3D7%26doi%3D10.1002%2Fmds.25337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Schmidt, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Champy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Séon-Méniel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franck, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raisman-Vozari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figadère, B.</span><span> </span><span class="NLM_article-title">Chemicals possessing a neurotrophin-like activity on dopaminergic neurons in primary culture</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">e6215</span><span class="refDoi"> DOI: 10.1371/journal.pone.0006215</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1371%2Fjournal.pone.0006215" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=19593444" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=e6215&author=F.+Schmidtauthor=P.+Champyauthor=B.+S%C3%A9on-M%C3%A9nielauthor=X.+Franckauthor=R.+Raisman-Vozariauthor=B.+Figad%C3%A8re&title=Chemicals+possessing+a+neurotrophin-like+activity+on+dopaminergic+neurons+in+primary+culture&doi=10.1371%2Fjournal.pone.0006215"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0006215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0006215%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DF.%26aulast%3DChampy%26aufirst%3DP.%26aulast%3DS%25C3%25A9on-M%25C3%25A9niel%26aufirst%3DB.%26aulast%3DFranck%26aufirst%3DX.%26aulast%3DRaisman-Vozari%26aufirst%3DR.%26aulast%3DFigad%25C3%25A8re%26aufirst%3DB.%26atitle%3DChemicals%2520possessing%2520a%2520neurotrophin-like%2520activity%2520on%2520dopaminergic%2520neurons%2520in%2520primary%2520culture%26jtitle%3DPLoS%2520One%26date%3D2009%26volume%3D4%26spage%3De6215%26doi%3D10.1371%2Fjournal.pone.0006215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Schmidt, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Douaron, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Champy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Séon-Méniel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raisman-Vozari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figadère, B.</span><span> </span><span class="NLM_article-title">Tryptamine-derived alkaloids from Annonaceae exerting neurotrophin-like properties on primary dopaminergic neurons</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5103</span><span class="NLM_x">–</span> <span class="NLM_lpage">5113</span><span class="refDoi"> DOI: 10.1016/j.bmc.2010.05.067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1016%2Fj.bmc.2010.05.067" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=5103-5113&author=F.+Schmidtauthor=G.+Le+Douaronauthor=P.+Champyauthor=M.+Amarauthor=B.+S%C3%A9on-M%C3%A9nielauthor=R.+Raisman-Vozariauthor=B.+Figad%C3%A8re&title=Tryptamine-derived+alkaloids+from+Annonaceae+exerting+neurotrophin-like+properties+on+primary+dopaminergic+neurons&doi=10.1016%2Fj.bmc.2010.05.067"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.05.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.05.067%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DF.%26aulast%3DLe%2BDouaron%26aufirst%3DG.%26aulast%3DChampy%26aufirst%3DP.%26aulast%3DAmar%26aufirst%3DM.%26aulast%3DS%25C3%25A9on-M%25C3%25A9niel%26aufirst%3DB.%26aulast%3DRaisman-Vozari%26aufirst%3DR.%26aulast%3DFigad%25C3%25A8re%26aufirst%3DB.%26atitle%3DTryptamine-derived%2520alkaloids%2520from%2520Annonaceae%2520exerting%2520neurotrophin-like%2520properties%2520on%2520primary%2520dopaminergic%2520neurons%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D5103%26epage%3D5113%26doi%3D10.1016%2Fj.bmc.2010.05.067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Mayo, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sainz, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, D. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antolín, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiter, R. J.</span><span> </span><span class="NLM_article-title">Melatonin and Parkinson’s disease</span> <span class="citation_source-journal">Endocr. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">178</span><span class="refDoi"> DOI: 10.1385/ENDO:27:2:169</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1385%2FENDO%3A27%3A2%3A169" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2005&pages=169-178&author=J.+C.+Mayoauthor=R.+M.+Sainzauthor=D.+X.+Tanauthor=I.+Antol%C3%ADnauthor=C.+Rodr%C3%ADguezauthor=R.+J.+Reiter&title=Melatonin+and+Parkinson%E2%80%99s+disease&doi=10.1385%2FENDO%3A27%3A2%3A169"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1385%2FENDO%3A27%3A2%3A169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252FENDO%253A27%253A2%253A169%26sid%3Dliteratum%253Aachs%26aulast%3DMayo%26aufirst%3DJ.%2BC.%26aulast%3DSainz%26aufirst%3DR.%2BM.%26aulast%3DTan%26aufirst%3DD.%2BX.%26aulast%3DAntol%25C3%25ADn%26aufirst%3DI.%26aulast%3DRodr%25C3%25ADguez%26aufirst%3DC.%26aulast%3DReiter%26aufirst%3DR.%2BJ.%26atitle%3DMelatonin%2520and%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DEndocr.%2520J.%26date%3D2005%26volume%3D27%26spage%3D169%26epage%3D178%26doi%3D10.1385%2FENDO%3A27%3A2%3A169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Cao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span> </span><span class="NLM_article-title">Effects of docosahexaenoic acid on the survival and neurite outgrowth of rat cortical neurons in primary cultures</span> <span class="citation_source-journal">J. Nutr. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">538</span><span class="NLM_x">–</span> <span class="NLM_lpage">546</span><span class="refDoi"> DOI: 10.1016/j.jnutbio.2005.02.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1016%2Fj.jnutbio.2005.02.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=16115542" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsVWiu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2005&pages=538-546&author=D.+Caoauthor=R.+Xueauthor=J.+Xuauthor=Z.+Liu&title=Effects+of+docosahexaenoic+acid+on+the+survival+and+neurite+outgrowth+of+rat+cortical+neurons+in+primary+cultures&doi=10.1016%2Fj.jnutbio.2005.02.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of docosahexaenoic acid on the survival and neurite outgrowth of rat cortical neurons in primary cultures</span></div><div class="casAuthors">Cao, Dehua; Xue, Renhao; Xu, Jun; Liu, Zhili</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nutritional Biochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">538-546</span>CODEN:
                <span class="NLM_cas:coden">JNBIEL</span>;
        ISSN:<span class="NLM_cas:issn">0955-2863</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Effects of docosahexaenoic acid (DHA) on survival and neurite outgrowth were investigated in primary cultures of rat cortical neurons.  Cell cultures were prepd. from cortex on embryonic day 18 (E-18) for treatment with a series of DHA concns. (12.5, 25, 50, 75, 100 and 200 μM).  Docosahexaenoic acid (25-50 μM) significantly enhanced neuronal viability, but lower concn. of DHA (12.5 μM) did not show an obvious effect.  In contrast, higher concns. of DHA (100-200 μM) exerted the significant opposite effects by decreasing neuronal viability.  Furthermore, treatment with 25 μM DHA significantly prevented the neurons from death after different culture days in vitro (DIV).  Moreover, measurements from the cultures exposed to 25 μM DHA immediately after plating showed significant increases in the percentage of cells with neurites, the mean no. of neurite branches, the total neuritic length per cell and the length of the longest neurite in each cell after 24 and 48 h in vitro (HIV).  The DHA-treated neurons had greater growth-assocd. protein-43 (GAP-43) immunoactivity and higher phosphatidylserine (PS) and phosphatidylethanolamine (PE) contents, but lower phosphatidylcholine (PC) content than control neurons.  The significant increased DHA contents were also obsd. in both PE and PS in the treated neurons.  These findings suggest that optimal DHA (25 μM) may have pos. effects on the survival and the neurite outgrowth of the cultured fetal rat cortical neurons, and the effects probably are related to DHA-stimulating neuron-specific protein synthesis and its enhancing the discrete phospholipid (PL) content through enrichment of DHA in the PL species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovQscmVZruy7Vg90H21EOLACvtfcHk0ljs7Ytq2VGkHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsVWiu7o%253D&md5=b36c888f3dfbf42d9cd2da52b088861d</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.jnutbio.2005.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jnutbio.2005.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DD.%26aulast%3DXue%26aufirst%3DR.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DZ.%26atitle%3DEffects%2520of%2520docosahexaenoic%2520acid%2520on%2520the%2520survival%2520and%2520neurite%2520outgrowth%2520of%2520rat%2520cortical%2520neurons%2520in%2520primary%2520cultures%26jtitle%3DJ.%2520Nutr.%2520Biochem.%26date%3D2005%26volume%3D16%26spage%3D538%26epage%3D546%26doi%3D10.1016%2Fj.jnutbio.2005.02.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Le Douaron, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadar, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debortoli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Séon-Méniel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrié, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michel, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Touboul, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunelle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raisman-Vozari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figadère, B.</span><span> </span><span class="NLM_article-title">Neuroprotective effects of a brain permeant 6-aminoquinoxaline derivative in cell culture conditions that model the loss of dopaminergic neurons in Parkinson disease</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">467</span><span class="NLM_x">–</span> <span class="NLM_lpage">479</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.10.067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1016%2Fj.ejmech.2014.10.067" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2015&pages=467-479&author=G.+Le+Douaronauthor=F.+Schmidtauthor=M.+Amarauthor=H.+Kadarauthor=L.+Debortoliauthor=A.+Latiniauthor=B.+S%C3%A9on-M%C3%A9nielauthor=L.+Ferri%C3%A9author=P.+P.+Michelauthor=D.+Touboulauthor=A.+Brunelleauthor=R.+Raisman-Vozariauthor=B.+Figad%C3%A8re&title=Neuroprotective+effects+of+a+brain+permeant+6-aminoquinoxaline+derivative+in+cell+culture+conditions+that+model+the+loss+of+dopaminergic+neurons+in+Parkinson+disease&doi=10.1016%2Fj.ejmech.2014.10.067"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.10.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.10.067%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BDouaron%26aufirst%3DG.%26aulast%3DSchmidt%26aufirst%3DF.%26aulast%3DAmar%26aufirst%3DM.%26aulast%3DKadar%26aufirst%3DH.%26aulast%3DDebortoli%26aufirst%3DL.%26aulast%3DLatini%26aufirst%3DA.%26aulast%3DS%25C3%25A9on-M%25C3%25A9niel%26aufirst%3DB.%26aulast%3DFerri%25C3%25A9%26aufirst%3DL.%26aulast%3DMichel%26aufirst%3DP.%2BP.%26aulast%3DTouboul%26aufirst%3DD.%26aulast%3DBrunelle%26aufirst%3DA.%26aulast%3DRaisman-Vozari%26aufirst%3DR.%26aulast%3DFigad%25C3%25A8re%26aufirst%3DB.%26atitle%3DNeuroprotective%2520effects%2520of%2520a%2520brain%2520permeant%25206-aminoquinoxaline%2520derivative%2520in%2520cell%2520culture%2520conditions%2520that%2520model%2520the%2520loss%2520of%2520dopaminergic%2520neurons%2520in%2520Parkinson%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D89%26spage%3D467%26epage%3D479%26doi%3D10.1016%2Fj.ejmech.2014.10.067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Adlard, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherny, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finkelstein, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gautier, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robb, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volitakis, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laughton, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolazzo, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkins, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deleva, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kok, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritchie, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanzi, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masters, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnham, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, A. I.</span><span> </span><span class="NLM_article-title">Rapid restoration of cognition in Alzheimer’s transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Ab</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span><span class="refDoi"> DOI: 10.1016/j.neuron.2008.06.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1016%2Fj.neuron.2008.06.018" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2008&pages=43-55&author=P.+A.+Adlardauthor=R.+A.+Chernyauthor=D.+I.+Finkelsteinauthor=E.+Gautierauthor=E.+Robbauthor=M.+Cortesauthor=I.+Volitakisauthor=X.+Liuauthor=J.+P.+Smithauthor=K.+Perezauthor=K.+Laughtonauthor=Q.-X.+Liauthor=S.+A.+Charmanauthor=J.+A.+Nicolazzoauthor=S.+Wilkinsauthor=K.+Delevaauthor=T.+Lynchauthor=G.+Kokauthor=C.+W.+Ritchieauthor=R.+E.+Tanziauthor=R.+Cappaiauthor=C.+L.+Mastersauthor=K.+J.+Barnhamauthor=A.+I.+Bush&title=Rapid+restoration+of+cognition+in+Alzheimer%E2%80%99s+transgenic+mice+with+8-hydroxy+quinoline+analogs+is+associated+with+decreased+interstitial+Ab&doi=10.1016%2Fj.neuron.2008.06.018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2008.06.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2008.06.018%26sid%3Dliteratum%253Aachs%26aulast%3DAdlard%26aufirst%3DP.%2BA.%26aulast%3DCherny%26aufirst%3DR.%2BA.%26aulast%3DFinkelstein%26aufirst%3DD.%2BI.%26aulast%3DGautier%26aufirst%3DE.%26aulast%3DRobb%26aufirst%3DE.%26aulast%3DCortes%26aufirst%3DM.%26aulast%3DVolitakis%26aufirst%3DI.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DSmith%26aufirst%3DJ.%2BP.%26aulast%3DPerez%26aufirst%3DK.%26aulast%3DLaughton%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DQ.-X.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DNicolazzo%26aufirst%3DJ.%2BA.%26aulast%3DWilkins%26aufirst%3DS.%26aulast%3DDeleva%26aufirst%3DK.%26aulast%3DLynch%26aufirst%3DT.%26aulast%3DKok%26aufirst%3DG.%26aulast%3DRitchie%26aufirst%3DC.%2BW.%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26aulast%3DCappai%26aufirst%3DR.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DBarnham%26aufirst%3DK.%2BJ.%26aulast%3DBush%26aufirst%3DA.%2BI.%26atitle%3DRapid%2520restoration%2520of%2520cognition%2520in%2520Alzheimer%25E2%2580%2599s%2520transgenic%2520mice%2520with%25208-hydroxy%2520quinoline%2520analogs%2520is%2520associated%2520with%2520decreased%2520interstitial%2520Ab%26jtitle%3DNeuron%26date%3D2008%26volume%3D59%26spage%3D43%26epage%3D55%26doi%3D10.1016%2Fj.neuron.2008.06.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Mandel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinreb, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amit, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span> </span><span class="NLM_article-title">Mechanism of neuroprotective action of the anti-Parkinson drug rasagiline and its derivatives</span> <span class="citation_source-journal">Brain Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">379</span><span class="NLM_x">–</span> <span class="NLM_lpage">387</span><span class="refDoi"> DOI: 10.1016/j.brainresrev.2004.12.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1016%2Fj.brainresrev.2004.12.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=15850677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjs1Clsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=379-387&author=S.+Mandelauthor=O.+Weinrebauthor=T.+Amitauthor=M.+B.+H.+Youdim&title=Mechanism+of+neuroprotective+action+of+the+anti-Parkinson+drug+rasagiline+and+its+derivatives&doi=10.1016%2Fj.brainresrev.2004.12.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of neuroprotective action of the anti-Parkinson drug rasagiline and its derivatives</span></div><div class="casAuthors">Mandel, Silvia; Weinreb, Orly; Amit, Tamar; Youdim, Moussa B. H.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">379-387</span>CODEN:
                <span class="NLM_cas:coden">BRERD2</span>;
        ISSN:<span class="NLM_cas:issn">0165-0173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The mitochondria are directly involved in cell survival and death.  Drugs that protect mitochondria viability and prevent apoptotic cascade mechanisms involved in mitochondrial permeability transition pore (MPTp) will be cytoprotective.  Rasagiline (N-propargyl-1R-aminoindan) is a novel, highly potent irreversible monoamine oxidase (MAO) B inhibitor, anti-Parkinson drug.  Unlike selegiline, rasagiline is not derived from amphetamine, is not metabolized to neurotoxic l-methamphetamine deriv., nor does it have sympathomimetic activity.  Rasagiline is effective as monotherapy or adjunct to L-dopa for patients with early and late Parkinson's disease (PD), and adverse events do not occur with greater frequency in subjects receiving rasagiline than those on placebo.  Controlled studies indicate that it might have a disease-modifying effect in PD that may be related to neuroprotection.  Its S-isomer, TVP1022, is a relatively inactive MAO inhibitor.  However, both drugs have similar neuroprotective activities in neuronal cell cultures in response to various neurotoxins and in vivo (global ischemia, neurotrauma, head injury, anoxia, etc.), indicating that MAO inhibition is not a pre-requisite for neuroprotection.  Structure activity studies have shown that the neuroprotective activity is assocd. with the propargyl moiety of rasagiline which protects mitochondrial viability and MPTp by activating Bcl-2 and protein kinase C (PKC), and down regulating pro-apoptotic FAS and Bax.  Rasagiline and its derivs. also process amyloid precursor protein (APP) to the neuroprotective-neurotrophic sol. APP alpha (sAPPα) by PKC and MAP kinase-dependent activation of α-secretase.  The neuroprotective activity of propargylamine has led us to develop novel bifunctional neuroprotective iron-chelating MAO-inhibiting drugs possessing propargyl moiety for the treatment of other neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqo-jzsUjjFfbVg90H21EOLACvtfcHk0lht_nMddbrosg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjs1Clsr0%253D&md5=7defa497360ae91d0d8bea6f1e1ee6b0</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.brainresrev.2004.12.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainresrev.2004.12.027%26sid%3Dliteratum%253Aachs%26aulast%3DMandel%26aufirst%3DS.%26aulast%3DWeinreb%26aufirst%3DO.%26aulast%3DAmit%26aufirst%3DT.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26atitle%3DMechanism%2520of%2520neuroprotective%2520action%2520of%2520the%2520anti-Parkinson%2520drug%2520rasagiline%2520and%2520its%2520derivatives%26jtitle%3DBrain%2520Res.%2520Rev.%26date%3D2005%26volume%3D48%26spage%3D379%26epage%3D387%26doi%3D10.1016%2Fj.brainresrev.2004.12.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Weinreb, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amit, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Am, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span> </span><span class="NLM_article-title">Rasagiline: a novel anti-Parkinsonian monoamine oxidase-B inhibitor with neuroprotective activity</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">330</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span><span class="refDoi"> DOI: 10.1016/j.pneurobio.2010.06.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1016%2Fj.pneurobio.2010.06.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=20600573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVWmt7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2010&pages=330-344&author=O.+Weinrebauthor=T.+Amitauthor=O.+Bar-Amauthor=M.+B.+H.+Youdim&title=Rasagiline%3A+a+novel+anti-Parkinsonian+monoamine+oxidase-B+inhibitor+with+neuroprotective+activity&doi=10.1016%2Fj.pneurobio.2010.06.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Rasagiline: A novel anti-Parkinsonian monoamine oxidase-B inhibitor with neuroprotective activity</span></div><div class="casAuthors">Weinreb, Orly; Amit, Tamar; Bar-Am, Orit; Youdim, Moussa B. H.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">330-344</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Rasagiline (N-propargyl-1-(R)-aminoindan) is a novel, highly potent irreversible monoamine oxidase (MAO)-B inhibitor, anti-Parkinsonian drug.  Rasagiline is effective as monotherapy or adjunct to L-Dopa for patients with early and late Parkinson's disease (PD).  Its S-isomer, TVP1022 is thousand times less potent as an MAO-B inhibitor.  However, both compds. have similar mol. mechanisms of neuroprotection in neuronal cell cultures and animal neurodegenerative models, indicating that the neuroprotective effect of rasagiline does not depend on inhibition of MAO-B, but rather is assocd. with the N-propargyl moiety, which promotes mitochondrial viability and stabilizes permeability transition by regulating Bcl-2 family proteins.  Novel findings demonstrated that the major metabolite of rasagiline, 1-(R)-aminoindan has antioxidant and neuroprotective capabilities and thus, may contribute to the overt activity of its parent compd., rasagiline.  This paper will review the earlier and present studies in the development of rasagiline for treatment of PD and discuss its pharmacol. and applicable mechanism of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSUYfAZtuEY7Vg90H21EOLACvtfcHk0lh3uyMv7-tSsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVWmt7%252FL&md5=02539198de5f5360d2d458de7a44bfe4</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2010.06.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2010.06.008%26sid%3Dliteratum%253Aachs%26aulast%3DWeinreb%26aufirst%3DO.%26aulast%3DAmit%26aufirst%3DT.%26aulast%3DBar-Am%26aufirst%3DO.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26atitle%3DRasagiline%253A%2520a%2520novel%2520anti-Parkinsonian%2520monoamine%2520oxidase-B%2520inhibitor%2520with%2520neuroprotective%2520activity%26jtitle%3DProg.%2520Neurobiol.%26date%3D2010%26volume%3D92%26spage%3D330%26epage%3D344%26doi%3D10.1016%2Fj.pneurobio.2010.06.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Guerreiro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toulorge, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marien, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sokoloff, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michel, P. P.</span><span> </span><span class="NLM_article-title">Paraxanthine, the primary metabolite of caffeine, provides protection against dopaminergic cell death via stimulation of ryanodine receptor channels</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">980</span><span class="NLM_x">–</span> <span class="NLM_lpage">989</span><span class="refDoi"> DOI: 10.1124/mol.108.048207</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1124%2Fmol.108.048207" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2008&pages=980-989&author=S.+Guerreiroauthor=D.+Toulorgeauthor=E.+Hirschauthor=M.+Marienauthor=P.+Sokoloffauthor=P.+P.+Michel&title=Paraxanthine%2C+the+primary+metabolite+of+caffeine%2C+provides+protection+against+dopaminergic+cell+death+via+stimulation+of+ryanodine+receptor+channels&doi=10.1124%2Fmol.108.048207"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1124%2Fmol.108.048207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.108.048207%26sid%3Dliteratum%253Aachs%26aulast%3DGuerreiro%26aufirst%3DS.%26aulast%3DToulorge%26aufirst%3DD.%26aulast%3DHirsch%26aufirst%3DE.%26aulast%3DMarien%26aufirst%3DM.%26aulast%3DSokoloff%26aufirst%3DP.%26aulast%3DMichel%26aufirst%3DP.%2BP.%26atitle%3DParaxanthine%252C%2520the%2520primary%2520metabolite%2520of%2520caffeine%252C%2520provides%2520protection%2520against%2520dopaminergic%2520cell%2520death%2520via%2520stimulation%2520of%2520ryanodine%2520receptor%2520channels%26jtitle%3DMol.%2520Pharmacol.%26date%3D2008%26volume%3D74%26spage%3D980%26epage%3D989%26doi%3D10.1124%2Fmol.108.048207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Xu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarzschild, M. A.</span><span> </span><span class="NLM_article-title">Neuroprotection by caffeine: time course and role of its metabolites in the MPTP model of Parkinson’s disease</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">167</span><span class="NLM_x">, </span> <span class="NLM_fpage">475</span><span class="NLM_x">–</span> <span class="NLM_lpage">481</span><span class="refDoi"> DOI: 10.1016/j.neuroscience.2010.02.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1016%2Fj.neuroscience.2010.02.020" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2010&pages=475-481&author=K.+Xuauthor=Y.+H.+Xuauthor=J.+F.+Chenauthor=M.+A.+Schwarzschild&title=Neuroprotection+by+caffeine%3A+time+course+and+role+of+its+metabolites+in+the+MPTP+model+of+Parkinson%E2%80%99s+disease&doi=10.1016%2Fj.neuroscience.2010.02.020"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2010.02.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2010.02.020%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DK.%26aulast%3DXu%26aufirst%3DY.%2BH.%26aulast%3DChen%26aufirst%3DJ.%2BF.%26aulast%3DSchwarzschild%26aufirst%3DM.%2BA.%26atitle%3DNeuroprotection%2520by%2520caffeine%253A%2520time%2520course%2520and%2520role%2520of%2520its%2520metabolites%2520in%2520the%2520MPTP%2520model%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNeuroscience%26date%3D2010%26volume%3D167%26spage%3D475%26epage%3D481%26doi%3D10.1016%2Fj.neuroscience.2010.02.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Hinsberg, O.</span><span> </span><span class="NLM_article-title">Ueber chinoxaline</span> <span class="citation_source-journal">Ber. Dtsch. Chem. Ges.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1884</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">318</span><span class="NLM_x">–</span> <span class="NLM_lpage">323</span><span class="refDoi"> DOI: 10.1002/cber.18840170193</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1002%2Fcber.18840170193" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1884&pages=318-323&author=O.+Hinsberg&title=Ueber+chinoxaline&doi=10.1002%2Fcber.18840170193"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fcber.18840170193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcber.18840170193%26sid%3Dliteratum%253Aachs%26aulast%3DHinsberg%26aufirst%3DO.%26atitle%3DUeber%2520chinoxaline%26jtitle%3DBer.%2520Dtsch.%2520Chem.%2520Ges.%26date%3D1884%26volume%3D17%26spage%3D318%26epage%3D323%26doi%3D10.1002%2Fcber.18840170193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Hui, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fakhfakh, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franck, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figadère, B.</span><span> </span><span class="NLM_article-title">A new preparation of 2-substituted-7-aminoquinoxalines and 2,3-disubstituted-7-aminoquinoxalines</span> <span class="citation_source-journal">Heterocycles</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">361</span><span class="refDoi"> DOI: 10.3987/COM-06-S(K)19</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.3987%2FCOM-06-S%28K%2919" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2007&pages=353-361&author=X.+Huiauthor=F.+Schmidtauthor=M.+A.+Fakhfakhauthor=X.+Franckauthor=B.+Figad%C3%A8re&title=A+new+preparation+of+2-substituted-7-aminoquinoxalines+and+2%2C3-disubstituted-7-aminoquinoxalines&doi=10.3987%2FCOM-06-S%28K%2919"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.3987%2FCOM-06-S%28K%2919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3987%252FCOM-06-S%2528K%252919%26sid%3Dliteratum%253Aachs%26aulast%3DHui%26aufirst%3DX.%26aulast%3DSchmidt%26aufirst%3DF.%26aulast%3DFakhfakh%26aufirst%3DM.%2BA.%26aulast%3DFranck%26aufirst%3DX.%26aulast%3DFigad%25C3%25A8re%26aufirst%3DB.%26atitle%3DA%2520new%2520preparation%2520of%25202-substituted-7-aminoquinoxalines%2520and%25202%252C3-disubstituted-7-aminoquinoxalines%26jtitle%3DHeterocycles%26date%3D2007%26volume%3D72%26spage%3D353%26epage%3D361%26doi%3D10.3987%2FCOM-06-S%28K%2919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Deng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span> </span><span class="NLM_article-title">Design and synthesis of small molecule RhoA inhibitors: a new promising therapy for cardiovascular diseases?</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">4508</span><span class="NLM_x">–</span> <span class="NLM_lpage">4522</span><span class="refDoi"> DOI: 10.1021/jm200161c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200161c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4508-4522&author=J.+Dengauthor=E.+G.+Fengauthor=S.+Maauthor=Y.+Zhangauthor=X.+F.+Liuauthor=H.+L.+Liauthor=H.+Huangauthor=J.+Zhuauthor=W.+L.+Zhuauthor=X.+Shenauthor=L.+Y.+Miaoauthor=H.+Liuauthor=H.+L.+Jiangauthor=J.+Li&title=Design+and+synthesis+of+small+molecule+RhoA+inhibitors%3A+a+new+promising+therapy+for+cardiovascular+diseases%3F&doi=10.1021%2Fjm200161c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm200161c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200161c%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DJ.%26aulast%3DFeng%26aufirst%3DE.%2BG.%26aulast%3DMa%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DX.%2BF.%26aulast%3DLi%26aufirst%3DH.%2BL.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DW.%2BL.%26aulast%3DShen%26aufirst%3DX.%26aulast%3DMiao%26aufirst%3DL.%2BY.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DH.%2BL.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520small%2520molecule%2520RhoA%2520inhibitors%253A%2520a%2520new%2520promising%2520therapy%2520for%2520cardiovascular%2520diseases%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D4508%26epage%3D4522%26doi%3D10.1021%2Fjm200161c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Holman, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, A. D.</span><span> </span><span class="NLM_article-title">Preparation and cyclization of some N-(2,2-dimethylpropargyl) homo- and heteroaromatic amines and the synthesis of some pyrido[2,3-d]pyrimidines</span> <span class="citation_source-journal">Aust. J. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">368</span><span class="NLM_x">–</span> <span class="NLM_lpage">374</span><span class="refDoi"> DOI: 10.1071/CH04260</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1071%2FCH04260" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2005&pages=368-374&author=M.+A.+Holmanauthor=N.+M.+Williamsonauthor=A.+D.+Ward&title=Preparation+and+cyclization+of+some+N-%282%2C2-dimethylpropargyl%29+homo-+and+heteroaromatic+amines+and+the+synthesis+of+some+pyrido%5B2%2C3-d%5Dpyrimidines&doi=10.1071%2FCH04260"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1071%2FCH04260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1071%252FCH04260%26sid%3Dliteratum%253Aachs%26aulast%3DHolman%26aufirst%3DM.%2BA.%26aulast%3DWilliamson%26aufirst%3DN.%2BM.%26aulast%3DWard%26aufirst%3DA.%2BD.%26atitle%3DPreparation%2520and%2520cyclization%2520of%2520some%2520N-%25282%252C2-dimethylpropargyl%2529%2520homo-%2520and%2520heteroaromatic%2520amines%2520and%2520the%2520synthesis%2520of%2520some%2520pyrido%255B2%252C3-d%255Dpyrimidines%26jtitle%3DAust.%2520J.%2520Chem.%26date%3D2005%26volume%3D58%26spage%3D368%26epage%3D374%26doi%3D10.1071%2FCH04260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Rousseau, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michel, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, E. C.</span><span> </span><span class="NLM_article-title">The iron-binding protein lactoferrin protects vulnerable dopamine neurons from degeneration by preserving mitochondrial calcium homeostasis</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">888</span><span class="NLM_x">–</span> <span class="NLM_lpage">898</span><span class="refDoi"> DOI: 10.1124/mol.113.087965</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1124%2Fmol.113.087965" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2013&pages=888-898&author=E.+Rousseauauthor=P.+P.+Michelauthor=E.+C.+Hirsch&title=The+iron-binding+protein+lactoferrin+protects+vulnerable+dopamine+neurons+from+degeneration+by+preserving+mitochondrial+calcium+homeostasis&doi=10.1124%2Fmol.113.087965"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1124%2Fmol.113.087965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.113.087965%26sid%3Dliteratum%253Aachs%26aulast%3DRousseau%26aufirst%3DE.%26aulast%3DMichel%26aufirst%3DP.%2BP.%26aulast%3DHirsch%26aufirst%3DE.%2BC.%26atitle%3DThe%2520iron-binding%2520protein%2520lactoferrin%2520protects%2520vulnerable%2520dopamine%2520neurons%2520from%2520degeneration%2520by%2520preserving%2520mitochondrial%2520calcium%2520homeostasis%26jtitle%3DMol.%2520Pharmacol.%26date%3D2013%26volume%3D84%26spage%3D888%26epage%3D898%26doi%3D10.1124%2Fmol.113.087965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Toulorge, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerreiro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hild, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maskos, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michel, P. P.</span><span> </span><span class="NLM_article-title">Neuroprotection of midbrain dopamine neurons by nicotine is gated by cytoplasmic Ca<sub>2</sub>+</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">2563</span><span class="NLM_x">–</span> <span class="NLM_lpage">2573</span><span class="refDoi"> DOI: 10.1096/fj.11-182824</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1096%2Ffj.11-182824" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=2563-2573&author=D.+Toulorgeauthor=S.+Guerreiroauthor=A.+Hildauthor=U.+Maskosauthor=E.+C.+Hirschauthor=P.+P.+Michel&title=Neuroprotection+of+midbrain+dopamine+neurons+by+nicotine+is+gated+by+cytoplasmic+Ca2%2B&doi=10.1096%2Ffj.11-182824"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1096%2Ffj.11-182824&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.11-182824%26sid%3Dliteratum%253Aachs%26aulast%3DToulorge%26aufirst%3DD.%26aulast%3DGuerreiro%26aufirst%3DS.%26aulast%3DHild%26aufirst%3DA.%26aulast%3DMaskos%26aufirst%3DU.%26aulast%3DHirsch%26aufirst%3DE.%2BC.%26aulast%3DMichel%26aufirst%3DP.%2BP.%26atitle%3DNeuroprotection%2520of%2520midbrain%2520dopamine%2520neurons%2520by%2520nicotine%2520is%2520gated%2520by%2520cytoplasmic%2520Ca2%252B%26jtitle%3DFASEB%2520J.%26date%3D2011%26volume%3D25%26spage%3D2563%26epage%3D2573%26doi%3D10.1096%2Ffj.11-182824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Michel, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agid, Y.</span><span> </span><span class="NLM_article-title">Chronic activation of the cyclic AMP signaling pathway promotes development and long-term survival of mesencephalic dopaminergic neurons</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">1633</span><span class="NLM_x">–</span> <span class="NLM_lpage">1642</span><span class="refDoi"> DOI: 10.1046/j.1471-4159.1996.67041633.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1046%2Fj.1471-4159.1996.67041633.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=8858948" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=1%3ACAS%3A528%3ADyaK28XmtVWitb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=1996&pages=1633-1642&author=P.+P.+Michelauthor=Y.+Agid&title=Chronic+activation+of+the+cyclic+AMP+signaling+pathway+promotes+development+and+long-term+survival+of+mesencephalic+dopaminergic+neurons&doi=10.1046%2Fj.1471-4159.1996.67041633.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic activation of the cyclic AMP signaling pathway promotes development and long-term survival of mesencephalic dopaminergic neurons</span></div><div class="casAuthors">Michel, Patrick P.; Agid, Yves</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1633-1642</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott-Raven</span>)
        </div><div class="casAbstract">Di-Bu cAMP (dbcAMP), a permeant analog of cAMP, prevented, for at least 3 wk, the death of tyrosine hydroxylase (TH)-immunopos. dopaminergic neurons, which occurred spontaneously by apoptosis in mesencephalic cultures.  Treatment with the cyclic nucleotide analog also led to a significant increase in the uptake of [3H]dopamine, attesting that the rescued TH+ neurons were fully functional and differentiated, dbcAMP was most effective when added immediately after plating, but delayed treatment could still arrest the ongoing degenerative process.  Trophic/survival effects were long-lasting, declining only progressively after withdrawal of dbcAMP from the culture medium.  They were independent of cell d. and still detectable in the absence of serum proteins.  The effects of dbcAMP were mimicked by depolarizing concns. of potassium and by agents that increase endogenous prodn. of cAMP, such as forskolin or 3-isobutyl-1-methylxanthine, but not by native cAMP, which cannot cross cell membranes.  Elimination of glial cells by arabinoside-C did not reduce the activity of dbcAMP.  GABAergic neurons, also present in these cultures, were much less dependent on the cyclic nucleotide analog for their survival, and serotoninergic cells were not dependent at all.  Therefore, cAMP-dependent signaling may be particularly crucial for the maturation and long-term survival of mesencephalic dopaminergic neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8wVJwOPv_7rVg90H21EOLACvtfcHk0lhR7IxSGBQfgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmtVWitb0%253D&md5=f976dd63e117454712bdc1811357e2f1</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.1996.67041633.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.1996.67041633.x%26sid%3Dliteratum%253Aachs%26aulast%3DMichel%26aufirst%3DP.%2BP.%26aulast%3DAgid%26aufirst%3DY.%26atitle%3DChronic%2520activation%2520of%2520the%2520cyclic%2520AMP%2520signaling%2520pathway%2520promotes%2520development%2520and%2520long-term%2520survival%2520of%2520mesencephalic%2520dopaminergic%2520neurons%26jtitle%3DJ.%2520Neurochem.%26date%3D1996%26volume%3D67%26spage%3D1633%26epage%3D1642%26doi%3D10.1046%2Fj.1471-4159.1996.67041633.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Michel, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agid, Y.</span><span> </span><span class="NLM_article-title">Rescue of mesencephalic dopamine neurons by anticancer drug cytosine arabinoside</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">1499</span><span class="NLM_x">–</span> <span class="NLM_lpage">1507</span><span class="refDoi"> DOI: 10.1046/j.1471-4159.1997.69041499.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1046%2Fj.1471-4159.1997.69041499.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=9326279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=1%3ACAS%3A528%3ADyaK2sXmsVCksLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=1997&pages=1499-1507&author=P.+P.+Michelauthor=M.+Rubergauthor=Y.+Agid&title=Rescue+of+mesencephalic+dopamine+neurons+by+anticancer+drug+cytosine+arabinoside&doi=10.1046%2Fj.1471-4159.1997.69041499.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Rescue of mesencephalic dopamine neurons by anticancer drug cytosine arabinoside</span></div><div class="casAuthors">Michel, Patrick P.; Ruberg, Merle; Agid, Yves</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1499-1507</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott-Raven</span>)
        </div><div class="casAbstract">Nanomolar concns. of cytosine arabinoside (ara-C), a structural analog of 2'-deoxycytidine (2'dC) used in the chemotherapy of cancer, proved to be highly effective in preventing the death of postmitotic dopaminergic neurons that occurs spontaneously by apoptosis in mesencephalic cultures.  The rescued cells were totally functional and highly differentiated.  The trophic/neuroprotective effects of ara-C were (1) specific for dopaminergic neurons; (2) long-lived, remaining detectable several days after withdrawal of the nucleoside analog from the culture medium; (3) still obsd. when the treatment was delayed after plating; (4) abolished by an excess of 2'dC or dCTP, or by exposure to the neurotoxin 1-methyl-4-phenylpyridinium; and (5) mimicked by ara-CTP, 5-fluoro-2'-deoxyuridine, and aphidicolin.  Autoradiog. studies revealed that ara-C was incorporated exclusively into astrocyte nuclei, suggesting that the dopaminotrophic activity was indirect and resulted from the antiproliferative action of the modified nucleoside on glial cells at concns. that were not neurotoxic.  No evidence was found for putative deleterious or trophic mols. secreted by proliferating or ara-C-treated astrocytes, resp., suggesting that neuroglial contact may play a role.  Our results suggest a possible mechanism underlying neurodegeneration in Parkinson's disease, where selective loss of dopaminergic neurons in the mesencephalon is accompanied by astrogliosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-6-ya9PGverVg90H21EOLACvtfcHk0lhR7IxSGBQfgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmsVCksLo%253D&md5=6097a5c963f110e6ff7b927b152d4b52</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.1997.69041499.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.1997.69041499.x%26sid%3Dliteratum%253Aachs%26aulast%3DMichel%26aufirst%3DP.%2BP.%26aulast%3DRuberg%26aufirst%3DM.%26aulast%3DAgid%26aufirst%3DY.%26atitle%3DRescue%2520of%2520mesencephalic%2520dopamine%2520neurons%2520by%2520anticancer%2520drug%2520cytosine%2520arabinoside%26jtitle%3DJ.%2520Neurochem.%26date%3D1997%26volume%3D69%26spage%3D1499%26epage%3D1507%26doi%3D10.1046%2Fj.1471-4159.1997.69041499.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Tian, D.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, D.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Z.-y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, M.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span> </span><span class="NLM_article-title">Attenuation of astrogliosis by suppressing of microglial proliferation with the cell cycle inhibitor olomoucine in rat spinal cord injury model</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">1154</span><span class="NLM_x">, </span> <span class="NLM_fpage">206</span><span class="NLM_x">–</span> <span class="NLM_lpage">214</span><span class="refDoi"> DOI: 10.1016/j.brainres.2007.04.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1016%2Fj.brainres.2007.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=17482149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmt1ynsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1154&publication_year=2007&pages=206-214&author=D.-S.+Tianauthor=Q.+Dongauthor=D.-J.+Panauthor=Y.+Heauthor=Z.-y.+Yuauthor=M.-J.+Xieauthor=W.+Wang&title=Attenuation+of+astrogliosis+by+suppressing+of+microglial+proliferation+with+the+cell+cycle+inhibitor+olomoucine+in+rat+spinal+cord+injury+model&doi=10.1016%2Fj.brainres.2007.04.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Attenuation of astrogliosis by suppressing of microglial proliferation with the cell cycle inhibitor olomoucine in rat spinal cord injury model</span></div><div class="casAuthors">Tian, Dai-shi; Dong, Qiang; Pan, Deng-ji; He, Yi; Yu, Zhi-yuan; Xie, Min-jie; Wang, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1154</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">206-214</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Microglial activation/proliferation and reactive astrogliosis are commonly obsd. and have been considered to be closely relevant pathol. processes during spinal cord injury (SCI).  However, the mol. mechanisms underlying this microglial-astroglial interaction are still poorly understood.  We showed recently that the continuous injection of the cell cycle inhibitor olomoucine not only markedly suppressed microglial proliferation and assocd. release of pro-inflammatory cytokines, but also attenuated astroglial scar formation and the lesion cavity and mitigated the functional deficits in rat SCI animal model.  In this study, we asked whether microglial activation/proliferation plays an initial role and also necessary in maintaining astrogliosis in SCI model.  Our results showed that traumatic induced microglial activation/proliferation precedes astrogliosis, and the up-regulated GFAP expression at both mRNA and protein levels was temporally posterior to the microglial activation.  Furthermore, when the cell cycle inhibitor olomoucine was administered only once 1 h post-SCI that should selectively suppress microglial proliferation, the subsequent SCI induced increase in GFAP expression at 1, 2 and 4 wk was significantly attenuated, suggesting that microglial activation/proliferation played an important role for the later onset astrogliosis after SCI.  Consistent with the results that microglial proliferation always precedes astroglial proliferation and there is at present no evidence of other astroglial precursors, which as always does not mean that they will not be uncovered by further searching, and in view of the fact that microglial-derived pro-inflammatory cytokines promote astrogliosis as we reported recently, these findings together suggest that by release of cytokines and other sol. products, the early onset microglial activation/proliferation can significantly influence the subsequent development of reactive astrogliosis and glial scar formation in SCI animal model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSNS9ziTBd8bVg90H21EOLACvtfcHk0lhR7IxSGBQfgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmt1ynsb8%253D&md5=5781b79baf8cac74cd121bef0974f5c0</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2007.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2007.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DTian%26aufirst%3DD.-S.%26aulast%3DDong%26aufirst%3DQ.%26aulast%3DPan%26aufirst%3DD.-J.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DZ.-y.%26aulast%3DXie%26aufirst%3DM.-J.%26aulast%3DWang%26aufirst%3DW.%26atitle%3DAttenuation%2520of%2520astrogliosis%2520by%2520suppressing%2520of%2520microglial%2520proliferation%2520with%2520the%2520cell%2520cycle%2520inhibitor%2520olomoucine%2520in%2520rat%2520spinal%2520cord%2520injury%2520model%26jtitle%3DBrain%2520Res.%26date%3D2007%26volume%3D1154%26spage%3D206%26epage%3D214%26doi%3D10.1016%2Fj.brainres.2007.04.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Hailer, N. P.</span><span> </span><span class="NLM_article-title">Immunosuppression after traumatic or ischemic CNS damage: It is neuroprotective and illuminates the role of microglial cells</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">233</span><span class="refDoi"> DOI: 10.1016/j.pneurobio.2007.12.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1016%2Fj.pneurobio.2007.12.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=18262323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitlektbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2008&pages=211-233&author=N.+P.+Hailer&title=Immunosuppression+after+traumatic+or+ischemic+CNS+damage%3A+It+is+neuroprotective+and+illuminates+the+role+of+microglial+cells&doi=10.1016%2Fj.pneurobio.2007.12.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Immunosuppression after traumatic or ischemic CNS damage: It is neuroprotective and illuminates the role of microglial cells</span></div><div class="casAuthors">Hailer, Nils P.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">211-233</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Acute traumatic and ischemic events in the central nervous system (CNS) invariably result in activation of microglial cells as local representatives of the immune system.  It is still under debate whether activated microglia promote neuronal survival, or whether they exacerbate the original extent of neuronal damage.  Protagonists of the view that microglial cells cause secondary damage have proposed that inhibition of microglial activation by immunosuppression is beneficial after acute CNS damage.  It is the aim of this review to analyze the effects of immunosuppressants on isolated microglial cells and neurons, and to scrutinize the effects of immunosuppression in different in vivo models of acute CNS trauma or ischemia.  It is found that the immunosuppressants cytosine-arabinoside, different steroids, cyclosporin A, FK506, rapamycin, mycophenolate mofetil, and minocycline all have direct inhibitory effects on microglial cells.  These effects are mainly exerted by inhibiting microglial proliferation or microglial secretion of neurotoxic substances such as proinflammatory cytokines and nitric oxide.  Furthermore, immunosuppression after acute CNS trauma or ischemia results in improved structure preservation and, mostly, in enhanced function.  However, all investigated immunosuppressants also have direct effects on neurons, and some immunosuppressants affect other glial cells such as astrocytes.  In summary, it is safe to conclude that immunosuppression after acute CNS trauma or ischemia is neuroprotective.  Furthermore, circumferential evidence indicates that microglial activation after traumatic or ischemic CNS damage is not beneficial to adjacent neurons in the immediate aftermath of such acute lesions.  Further expts. with more specific agents or genetic approaches that specifically inhibit microglial cells are needed in order to fully answer the question of whether microglial activation is "good or bad".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV7s6ccRvs77Vg90H21EOLACvtfcHk0lhR7IxSGBQfgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitlektbk%253D&md5=9c3cb72eae0057051102e54a47bab58c</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2007.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2007.12.001%26sid%3Dliteratum%253Aachs%26aulast%3DHailer%26aufirst%3DN.%2BP.%26atitle%3DImmunosuppression%2520after%2520traumatic%2520or%2520ischemic%2520CNS%2520damage%253A%2520It%2520is%2520neuroprotective%2520and%2520illuminates%2520the%2520role%2520of%2520microglial%2520cells%26jtitle%3DProg.%2520Neurobiol.%26date%3D2008%26volume%3D84%26spage%3D211%26epage%3D233%26doi%3D10.1016%2Fj.pneurobio.2007.12.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Mourlevat, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troadec, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michel, P. P.</span><span> </span><span class="NLM_article-title">Prevention of dopaminergic neuronal death by cyclic AMP in mixed neuronal/Glial mesencephalic cultures requires the repression of presumptive astrocytes</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">578</span><span class="NLM_x">–</span> <span class="NLM_lpage">586</span><span class="refDoi"> DOI: 10.1124/mol.64.3.578</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1124%2Fmol.64.3.578" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2003&pages=578-586&author=S.+Mourlevatauthor=J.+D.+Troadecauthor=M.+Rubergauthor=P.+P.+Michel&title=Prevention+of+dopaminergic+neuronal+death+by+cyclic+AMP+in+mixed+neuronal%2FGlial+mesencephalic+cultures+requires+the+repression+of+presumptive+astrocytes&doi=10.1124%2Fmol.64.3.578"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1124%2Fmol.64.3.578&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.64.3.578%26sid%3Dliteratum%253Aachs%26aulast%3DMourlevat%26aufirst%3DS.%26aulast%3DTroadec%26aufirst%3DJ.%2BD.%26aulast%3DRuberg%26aufirst%3DM.%26aulast%3DMichel%26aufirst%3DP.%2BP.%26atitle%3DPrevention%2520of%2520dopaminergic%2520neuronal%2520death%2520by%2520cyclic%2520AMP%2520in%2520mixed%2520neuronal%252FGlial%2520mesencephalic%2520cultures%2520requires%2520the%2520repression%2520of%2520presumptive%2520astrocytes%26jtitle%3DMol.%2520Pharmacol.%26date%3D2003%26volume%3D64%26spage%3D578%26epage%3D586%26doi%3D10.1124%2Fmol.64.3.578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Ciliax, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heilman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demchyshyn, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pristupa, Z. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ince, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hersch, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niznik, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levey, A. I.</span><span> </span><span class="NLM_article-title">The dopamine transporter: immunochemical characterization and localization in brain</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1714</span><span class="NLM_x">–</span> <span class="NLM_lpage">1723</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1523%2FJNEUROSCI.15-03-01714.1995" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=7534339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=1%3ACAS%3A528%3ADyaK2MXksVegu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1995&pages=1714-1723&author=B.+J.+Ciliaxauthor=C.+Heilmanauthor=L.+L.+Demchyshynauthor=Z.+B.+Pristupaauthor=E.+Inceauthor=S.+M.+Herschauthor=H.+B.+Niznikauthor=A.+I.+Levey&title=The+dopamine+transporter%3A+immunochemical+characterization+and+localization+in+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The dopamine transporter: immunochemical characterization and localization in brain</span></div><div class="casAuthors">Ciliax, Brian J.; Heilman, Craig; Demchyshyn, Lidia L.; Pristupa, Zdenek B.; Ince, Ernesto; Hersch, Steven M.; Niznik, Hyman B.; Levey, Allan I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3, Pt. 1</span>),
    <span class="NLM_cas:pages">1714-23</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Antibodies specific for the dopamine transporter (DAT) were developed and characterized by immunoblot anal., immunopptn., and immunocytochem., and used for immunolocalization of transporter protein in rat brain at the light microscopic level.  Antibodies targeting the N-terminus, the second extracellular loop, and the C-terminus were generated from fusion proteins contg. amino acid sequences from these resp. regions.  Immunoblot anal. demonstrated that N-terminus and loop antibodies were specific for expressed cloned DAT, recognized transporter protein in rat and human striatal membranes, and were sensitive to preabsorption with excess homologs fusion protein.  Immunopptn. studies demonstrated that anti-DAT antisera recognized solubilized, radiolabeled DAT protein in a concn.-dependent manner.  DAT immunocytochem. with these antibodies were also sensitive to preabsorption with fusion protein and to lesions of dopaminergic mesostriatal and mesocorticolimbic pathways.  Regional distribution of DAT coincided with established dopaminergic innervation of several regions, including ventral mesencephalon, medial forebrain bundle, and dorsal and ventral striatum.  However, certain mismatches between immunocytochem. distributions of DAT and tyrosine hydroxylase were apparent, indicating that dopaminergic systems are heterogeneous and may use independent mechanisms for the regulation of dopamine levels in brain.  The generation of specific DAT antibodies will permit further characterization of the cellular and subcellular localization of DAT protein, and of dopaminergic circuits in neurol. and psychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfjjVCGF3sKbVg90H21EOLACvtfcHk0liRRipwQPxENQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXksVegu7w%253D&md5=8da0687e1226112c5e21eed4f90ed095</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.15-03-01714.1995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.15-03-01714.1995%26sid%3Dliteratum%253Aachs%26aulast%3DCiliax%26aufirst%3DB.%2BJ.%26aulast%3DHeilman%26aufirst%3DC.%26aulast%3DDemchyshyn%26aufirst%3DL.%2BL.%26aulast%3DPristupa%26aufirst%3DZ.%2BB.%26aulast%3DInce%26aufirst%3DE.%26aulast%3DHersch%26aufirst%3DS.%2BM.%26aulast%3DNiznik%26aufirst%3DH.%2BB.%26aulast%3DLevey%26aufirst%3DA.%2BI.%26atitle%3DThe%2520dopamine%2520transporter%253A%2520immunochemical%2520characterization%2520and%2520localization%2520in%2520brain%26jtitle%3DJ.%2520Neurosci.%26date%3D1995%26volume%3D15%26spage%3D1714%26epage%3D1723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Toulorge, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerreiro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michel, P. P.</span><span> </span><span class="NLM_article-title">KATP channel blockade protects midbrain dopamine neurons by repressing a glia-to-neuron signaling cascade that ultimately disrupts mitochondrial calcium homeostasis</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">553</span><span class="NLM_x">–</span> <span class="NLM_lpage">564</span><span class="refDoi"> DOI: 10.1111/j.1471-4159.2010.06785.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1111%2Fj.1471-4159.2010.06785.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=20456014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=1%3ACAS%3A528%3ADC%252BC3cXovFKitr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2010&pages=553-564&author=D.+Toulorgeauthor=S.+Guerreiroauthor=E.+C.+Hirschauthor=P.+P.+Michel&title=KATP+channel+blockade+protects+midbrain+dopamine+neurons+by+repressing+a+glia-to-neuron+signaling+cascade+that+ultimately+disrupts+mitochondrial+calcium+homeostasis&doi=10.1111%2Fj.1471-4159.2010.06785.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">KATP channel blockade protects midbrain dopamine neurons by repressing a glia-to-neuron signaling cascade that ultimately disrupts mitochondrial calcium homeostasis</span></div><div class="casAuthors">Toulorge, Damien; Guerreiro, Serge; Hirsch, Etienne C.; Michel, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">553-564</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">While KATP channels serve primarily as metabolic gatekeepers in excitable cells, they might also participate in other important cellular functions.  Here, we demonstrate that KATP channel blockade with the sulfonylurea deriv. glibenclamide provided robust protection to dopamine neurons undergoing spontaneous and selective degeneration in midbrain cultures.  Unexpectedly, glibenclamide operated not by a direct effect on dopamine neurons but instead by halting the proliferation of a population of immature glial cells lacking astrocytic and microglial markers.  The antimitotic effect of glibenclamide appeared essential to unmask a pro-survival phosphoinositide 3-kinase (PI3K)/Akt-dependent signaling pathway that controlled shuttling of calcium from endoplasmic reticulum to mitochondria in dopamine neurons.  Preventing integrin-ligand interactions with a decoy ligand, the Arg-Gly-Asp-Ser sequence peptide, reproduced survival promotion by glibenclamide via a mechanism that also required PI3K/Akt-dependent regulation of mitochondrial calcium.  Noticeably, Arg-Gly-Asp-Ser did not cause a redn. in glial cell nos. indicating that it prevented the death process downstream of the level at which glibenclamide intervenes.  Based on these results, we propose that KATP channel blockade protected dopamine neurons by inhibiting a glia-to-neuron signaling pathway that propagates through integrin/ ligand interactions and ultimately disrupts PI3K/Akt-dependent signaling and mitochondrial calcium homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7LYz6Qevl3bVg90H21EOLACvtfcHk0liRRipwQPxENQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXovFKitr8%253D&md5=df2d7ae94cf5e264d22d6430f8fd3896</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2010.06785.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2010.06785.x%26sid%3Dliteratum%253Aachs%26aulast%3DToulorge%26aufirst%3DD.%26aulast%3DGuerreiro%26aufirst%3DS.%26aulast%3DHirsch%26aufirst%3DE.%2BC.%26aulast%3DMichel%26aufirst%3DP.%2BP.%26atitle%3DKATP%2520channel%2520blockade%2520protects%2520midbrain%2520dopamine%2520neurons%2520by%2520repressing%2520a%2520glia-to-neuron%2520signaling%2520cascade%2520that%2520ultimately%2520disrupts%2520mitochondrial%2520calcium%2520homeostasis%26jtitle%3DJ.%2520Neurochem.%26date%3D2010%26volume%3D114%26spage%3D553%26epage%3D564%26doi%3D10.1111%2Fj.1471-4159.2010.06785.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Fill, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copello, J. A.</span><span> </span><span class="NLM_article-title">Ryanodine receptor calcium release channels</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">893</span><span class="NLM_x">–</span> <span class="NLM_lpage">922</span><span class="refDoi"> DOI: 10.1152/physrev.00013.2002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1152%2Fphysrev.00013.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=12270947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=1%3ACAS%3A528%3ADC%252BD38Xot1Ggurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2002&pages=893-922&author=M.+Fillauthor=J.+A.+Copello&title=Ryanodine+receptor+calcium+release+channels&doi=10.1152%2Fphysrev.00013.2002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Ryanodine receptor calcium release channels</span></div><div class="casAuthors">Fill, Michael; Copello, Julio A.</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">893-922</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  The ryanodine receptors (RyRs) are a family of Ca2+ release channels found on intracellular Ca2+ storage/release organelles.  The RyR channels are ubiquitously expressed in many types of cells and participate in a variety of important Ca2+ signaling phenomena (neurotransmission, secretion, etc.).  In striated muscle, the RyR channels represent the primary pathway for Ca2+ release during the excitation-contraction coupling process.  In general, the signals that activate the RyR channels are known (e.g., sarcolemmal Ca2+ influx or depolarization), but the specific mechanisms involved are still being debated.  The signals that modulate and/or turn off the RyR channels remain ambiguous and the mechanisms involved unclear.  Over the last decade, studies of RyR-mediated Ca2+ release have taken many forms and have steadily advanced investigators' knowledge.  This robust field, however, is not without controversial ideas and contradictory results.  Controversies surrounding the complex Ca2+ regulation of single RyR channels receive particular attention here.  In addn., a large body of information is synthesized into a focused perspective of single RyR channel function.  The present status of the single RyR channel field and its likely future directions are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5A5-cHXQNgLVg90H21EOLACvtfcHk0lg5dqWMlxXsOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xot1Ggurk%253D&md5=5bc6b275c4a2f4876b29d89d2ffee8a7</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00013.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00013.2002%26sid%3Dliteratum%253Aachs%26aulast%3DFill%26aufirst%3DM.%26aulast%3DCopello%26aufirst%3DJ.%2BA.%26atitle%3DRyanodine%2520receptor%2520calcium%2520release%2520channels%26jtitle%3DPhysiol.%2520Rev.%26date%3D2002%26volume%3D82%26spage%3D893%26epage%3D922%26doi%3D10.1152%2Fphysrev.00013.2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Verkhratsky, A.</span><span> </span><span class="NLM_article-title">Physiology and pathophysiology of the calcium store in the endoplasmic reticulum of neurons</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">279</span><span class="refDoi"> DOI: 10.1152/physrev.00004.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1152%2Fphysrev.00004.2004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2005&pages=201-279&author=A.+Verkhratsky&title=Physiology+and+pathophysiology+of+the+calcium+store+in+the+endoplasmic+reticulum+of+neurons&doi=10.1152%2Fphysrev.00004.2004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00004.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00004.2004%26sid%3Dliteratum%253Aachs%26aulast%3DVerkhratsky%26aufirst%3DA.%26atitle%3DPhysiology%2520and%2520pathophysiology%2520of%2520the%2520calcium%2520store%2520in%2520the%2520endoplasmic%2520reticulum%2520of%2520neurons%26jtitle%3DPhysiol.%2520Rev.%26date%3D2005%26volume%3D85%26spage%3D201%26epage%3D279%26doi%3D10.1152%2Fphysrev.00004.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Lin, L.-F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lile, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bektesh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, F.</span><span> </span><span class="NLM_article-title">GDNF: a glial cell line derived neurotrophic factor for midbrain dopaminergic neurons</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">260</span><span class="NLM_x">, </span> <span class="NLM_fpage">1130</span><span class="NLM_x">–</span> <span class="NLM_lpage">1132</span><span class="refDoi"> DOI: 10.1126/science.8493557</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1126%2Fscience.8493557" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=260&publication_year=1993&pages=1130-1132&author=L.-F.+H.+Linauthor=D.+H.+Dohertyauthor=J.+D.+Lileauthor=S.+Bekteshauthor=F.+Collins&title=GDNF%3A+a+glial+cell+line+derived+neurotrophic+factor+for+midbrain+dopaminergic+neurons&doi=10.1126%2Fscience.8493557"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1126%2Fscience.8493557&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.8493557%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DL.-F.%2BH.%26aulast%3DDoherty%26aufirst%3DD.%2BH.%26aulast%3DLile%26aufirst%3DJ.%2BD.%26aulast%3DBektesh%26aufirst%3DS.%26aulast%3DCollins%26aufirst%3DF.%26atitle%3DGDNF%253A%2520a%2520glial%2520cell%2520line%2520derived%2520neurotrophic%2520factor%2520for%2520midbrain%2520dopaminergic%2520neurons%26jtitle%3DScience%26date%3D1993%26volume%3D260%26spage%3D1130%26epage%3D1132%26doi%3D10.1126%2Fscience.8493557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Cipriani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desjardins, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burdett, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarzschild, M. A.</span><span> </span><span class="NLM_article-title">Urate and its transgenic depletion modulate neuronal vulnerability in a cellular model of Parkinson’s disease</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e37331</span><span class="refDoi"> DOI: 10.1371/journal.pone.0037331</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1371%2Fjournal.pone.0037331" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e37331&author=S.+Ciprianiauthor=C.+A.+Desjardinsauthor=T.+C.+Burdettauthor=Y.+Xuauthor=K.+Xuauthor=M.+A.+Schwarzschild&title=Urate+and+its+transgenic+depletion+modulate+neuronal+vulnerability+in+a+cellular+model+of+Parkinson%E2%80%99s+disease&doi=10.1371%2Fjournal.pone.0037331"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0037331&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0037331%26sid%3Dliteratum%253Aachs%26aulast%3DCipriani%26aufirst%3DS.%26aulast%3DDesjardins%26aufirst%3DC.%2BA.%26aulast%3DBurdett%26aufirst%3DT.%2BC.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DK.%26aulast%3DSchwarzschild%26aufirst%3DM.%2BA.%26atitle%3DUrate%2520and%2520its%2520transgenic%2520depletion%2520modulate%2520neuronal%2520vulnerability%2520in%2520a%2520cellular%2520model%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De37331%26doi%3D10.1371%2Fjournal.pone.0037331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Troadec, J.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marien, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darios, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colpaert, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michel, P. P.</span><span> </span><span class="NLM_article-title">Noradrenaline provides long-term protection to dopaminergic neurons by reducing oxidative stress</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">200</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span><span class="refDoi"> DOI: 10.1046/j.1471-4159.2001.00556.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1046%2Fj.1471-4159.2001.00556.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=11595772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnsV2isbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2001&pages=200-210&author=J.-D.+Troadecauthor=M.+Marienauthor=F.+Dariosauthor=A.+Hartmannauthor=M.+Rubergauthor=F.+Colpaertauthor=P.+P.+Michel&title=Noradrenaline+provides+long-term+protection+to+dopaminergic+neurons+by+reducing+oxidative+stress&doi=10.1046%2Fj.1471-4159.2001.00556.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Noradrenaline provides long-term protection to dopaminergic neurons by reducing oxidative stress</span></div><div class="casAuthors">Troadec, Jean-Denis; Marien, Marc; Darios, Frederic; Hartmann, Andreas; Ruberg, Merle; Colpaert, Francis; Michel, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">200-210</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">To better understand the neurotrophic function of the neurotransmitter noradrenaline, the authors have developed a model of mesencephalic cultures in which the authors find low concns. (0.3-10 μM) of noradrenaline to be remarkably effective in promoting long-term survival and function of dopaminergic neurons.  This protective action reproduced the effect of caspase inhibition.  It was atypical in that it occurred independently of adrenoceptor activation and was mimicked by some antioxidants, redox metal chelators and the hydroxyl radical detoxifying enzyme catalase.  Interestingly, intracellular reactive oxygen species (ROS) were drastically reduced by treatment with noradrenaline, indicating that the neurotransmitter itself acted as an antioxidant.  Prevention of oxidative stress was, however, independent of the glutathione antioxidant defense system.  Chem. analogs of noradrenaline bearing two free hydroxyl groups in the ortho position of the arom. ring (o-catechols), as well as o-catechol itself, mimicked the survival promoting effects of the neurotransmitter, suggesting that this diphenolic structure was crit. for both neuroprotection and redn. of ROS prodn.  Paradoxically, the autoxidn. of noradrenaline and the ensuing prodn. of quinone metabolites may be required for both effects, as the neurotransmitter was spontaneously and rapidly degraded over time in the culture medium.  These results support the concept that central noradrenergic mechanisms have a neuroprotective role, perhaps in part by reducing oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr_rqtGZFPa7Vg90H21EOLACvtfcHk0lg5dqWMlxXsOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnsV2isbY%253D&md5=56ef166f3fe786abcfaed5a696294da4</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2001.00556.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2001.00556.x%26sid%3Dliteratum%253Aachs%26aulast%3DTroadec%26aufirst%3DJ.-D.%26aulast%3DMarien%26aufirst%3DM.%26aulast%3DDarios%26aufirst%3DF.%26aulast%3DHartmann%26aufirst%3DA.%26aulast%3DRuberg%26aufirst%3DM.%26aulast%3DColpaert%26aufirst%3DF.%26aulast%3DMichel%26aufirst%3DP.%2BP.%26atitle%3DNoradrenaline%2520provides%2520long-term%2520protection%2520to%2520dopaminergic%2520neurons%2520by%2520reducing%2520oxidative%2520stress%26jtitle%3DJ.%2520Neurochem.%26date%3D2001%26volume%3D79%26spage%3D200%26epage%3D210%26doi%3D10.1046%2Fj.1471-4159.2001.00556.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Miller, M. J.</span><span> </span><span class="NLM_article-title">Syntheses and therapeutic potential of hydroxamic acid based siderophores and analogues</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">1563</span><span class="NLM_x">–</span> <span class="NLM_lpage">1579</span><span class="refDoi"> DOI: 10.1021/cr00097a011</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr00097a011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1989&pages=1563-1579&author=M.+J.+Miller&title=Syntheses+and+therapeutic+potential+of+hydroxamic+acid+based+siderophores+and+analogues&doi=10.1021%2Fcr00097a011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fcr00097a011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr00097a011%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DM.%2BJ.%26atitle%3DSyntheses%2520and%2520therapeutic%2520potential%2520of%2520hydroxamic%2520acid%2520based%2520siderophores%2520and%2520analogues%26jtitle%3DChem.%2520Rev.%26date%3D1989%26volume%3D89%26spage%3D1563%26epage%3D1579%26doi%3D10.1021%2Fcr00097a011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Von Bonsdorff, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindeberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nyman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harju, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkkinen, J.</span><span> </span><span class="NLM_article-title">Development of a pharmaceutical apotransferrin product for iron binding therapy</span> <span class="citation_source-journal">Biologicals</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">37</span><span class="refDoi"> DOI: 10.1006/biol.2001.0273</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1006%2Fbiol.2001.0273" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=11482890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlsFyns7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2001&pages=27-37&author=L.+Von+Bonsdorffauthor=H.+Toloauthor=E.+Lindebergauthor=T.+Nymanauthor=A.+Harjuauthor=J.+Parkkinen&title=Development+of+a+pharmaceutical+apotransferrin+product+for+iron+binding+therapy&doi=10.1006%2Fbiol.2001.0273"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Pharmaceutical Apotransferrin Product for Iron Binding Therapy</span></div><div class="casAuthors">von Bonsdorff, Leni; Tolo, Hannele; Lindeberg, Enni; Nyman, Tuula; Harju, Anna; Parkkinen, Jaakko</div><div class="citationInfo"><span class="NLM_cas:title">Biologicals</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">27-37</span>CODEN:
                <span class="NLM_cas:coden">BILSEC</span>;
        ISSN:<span class="NLM_cas:issn">1045-1056</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">High-dose chemotherapy of patients with hematol. malignancies results in extracellular iron accumulation and appearance of non-transferrin-bound iron, which is thought to predispose the patients to septic infections and contribute to organ toxicity.  We describe the development of a human plasma-derived apotransferrin product for iron binding therapy.  The product is purified from Cohn fraction IV of human plasma by two ion exchange chromatog. steps and ultrafiltration.  The process comprises solvent detergent treatment as the main virus inactivation step and 15 nm virus filtration and polyethylene glycol pptn. as removal steps for physico-chem. resistant infectious agents.  Product characterization by electrospray and MALDI-TOF mass spectrometry indicated no other chem. modifications than N-linked glycan chains and disulfide bonds, except minor oxidn.  The purity of the product was more than 98%, main impurities being IgG, IgA and hemopexin.  The product had intact iron binding capacity and native conformation.  A stable liq. formulation for the finished product was developed.  The product has proved safe and well tolerated in early clin. trials in iron binding therapy.  (c) 2001 The International Association of Biological Standardization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodrpZmf7RmJbVg90H21EOLACvtfcHk0lg0J0nohRQ-CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlsFyns7s%253D&md5=261cd593c924e385b27e566b52516e41</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1006%2Fbiol.2001.0273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbiol.2001.0273%26sid%3Dliteratum%253Aachs%26aulast%3DVon%2BBonsdorff%26aufirst%3DL.%26aulast%3DTolo%26aufirst%3DH.%26aulast%3DLindeberg%26aufirst%3DE.%26aulast%3DNyman%26aufirst%3DT.%26aulast%3DHarju%26aufirst%3DA.%26aulast%3DParkkinen%26aufirst%3DJ.%26atitle%3DDevelopment%2520of%2520a%2520pharmaceutical%2520apotransferrin%2520product%2520for%2520iron%2520binding%2520therapy%26jtitle%3DBiologicals%26date%3D2001%26volume%3D29%26spage%3D27%26epage%3D37%26doi%3D10.1006%2Fbiol.2001.0273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Bové, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Przedborski, S.</span><span> </span><span class="NLM_article-title">Toxin-induced models of Parkinson’s disease</span> <span class="citation_source-journal">NeuroRx</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">484</span><span class="NLM_x">–</span> <span class="NLM_lpage">494</span><span class="refDoi"> DOI: 10.1602/neurorx.2.3.484</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1602%2Fneurorx.2.3.484" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=484-494&author=J.+Bov%C3%A9author=D.+Prouauthor=C.+Perierauthor=S.+Przedborski&title=Toxin-induced+models+of+Parkinson%E2%80%99s+disease&doi=10.1602%2Fneurorx.2.3.484"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1602%2Fneurorx.2.3.484&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1602%252Fneurorx.2.3.484%26sid%3Dliteratum%253Aachs%26aulast%3DBov%25C3%25A9%26aufirst%3DJ.%26aulast%3DProu%26aufirst%3DD.%26aulast%3DPerier%26aufirst%3DC.%26aulast%3DPrzedborski%26aufirst%3DS.%26atitle%3DToxin-induced%2520models%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNeuroRx%26date%3D2005%26volume%3D2%26spage%3D484%26epage%3D494%26doi%3D10.1602%2Fneurorx.2.3.484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Smeyne, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson-Lewis, V.</span><span> </span><span class="NLM_article-title">The MPTP model of Parkinson’s disease</span> <span class="citation_source-journal">Mol. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">66</span><span class="refDoi"> DOI: 10.1016/j.molbrainres.2004.09.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1016%2Fj.molbrainres.2004.09.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=15790530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisFGmu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2005&pages=57-66&author=R.+J.+Smeyneauthor=V.+Jackson-Lewis&title=The+MPTP+model+of+Parkinson%E2%80%99s+disease&doi=10.1016%2Fj.molbrainres.2004.09.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">The MPTP model of Parkinson's disease</span></div><div class="casAuthors">Smeyne, Richard Jay; Jackson-Lewis, Vernice</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Brain Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-66</span>CODEN:
                <span class="NLM_cas:coden">MBREE4</span>;
        ISSN:<span class="NLM_cas:issn">0169-328X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The biochem. and cellular changes that occur following administration of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) are remarkably similar to that seen in idiopathic Parkinson's disease (PD).  In this review, we detail the mol. activities of this compd. from peripheral intoxication through its various biotransformations.  In addn., we detail the interplay that occurs between the different cellular compartments (neurons and glia) that eventually consort to kill substantia nigra pars compacta (SNpc) neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrE6gdfZbJXHLVg90H21EOLACvtfcHk0lg0J0nohRQ-CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisFGmu70%253D&md5=b89c5ca3ec56aea5bba5529bb86a8ea4</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.molbrainres.2004.09.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molbrainres.2004.09.017%26sid%3Dliteratum%253Aachs%26aulast%3DSmeyne%26aufirst%3DR.%2BJ.%26aulast%3DJackson-Lewis%26aufirst%3DV.%26atitle%3DThe%2520MPTP%2520model%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DMol.%2520Brain%2520Res.%26date%3D2005%26volume%3D134%26spage%3D57%26epage%3D66%26doi%3D10.1016%2Fj.molbrainres.2004.09.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Kuroiwa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araki, T.</span><span> </span><span class="NLM_article-title">Biochemical alterations of the striatum in an MPTP-treated mouse model of Parkinson’s disease</span> <span class="citation_source-journal">Metab. Brain Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">177</span><span class="NLM_x">–</span> <span class="NLM_lpage">183</span><span class="refDoi"> DOI: 10.1007/s11011-010-9195-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1007%2Fs11011-010-9195-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=20431930" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=1%3ACAS%3A280%3ADC%252BC3czpsFaqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2010&pages=177-183&author=H.+Kuroiwaauthor=H.+Yokoyamaauthor=H.+Kimotoauthor=H.+Katoauthor=T.+Araki&title=Biochemical+alterations+of+the+striatum+in+an+MPTP-treated+mouse+model+of+Parkinson%E2%80%99s+disease&doi=10.1007%2Fs11011-010-9195-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical alterations of the striatum in an MPTP-treated mouse model of Parkinson's disease</span></div><div class="casAuthors">Kuroiwa Hayato; Yokoyama Hironori; Kimoto Hiroki; Kato Hiroyuki; Araki Tsutomu</div><div class="citationInfo"><span class="NLM_cas:title">Metabolic brain disease</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">177-83</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">We investigated the biochemical alterations of the striatum of mice subjected to seven experimental schedules with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride (MPTP) treatment.  The mice were treated intraperitoneally (i.p.) with MPTP (20 mg/kg in saline) four times a day at 2-hr intervals showed severe and persistent depletions of dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) in the striatum, as compared with those (1) treated with MPTP (15 mg/kg in saline, i.p.) once a day for 14 consecutive days; (2)MPTP (30 mg/kg in saline, i.p.) twice a day for 5 consecutive days; (3) MPTP (10 mg/kg in saline, i.p.) four times a day at 1-hr intervals for 2 consecutive days; (4) MPTP (20 mg/kg in saline, i.p.) once a day for 4 consecutive days; (5) MPTP (20 mg/kg in saline, i.p.) twice a day for 2 consecutive days; (6) MPTP (20 mg/kg in saline, i.p.) twice a day for 4 consecutive days.  In our Western blot analysis, furthermore, the mice that received MPTP (20 mg/kg in saline) four times a day at 2-hr intervals showed a severe decrease of the striatal tyrosine hydroxylase (TH) protein levels and a significant increase of the striatal glial fibrillary acidic protein (GFAP) levels.  These results demonstrate that the model with acute MPTP treatment can cause severe neuronal damage in the mouse striatum, as compared to the model with continuous treatment with MPTP.  Thus our findings may support the validity of acute MPTP treatment model for unraveling in the neurodegenerative processes in PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQk1VQNiZGs08ERNNga7KD-fW6udTcc2ea5iJ1qZIF_rLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3czpsFaqtQ%253D%253D&md5=f4185a28a783039e1df56713da1d84ce</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1007%2Fs11011-010-9195-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11011-010-9195-9%26sid%3Dliteratum%253Aachs%26aulast%3DKuroiwa%26aufirst%3DH.%26aulast%3DYokoyama%26aufirst%3DH.%26aulast%3DKimoto%26aufirst%3DH.%26aulast%3DKato%26aufirst%3DH.%26aulast%3DAraki%26aufirst%3DT.%26atitle%3DBiochemical%2520alterations%2520of%2520the%2520striatum%2520in%2520an%2520MPTP-treated%2520mouse%2520model%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DMetab.%2520Brain%2520Dis.%26date%3D2010%26volume%3D25%26spage%3D177%26epage%3D183%26doi%3D10.1007%2Fs11011-010-9195-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Dehmer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heneka, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sastre, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dichgans, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, J. B.</span><span> </span><span class="NLM_article-title">Protection by pioglitazone in the MPTP model of Parkinson’s disease correlates with IkBα induction and block of NFKB and iNOS activation</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">494</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span><span class="refDoi"> DOI: 10.1046/j.1471-4159.2003.02210.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1046%2Fj.1471-4159.2003.02210.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=14690537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntlWjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2004&pages=494-501&author=T.+Dehmerauthor=M.+T.+Henekaauthor=M.+Sastreauthor=J.+Dichgansauthor=J.+B.+Schulz&title=Protection+by+pioglitazone+in+the+MPTP+model+of+Parkinson%E2%80%99s+disease+correlates+with+IkB%CE%B1+induction+and+block+of+NFKB+and+iNOS+activation&doi=10.1046%2Fj.1471-4159.2003.02210.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with IκBα induction and block of NFκB and iNOS activation</span></div><div class="casAuthors">Dehmer, Thomas; Heneka, Michael T.; Sastre, Magdalena; Dichgans, Johannes; Schulz, Joerg B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">494-501</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Inflammation has been implicated in the pathogenesis of Parkinson's disease (PD).  In the chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model of PD, inducible NO synthase (iNOS) derived nitric oxide (NO) is an important mediator of dopaminergic cell death.  Ligands of the peroxisome proliferator-activated receptor (PPAR) exert anti-inflammatory effects.  We here investigated whether pioglitazone, a PPARγ agonist, protected mice from MPTP-induced dopaminergic cell loss, glial activation, and loss of catecholamines in the striatum.  As shown by western blot, PPARγ was expressed in the striatum and the substantia nigra of vehicle- and MPTP-treated mice.  Oral administration of 20 mg/(kg day) of pioglitazone protected tyrosine hydroxylase (TH)-pos. substantia nigra neurons from death induced by 5×30 mg/kg MPTP.  However, the decrease of dopamine in the striatum was only partially prevented.  In mice treated with pioglitazone, there were a reduced activation of microglia, reduced induction of iNOS-pos. cells and less glial fibrillary acidic protein pos. cells in both striatum and substantia nigra pars compacta.  In addn., treatment with pioglitazone almost completely blocked staining of TH-pos. neurons for nitrotyrosine, a marker of NO-mediated cell damage.  Because an increase in inhibitory protein-κ-Bα (IκBα) expression and inhibition of translocation of the nuclear factor kappaB (NFκB) subunit p65 to the nucleus in dopaminergic neurons, glial cells and astrocytes correlated with the protective effects of pioglitazone, our results suggest that pioglitazone sequentially acts through PPARγ activation, IκBα induction, block of NFκB activation, iNOS induction and NO-mediated toxicity.  In conclusion, treatment with pioglitazone may offer a treatment opportunity in PD to slow the progression of disease that is mediated by inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnWWHNApdYerVg90H21EOLACvtfcHk0lj-H1kZKNoh2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntlWjug%253D%253D&md5=c95ad2e413d42738e73d25096a1aaff9</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2003.02210.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2003.02210.x%26sid%3Dliteratum%253Aachs%26aulast%3DDehmer%26aufirst%3DT.%26aulast%3DHeneka%26aufirst%3DM.%2BT.%26aulast%3DSastre%26aufirst%3DM.%26aulast%3DDichgans%26aufirst%3DJ.%26aulast%3DSchulz%26aufirst%3DJ.%2BB.%26atitle%3DProtection%2520by%2520pioglitazone%2520in%2520the%2520MPTP%2520model%2520of%2520Parkinson%25E2%2580%2599s%2520disease%2520correlates%2520with%2520IkB%25CE%25B1%2520induction%2520and%2520block%2520of%2520NFKB%2520and%2520iNOS%2520activation%26jtitle%3DJ.%2520Neurochem.%26date%3D2004%26volume%3D88%26spage%3D494%26epage%3D501%26doi%3D10.1046%2Fj.1471-4159.2003.02210.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Michel, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez-Fischer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerreiro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hild, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, E. C.</span><span> </span><span class="NLM_article-title">Role of activity-dependent mechanisms in the control of dopaminergic neuron survival</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">289</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span><span class="refDoi"> DOI: 10.1111/j.1471-4159.2006.04424.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1111%2Fj.1471-4159.2006.04424.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=17402966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltVKitr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2007&pages=289-297&author=P.+P.+Michelauthor=D.+Alvarez-Fischerauthor=S.+Guerreiroauthor=A.+Hildauthor=A.+Hartmannauthor=E.+C.+Hirsch&title=Role+of+activity-dependent+mechanisms+in+the+control+of+dopaminergic+neuron+survival&doi=10.1111%2Fj.1471-4159.2006.04424.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Role of activity-dependent mechanisms in the control of dopaminergic neuron survival</span></div><div class="casAuthors">Michel, Patrick P.; Alvarez-Fischer, Daniel; Guerreiro, Serge; Hild, Audrey; Hartmann, Andreas; Hirsch, Etienne C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">289-297</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Dopaminergic neurons that constitute the nigrostriatal pathway are characterized by singular elec. properties that allow them to discharge in vivo spontaneously in a spectrum of patterns ranging from pacemaker to random and bursting modes.  These electrophysiol. features allow dopaminergic neurons to optimize the release of dopamine in their terminal fields.  However, there is emerging evidence indicating that elec. activity might also participate in the control of dopaminergic neuron survival, not only during development, but also in the adult brain, thus raising the possibility that alterations in ionic currents could contribute actively to the demise of these neurons in Parkinson disease.  This review focuses on the mechanisms by which activity-dependent mechanisms might modulate dopaminergic cell survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz_cYB0Mi9K7Vg90H21EOLACvtfcHk0lj-H1kZKNoh2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltVKitr0%253D&md5=3a5ea28280a268d10dafe504443b8ea2</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.04424.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.04424.x%26sid%3Dliteratum%253Aachs%26aulast%3DMichel%26aufirst%3DP.%2BP.%26aulast%3DAlvarez-Fischer%26aufirst%3DD.%26aulast%3DGuerreiro%26aufirst%3DS.%26aulast%3DHild%26aufirst%3DA.%26aulast%3DHartmann%26aufirst%3DA.%26aulast%3DHirsch%26aufirst%3DE.%2BC.%26atitle%3DRole%2520of%2520activity-dependent%2520mechanisms%2520in%2520the%2520control%2520of%2520dopaminergic%2520neuron%2520survival%26jtitle%3DJ.%2520Neurochem.%26date%3D2007%26volume%3D101%26spage%3D289%26epage%3D297%26doi%3D10.1111%2Fj.1471-4159.2006.04424.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Traver, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marien, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michel, P. P.</span><span> </span><span class="NLM_article-title">The phenotypic differentiation of locus ceruleus noradrenergic neurons mediated by brain derived neurotrophic factor is enhanced by corticotropin releasing factor through the activation of a cAMP-dependent signaling pathway</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">30</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span><span class="refDoi"> DOI: 10.1124/mol.106.022715</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1124%2Fmol.106.022715" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=30-40&author=S.+Traverauthor=M.+Marienauthor=E.+Martinauthor=E.+C.+Hirschauthor=P.+P.+Michel&title=The+phenotypic+differentiation+of+locus+ceruleus+noradrenergic+neurons+mediated+by+brain+derived+neurotrophic+factor+is+enhanced+by+corticotropin+releasing+factor+through+the+activation+of+a+cAMP-dependent+signaling+pathway&doi=10.1124%2Fmol.106.022715"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1124%2Fmol.106.022715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.106.022715%26sid%3Dliteratum%253Aachs%26aulast%3DTraver%26aufirst%3DS.%26aulast%3DMarien%26aufirst%3DM.%26aulast%3DMartin%26aufirst%3DE.%26aulast%3DHirsch%26aufirst%3DE.%2BC.%26aulast%3DMichel%26aufirst%3DP.%2BP.%26atitle%3DThe%2520phenotypic%2520differentiation%2520of%2520locus%2520ceruleus%2520noradrenergic%2520neurons%2520mediated%2520by%2520brain%2520derived%2520neurotrophic%2520factor%2520is%2520enhanced%2520by%2520corticotropin%2520releasing%2520factor%2520through%2520the%2520activation%2520of%2520a%2520cAMP-dependent%2520signaling%2520pathway%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D70%26spage%3D30%26epage%3D40%26doi%3D10.1124%2Fmol.106.022715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Michel, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marien, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colpaert, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agid, Y.</span><span> </span><span class="NLM_article-title">Adenosine prevents the death of mesencephalic dopaminergic neurons by a mechanism that involves astrocytes</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">2074</span><span class="NLM_x">–</span> <span class="NLM_lpage">2082</span><span class="refDoi"> DOI: 10.1046/j.1471-4159.1999.0722074.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1046%2Fj.1471-4159.1999.0722074.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10217287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=1%3ACAS%3A528%3ADyaK1MXis12lt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1999&pages=2074-2082&author=P.+P.+Michelauthor=M.+Marienauthor=M.+Rubergauthor=F.+Colpaertauthor=Y.+Agid&title=Adenosine+prevents+the+death+of+mesencephalic+dopaminergic+neurons+by+a+mechanism+that+involves+astrocytes&doi=10.1046%2Fj.1471-4159.1999.0722074.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine prevents the death of mesencephalic dopaminergic neurons by a mechanism that involves astrocytes</span></div><div class="casAuthors">Michel, Patrick P.; Marien, Marc; Ruberg, Merle; Colpaert, Francis; Agid, Yves</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2074-2082</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The purinergic nucleoside adenosine effectively prevented the death of dopaminergic neurons that occurs spontaneously and progressively in cultures of rat mesencephalon.  Adenosine also significantly increased dopamine uptake, attesting to the state of differentiation and functional integrity of the neurons that were rescued.  The effects of adenosine were (a) specific to the dopaminergic neurons in these cultures, (b) long-lived, (c) still obsd. when the treatment was delayed after plating, (d) potentiated by inhibition of adenosine deaminase, and (e) abolished when this enzyme was added in excess to the culture medium.  The action of adenosine was mimicked by 5'-(N-ethylcarboxamido)adenosine and dibutyryl-cAMP, but not by CGS-21680, suggesting the possible involvement of A2B subtype purinergic receptors.  ATP was also neuroprotective, but its action resulted principally from conversion to adenosine by ectonucleotidases.  Several anticancer drugs, including cytosine arabinoside, have been shown previously to prevent apoptosis in cultured dopaminergic neurons by a mechanism that requires the inhibition of proliferating astrocytes.  In the presence of adenosine, astrocytes were more differentiated, and their proliferation rate was significantly reduced, suggesting that the neurotrophic effect of the adenine nucleoside resulted also from the repression of the astroglial cells.  The authors did not find evidence of a trophic intermediary in adenosine-treated cultures, however, leading to the hypothesis that limitation of astrocyte replication in itself and/or ensuing changes in the glial phenotype were crucial.  The authors' results suggest that mols. that modulate adenine nucleotide/nucleoside release may be useful for the treatment of chronic neurodegenerative conditions affecting dopaminergic neurons, such as Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoka4zRCdtAiLVg90H21EOLACvtfcHk0liTFFYrt744_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXis12lt7c%253D&md5=88526bb957f28033481b0619f0e64709</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.1999.0722074.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.1999.0722074.x%26sid%3Dliteratum%253Aachs%26aulast%3DMichel%26aufirst%3DP.%2BP.%26aulast%3DMarien%26aufirst%3DM.%26aulast%3DRuberg%26aufirst%3DM.%26aulast%3DColpaert%26aufirst%3DF.%26aulast%3DAgid%26aufirst%3DY.%26atitle%3DAdenosine%2520prevents%2520the%2520death%2520of%2520mesencephalic%2520dopaminergic%2520neurons%2520by%2520a%2520mechanism%2520that%2520involves%2520astrocytes%26jtitle%3DJ.%2520Neurochem.%26date%3D1999%26volume%3D72%26spage%3D2074%26epage%3D2082%26doi%3D10.1046%2Fj.1471-4159.1999.0722074.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Rougé-Pont, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrous, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Moal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piazza, P. V.</span><span> </span><span class="NLM_article-title">Release of endogenous dopamine in cultured mesencephalic neurons: influence of dopaminergic agonists and glucocorticoid antagonists</span> <span class="citation_source-journal">Eur. J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">2343</span><span class="NLM_x">–</span> <span class="NLM_lpage">2350</span><span class="refDoi"> DOI: 10.1046/j.1460-9568.1999.00650.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1046%2Fj.1460-9568.1999.00650.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10383623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=1%3ACAS%3A280%3ADyaK1MzhsFektw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1999&pages=2343-2350&author=F.+Roug%C3%A9-Pontauthor=D.+N.+Abrousauthor=M.+Le+Moalauthor=P.+V.+Piazza&title=Release+of+endogenous+dopamine+in+cultured+mesencephalic+neurons%3A+influence+of+dopaminergic+agonists+and+glucocorticoid+antagonists&doi=10.1046%2Fj.1460-9568.1999.00650.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Release of endogenous dopamine in cultured mesencephalic neurons: influence of dopaminergic agonists and glucocorticoid antagonists</span></div><div class="casAuthors">Rouge-Pont F; Abrous D N; Le Moal M; Piazza P V</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2343-50</span>
        ISSN:<span class="NLM_cas:issn">0953-816X</span>.
    </div><div class="casAbstract">Several electrochemical techniques allow the measurement of dopamine release in freely moving animals and brain slices.  In this report, we applied one of these techniques, coulometry, coupled to high-performance liquid chromatography (HPLC), to the study of dopamine release in primary cultures of embryonic mesencephalic dopaminergic neurons.  Between day 9 and 33 of culture, concentrations of dopamine, above the detection threshold, were found in the incubation buffer (Krebs ringer buffer, KRB).  Concentrations of dopamine in the incubation buffer reflected neuronal release as they were: (i) positively correlated with the number of tyrosine hydroxylase-positive dopamine neurons in the culture; (ii) tetrodotoxin (TTX) sensitive and Ca2+ dependent; (iii) increased by a depolarizing stimulus, e.g.  K+ (20 mM), or by the indirect dopamine agonists amphetamine and cocaine; (iv) decreased by a hyperpolarizing stimulus, e.g. the dopamine D2-like receptor agonist quinpirole.  Dopamine release in this model was also sensitive to the manipulation of glucocorticoids, potent modulators of dopamine release in vivo.  Long-term treatment of the cell cultures with RU 39305, a selective antagonist of glucocorticoid receptors (GR), but not with spironolactone, a selective antagonist of mineralocorticoid receptors (MR), dose-dependently decreased K+-stimulated dopamine release.  In conclusion, these results demonstrate an in vitro model that allows the studying of the release of endogenous dopamine in cell cultures and the effects of glucocorticoid hormones on the release dynamics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS1x0cofaq7d0PI-fCgwosgfW6udTcc2eac9gaXhEy2Dbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1MzhsFektw%253D%253D&md5=1452426e00e276d8ff3d55702d3e711f</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1046%2Fj.1460-9568.1999.00650.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1460-9568.1999.00650.x%26sid%3Dliteratum%253Aachs%26aulast%3DRoug%25C3%25A9-Pont%26aufirst%3DF.%26aulast%3DAbrous%26aufirst%3DD.%2BN.%26aulast%3DLe%2BMoal%26aufirst%3DM.%26aulast%3DPiazza%26aufirst%3DP.%2BV.%26atitle%3DRelease%2520of%2520endogenous%2520dopamine%2520in%2520cultured%2520mesencephalic%2520neurons%253A%2520influence%2520of%2520dopaminergic%2520agonists%2520and%2520glucocorticoid%2520antagonists%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D1999%26volume%3D11%26spage%3D2343%26epage%3D2350%26doi%3D10.1046%2Fj.1460-9568.1999.00650.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Douhou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debeir, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murer, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dufour, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanchard, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moussaoui, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohme, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agid, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raisman-Vozari, R.</span><span> </span><span class="NLM_article-title">Effect of chronic treatment with riluzole on the nigrostriatal dopaminergic system in weaver mutant mice</span> <span class="citation_source-journal">Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">176</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">–</span> <span class="NLM_lpage">253</span><span class="refDoi"> DOI: 10.1006/exnr.2002.7935</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1006%2Fexnr.2002.7935" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=12093102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=1%3ACAS%3A528%3ADC%252BD38XkvFKrs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2002&pages=247-253&author=A.+Douhouauthor=T.+Debeirauthor=M.+G.+Murerauthor=L.+Doauthor=N.+Dufourauthor=V.+Blanchardauthor=S.+Moussaouiauthor=G.+A.+Bohmeauthor=Y.+Agidauthor=R.+Raisman-Vozari&title=Effect+of+chronic+treatment+with+riluzole+on+the+nigrostriatal+dopaminergic+system+in+weaver+mutant+mice&doi=10.1006%2Fexnr.2002.7935"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of Chronic Treatment with Riluzole on the Nigrostriatal Dopaminergic System in Weaver Mutant Mice</span></div><div class="casAuthors">Douhou, Aicha; Debeir, Thomas; Murer, Mario Gustavo; Do, Louis; Dufour, Noelle; Blanchard, Veronique; Moussaoui, Saliha; Bohme, Georg Andrees; Agid, Yves; Raisman-Vozari, Rita</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">247-253</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">The effects of a chronic treatment with the anti-glutamate and sodium channel modulating neuroprotective agent riluzole on the degeneration of dopamine-contg. neurons were studied in the brain of weaver mutant mice.  In these animals, as in Parkinson's disease, dopaminergic neurons of the nigro-striatal pathway undergo spontaneous and progressive cell death.  Homozygous weaver mice were orally treated twice a day with either 8 mg/kg riluzole or placebo for 2 mo.  Quantification of tyrosine-hydroxylase and dopamine-transporter axonal immunostaining in the striatum revealed that riluzole significantly increased the d. of striatal dopaminergic nerve terminals.  These results suggest that riluzole protects dopaminergic processes in the weaver mice and/or promotes their neuroplasticity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA720pf2gBC7Vg90H21EOLACvtfcHk0liTFFYrt744_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkvFKrs74%253D&md5=d87e43c23e7d0ebb91c4ef69319afdb2</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1006%2Fexnr.2002.7935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fexnr.2002.7935%26sid%3Dliteratum%253Aachs%26aulast%3DDouhou%26aufirst%3DA.%26aulast%3DDebeir%26aufirst%3DT.%26aulast%3DMurer%26aufirst%3DM.%2BG.%26aulast%3DDo%26aufirst%3DL.%26aulast%3DDufour%26aufirst%3DN.%26aulast%3DBlanchard%26aufirst%3DV.%26aulast%3DMoussaoui%26aufirst%3DS.%26aulast%3DBohme%26aufirst%3DG.%2BA.%26aulast%3DAgid%26aufirst%3DY.%26aulast%3DRaisman-Vozari%26aufirst%3DR.%26atitle%3DEffect%2520of%2520chronic%2520treatment%2520with%2520riluzole%2520on%2520the%2520nigrostriatal%2520dopaminergic%2520system%2520in%2520weaver%2520mutant%2520mice%26jtitle%3DExp.%2520Neurol.%26date%3D2002%26volume%3D176%26spage%3D247%26epage%3D253%26doi%3D10.1006%2Fexnr.2002.7935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Höglinger, G. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrard, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michel, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medja, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombès, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friguet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, E. C.</span><span> </span><span class="NLM_article-title">Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson’s disease</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">1297</span><span class="NLM_x">–</span> <span class="NLM_lpage">1307</span><span class="refDoi"> DOI: 10.1046/j.1471-4159.2003.01952.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1046%2Fj.1471-4159.2003.01952.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=12911637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=1%3ACAS%3A280%3ADC%252BD3sznslGltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2003&pages=1297-1307&author=G.+U.+H%C3%B6glingerauthor=G.+Carrardauthor=P.+P.+Michelauthor=F.+Medjaauthor=A.+Lomb%C3%A8sauthor=M.+Rubergauthor=B.+Friguetauthor=E.+C.+Hirsch&title=Dysfunction+of+mitochondrial+complex+I+and+the+proteasome%3A+interactions+between+two+biochemical+deficits+in+a+cellular+model+of+Parkinson%E2%80%99s+disease&doi=10.1046%2Fj.1471-4159.2003.01952.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson's disease</span></div><div class="casAuthors">Hoglinger Gunter U; Carrard Geraldine; Michel Patrick P; Medja Fadia; Lombes Anne; Ruberg Merle; Friguet Bertrand; Hirsch Etienne C</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurochemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1297-307</span>
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    </div><div class="casAbstract">Two biochemical deficits have been described in the substantia nigra in Parkinson's disease, decreased activity of mitochondrial complex I and reduced proteasomal activity.  We analysed interactions between these deficits in primary mesencephalic cultures.  Proteasome inhibitors (epoxomicin, MG132) exacerbated the toxicity of complex I inhibitors [rotenone, 1-methyl-4-phenylpyridinium (MPP+)] and of the toxic dopamine analogue 6-hydroxydopamine, but not of inhibitors of mitochondrial complex II-V or excitotoxins [N-methyl-d-aspartate (NMDA), kainate].  Rotenone and MPP+ increased free radicals and reduced proteasomal activity via adenosine triphosphate (ATP) depletion. 6-hydroxydopamine also increased free radicals, but did not affect ATP levels and increased proteasomal activity, presumably in response to oxidative damage.  Proteasome inhibition potentiated the toxicity of rotenone, MPP+ and 6-hydroxydopamine at concentrations at which they increased free radical levels >/= 40% above baseline, exceeding the cellular capacity to detoxify oxidized proteins reduced by proteasome inhibition, and also exacerbated ATP depletion caused by complex I inhibition.  Consistently, both free radical scavenging and stimulation of ATP production by glucose supplementation protected against the synergistic toxicity.  In summary, proteasome inhibition increases neuronal vulnerability to normally subtoxic levels of free radicals and amplifies energy depletion following complex I inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ_GDPXA9Djz825P7XSLhESfW6udTcc2eb6VLDy1BlvoLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3sznslGltw%253D%253D&md5=31bfe804be13eb54a57f6e4374e56d6d</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2003.01952.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2003.01952.x%26sid%3Dliteratum%253Aachs%26aulast%3DH%25C3%25B6glinger%26aufirst%3DG.%2BU.%26aulast%3DCarrard%26aufirst%3DG.%26aulast%3DMichel%26aufirst%3DP.%2BP.%26aulast%3DMedja%26aufirst%3DF.%26aulast%3DLomb%25C3%25A8s%26aufirst%3DA.%26aulast%3DRuberg%26aufirst%3DM.%26aulast%3DFriguet%26aufirst%3DB.%26aulast%3DHirsch%26aufirst%3DE.%2BC.%26atitle%3DDysfunction%2520of%2520mitochondrial%2520complex%2520I%2520and%2520the%2520proteasome%253A%2520interactions%2520between%2520two%2520biochemical%2520deficits%2520in%2520a%2520cellular%2520model%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurochem.%26date%3D2003%26volume%3D86%26spage%3D1297%26epage%3D1307%26doi%3D10.1046%2Fj.1471-4159.2003.01952.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Scorza, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silveira, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zapata-Torres, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassels, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reyes-Parada, M.</span><span> </span><span class="NLM_article-title">Monoamine oxidase inhibitory properties of some methoxylated and alkylthioamphetamine derivatives: structure-activity relationships</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1361</span><span class="NLM_x">–</span> <span class="NLM_lpage">1369</span><span class="refDoi"> DOI: 10.1016/S0006-2952(97)00405-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;key=10.1016%2FS0006-2952%2897%2900405-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1997&pages=1361-1369&author=M.+C.+Scorzaauthor=C.+Carrauauthor=R.+Silveiraauthor=G.+Zapata-Torresauthor=B.+K.+Casselsauthor=M.+Reyes-Parada&title=Monoamine+oxidase+inhibitory+properties+of+some+methoxylated+and+alkylthioamphetamine+derivatives%3A+structure-activity+relationships&doi=10.1016%2FS0006-2952%2897%2900405-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2FS0006-2952%2897%2900405-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-2952%252897%252900405-X%26sid%3Dliteratum%253Aachs%26aulast%3DScorza%26aufirst%3DM.%2BC.%26aulast%3DCarrau%26aufirst%3DC.%26aulast%3DSilveira%26aufirst%3DR.%26aulast%3DZapata-Torres%26aufirst%3DG.%26aulast%3DCassels%26aufirst%3DB.%2BK.%26aulast%3DReyes-Parada%26aufirst%3DM.%26atitle%3DMonoamine%2520oxidase%2520inhibitory%2520properties%2520of%2520some%2520methoxylated%2520and%2520alkylthioamphetamine%2520derivatives%253A%2520structure-activity%2520relationships%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1997%26volume%3D54%26spage%3D1361%26epage%3D1369%26doi%3D10.1016%2FS0006-2952%2897%2900405-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i86"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00297">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_82688"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b00297">10.1021/acs.jmedchem.6b00297</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings and the associated biological data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00297/suppl_file/jm6b00297_si_001.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00297/suppl_file/jm6b00297_si_001.csv">jm6b00297_si_001.csv (2.89 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b00297&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-13%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b00297%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b00297" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67994698e8bc123e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
